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Abstract 
 
Imprinted loci are critical in foetal development and most are regulated by the 
methylation-specific CTCF binding protein which binds imprinting control regions 
(ICRs). The ICR is located between two genes that comprise imprinted loci, which are 
reciprocally expressed in a parent-of-origin specific manner. Maternally 
hypomethylated ICRs allow CTCF binding, creating a boundary element which 
prevents downstream enhancers from acting on the paternally expressed gene 
upstream of the ICR. Conversely, the hypermethylated (imprinted) paternal ICR 
prevents CTCF binding, allowing downstream enhancers to act on the gene upstream 
of the ICR, while suppressing the downstream maternally expressed gene. Alcohol 
and its metabolites are able to reach the testes via the blood supply and are known 
to reduce global DNA methylation by disrupting the folate, methyl group and 
homocysteine pathway. This may therefore affect gene expression at imprinted loci, 
whose parental alleles are discriminated by the imprinting status at the ICR.  
 
The effect of pre-conception paternal alcohol exposure on the DNA methylation of 
three paternally imprinted ICRs (H19, Rasgrf1, IG-DMR) as well as the maternally 
imprinted Snrpn ICR was examined in mouse sperm and their offspring. Male mice 
were gavaged with ethanol or sucrose. DNA was extracted from sperm of treated 
males and tail biopsies from offspring. Samples were bisulphite modified and the ICRs 
PCR amplified. DNA methylation patterns of ICRs were analysed by sequencing and 
quantitatively via pyrosequencing. Sperm samples of ethanol treated males did not 
show significant demethylation when compared to sucrose treated mice, with the 
exception of H19 CpG 7, Rasgrf1 CpG 26 and Snrpn CpG 10 (p=0.024, 0.014 and 
  VI
0.002, respectively). However, a significant reduction in DNA methylation at the H19 
CTCF 1 (p=0.0017) and CTCF 2 (p=0.0007) binding sites in the offspring of ethanol 
treated sires was observed. A lower growth rate trend was observed in female and 
male offspring sired by ethanol treated males. At days 35 and 42 (p<0.05), offspring 
sired by ethanol treated males had a significantly lower weight than controls. These 
data suggest that excessive paternal exposure to ethanol prior to conception has the 
ability to negatively influence the epigenetic state of developmentally significant 
imprinted genes in offspring. Decreased DNA methylation profiles of the H19 CTCF1 
and CTCF 2 regions in the offspring of ethanol treated sires were significantly 
correlated with reduced postnatal growth at days 35 and 42 (p<0.05). Furthermore, 
the effect of treatment (ethanol) on growth (retardation) was shown to be mediated 
to a limited extent through (a decrease in) DNA methylation in offspring.  
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Chapter 1 
1. Introduction 
 
1.1. In High Spirits – Foetal Alcohol Spectrum Disorder 
 
1.1.1. In the beginning 
 
The angel of the Lord suddenly appeared to Manoah’s childless wife and 
proclaimed, “Behold now, thou art barren, and barest not: but thou shalt 
conceive, and bear a son. Now therefore beware, I pray thee, and drink not 
wine nor strong drink…” (Judges, 13: 3 – 4). This passage taken from Judges 
tells the story of the conception of the legendary hero, Samson, and accounts 
for one of the earliest Biblical references to the connection between alcohol 
consumption and adverse effects on foetal outcome (Abel, 1997). This 
connection has also been traced as far back as the Greek philosopher, 
Aristotle, who wrote “Foolish, drunken, and harebrained women, most often 
bring forth children like unto themselves, morose and languid” (Abel, 1990). 
In fact, these are just two of many early references that indicate that although 
historically the connection between prenatal alcohol consumption and 
subsequent developmental abnormalities was not completely understood, the 
link between the two was indeed noted. 
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Recently, a closer inspection was taken by the medical profession into the 
effects of alcohol exposure to unborn children. During the early 18th century 
the price of gin dropped dramatically in England, resulting in levels of 
consumption soaring to 11 million gallons in 1750 (Abel and Bilitzke, 1990). 
The gin epidemic was rife and concerns mounted regarding the negative 
impacts of such intake on exposed foetuses (Friedler, 1996). This prompted 
the College of Physicians to draft a letter to parliament stating that “the fatal 
effects of the frequent use of several sorts of distilled spirituous liquors upon 
great numbers of both sexes rendering them diseased, not fit for business, 
poor, a burthen to themselves and neighbours and too often the cause of 
weak, feeble, and distempered children” (Abel, 1990). 
 
Recognition of the adverse effects of alcohol on offspring development began 
to peak in the mid 1900s, with a number of publications describing some 
characteristics of children born of alcoholics  (Lemoine et al., 1968). However, 
it was not until 1973 that the full spectrum of developmental defects 
associated with in utero alcohol exposure was explored in individuals who 
were severely affected by maternal alcohol abuse, and the term “foetal 
alcohol syndrome” (FAS) was coined (Jones et al., 1973). These findings by 
Jones and Smith were important in emphasizing the teratogenic properties of 
alcohol, and provoked much investigation into its effect on the developing 
human body (Sulik et al., 1981). 
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1.1.2. Foetal alcohol syndrome 
 
Prolonged levels of maternal alcohol exposure during pregnancy have been 
implicated in a range of unfavourable foetal outcomes, collectively known as 
Foetal Alcohol Spectrum Disorder or FASD (Burd et al., 2003), with the most 
severe of these outcomes being Foetal Alcohol Syndrome (FAS). FAS can 
manifest variably resulting in diverse combinations of craniofacial, growth 
and neurobehavioral abnormalities associated with a multitude of symptoms 
and psycho-social problems. These include attention deficit-hyperactivity 
disorder (ADHD), learning disabilities, behavioural disorders (Burd et al., 
2003), facial dysmorphia, reduced body growth and central nervous system 
abnormalities, of which mental retardation is the most prevalent (O'Leary, 
2004). The quintessential characteristics of FAS which all diagnoses are based 
upon are prenatal and postnatal growth retardation, mental disability and the 
distinct craniofacial abnormalities, which include a thin upper lip, smooth 
filtrum and a flat nasal bridge.     
    
The Centre for Disease Control has reported prevalence rates of 0.2 to 1.5 
cases per 1000 live births in the United States (Cordero et al., 2004). Roughly 
15% of American women of childbearing age are regarded as moderate to 
heavy drinkers, and nearly 2% to 3% are at risk of dangerously exposing 
their unborn child to the adverse effects of alcohol (Cordero et al., 2004). 
While an average FAS rate of 0.97 per 1000 children has been reported 
globally, a staggering rate of 65.2 - 89.2 per 1000 children – the highest 
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world-wide – has been reported in the Western Cape, South Africa (May et 
al., 2000; Viljoen et al., 2005; May et al., 2007). This statistic emphasizes the 
importance, if not the necessity of foetal alcohol related research, especially 
in South Africa. 
 
Although FAS research has been primarily focused on maternal drinking 
during pregnancy, it is surprising to note that there is substantial and 
compelling evidence of a paternal contribution. As early as 1621, Gellius in 
the Anatomy of Melancholy noted that “if a drunken man get a child, it will 
never likely have a good brain” (Friedler, 1996), that is, it was observed that 
children of alcoholic men had “weak” brains. It is of significant interest to 
note that even before the potential adverse effects of excessive paternal 
alcohol consumption were formally acknowledged, in 1911, Forel cites an 
account by Schweighofer where a woman marries a man, who both do not 
abuse alcohol, and have three children of good health. The man dies and the 
woman re-marries a drunkard. She bares more three children: one became a 
drunkard; another had “infantilism”; and the third was a social degenerate 
and a drunk. Two of these children also had tuberculosis, which hadn’t been 
seen in the family. The woman then marries a third time to a sober man, and 
produces children of good health once again.  
 
Research on the influence of alcohol on mammalian offspring began in 1888, 
where Mairet and Cambemale (Stockard, 1913) treated a dog with absinthe, 
which was mated with a normal bitch. She gave birth to twelve pups – two 
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were still-born, three died after 14 days, and the rest died later due to 
intestinal complications and tuberculosis. In 1916 Charles Stockard, later 
joined by George Papanicolaou, made some fascinating observations about 
the transmission of deformities in descendents of alcoholised male guinea 
pigs (Stockard and Papanicolaou, 1916a). For over seven years their research 
tracked the development of offspring sired by males exposed to alcohol 
fumes through successive generations. They noted that the effect of alcohol 
on the male was of such a nature that an exposed male almost invariably 
“begets defective offspring even when mated with a vigorous normal 
female” (Stockard and Papanicolaou, 1916a). These defects primarily 
involved the central nervous system and special sense organs, including 
opaque lenses and cornea of the eye, and in some cases even complete 
absence of eyes. Other abnormalities included low birth weights and limb 
deformities. Subsequently, experimentation and reports in the 1970s exposed 
the adverse effects of not only maternal, but paternal alcohol consumption 
on their offspring (Sulik et al., 1981).  
 
The potential contribution of the father to FASD aetiology has remained of 
interest to researchers and is receiving increased attention. Lemoine et al. 
(1968) reported the first case of infants born with characteristic FASD 
symptoms to mothers who had not consumed alcohol during pregnancy, but 
whose fathers were alcoholics (Lemoine et al., 1968). It was later noted that 
75% of children with FAS had biological fathers who were heavy drinkers or 
alcoholics (Abel et al., 1983). This evidence opened the prospect that a 
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number of FAS cases attributed to maternal alcohol abuse during pregnancy 
may have in fact been a result or partly due to excessive paternal drinking 
(Abel, 2004). The possibility of paternal preconception alcohol abuse on 
foetal development prompted further investigation, and studies using rat 
models found evidence that paternal exposure to alcohol had significant 
effects on the neurobehaviour of subsequent offspring (Jamerson et al., 
2004). Others have reported congenital malformations, low birth weights, 
growth retardation and neonatal mortality associated with preconception 
paternal alcohol intake (Friedler, 1996), providing convincing evidence for the 
potential for paternally mediated foetal alcohol effects. 
 
1.2. Paternally conceivable 
 
The link between paternal consumption of alcohol and subsequent alcohol-
related phenotypic effects in offspring is supported in the literature, but how 
can one provide a plausible explanation for these effects? After all, the alcohol 
consumed during paternal drinking cannot come into direct contact with a 
developing foetus, as is credible in the case of maternal alcohol intake during 
pregnancy. In order to begin to grasp the concept of paternal alcohol effects 
on sired offspring, we need to focus on the very essence of foetal alcohol 
syndrome… the alcohol itself. 
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1.2.1. The biological effects of alcohol 
 
Alcohol is a well known teratogen and able to cause developmental 
abnormalities in the foetus (Randall, 1987; Randall et al., 1994; Boehm et al., 
1997; Ogawa et al., 2005; Camarillo and Miranda, 2008). These teratogenic 
effects have been studied in both humans and in animal models. As described 
previously, researchers have shown that foetal exposure to excessive levels of 
alcohol can result in a wide variety of neurobehavioural deficits, primary of 
which include central nervous system dysfunction, growth deficiencies and 
distinct facial anomalies, with varying degrees of severity. But mechanistically, 
how is alcohol able to induce these effects? 
 
Many mechanisms have been proposed in an attempt to explain the 
teratogenic effects of alcohol on the developing foetus. In addition to the fact 
that alcohol itself has the ability to act as a direct cytotoxic agent (De Vito et 
al., 2000), the metabolic products that arise from its subsequent breakdown in 
the body play a significant role in alcohol’s deleterious effects (Poggi et al., 
2003; Fernandez-Checa, 2003). This therefore highlights the fact that there is 
no single mechanism that accounts for the range and extent of phenotypes 
evident in children born with foetal alcohol effects as a result of being exposed 
to significantly high levels of alcohol. As the focus of this research is on 
paternal effects of excessive alcohol intake, the direct effects of this teratogen 
on the developing foetus will not be discussed further, but the emphasis will 
be on the metabolic aspects of alcohol and its potential effect on male 
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gametogenesis. 
 
1.2.2. The Effects of Alcohol Metabolism 
 
Recent reviews (Halsted et al., 2002b; Schalinske and Nieman, 2005) have 
shown that the metabolism of alcohol and the interplay of its metabolites on 
the folate, methionine and homocysteine pathways. The metabolism of these 
three compounds is intricately connected and is vital for the maintenance of 
optimal health (Wagner, 1995). It has been shown that folate deficiency is a 
common clinical sign of chronic alcohol abuse and has been implicated in the 
development of alcoholism-related complications, such as alcoholic liver 
disease (Eichner et al., 1971). Researchers have also found that disruption of 
this pathway has been associated with various disorders including, among 
others, birth defects and neurological abnormalities (Boyles et al., 2006).  
 
To understand the biological importance and therefore pathologies associated 
with disrupted folate, methionine and homocysteine metabolism, a closer 
inspection of these processes needs to be considered. As a coenzyme, folate is 
required to supply methyl groups for S-adenosylmethionine (SAM)-dependent 
transmethylation reactions. In the folate-dependent pathway, the B12-
dependent enzyme methionine synthase (MS) is responsible for transferring 
the methyl group contained within the 5-methyl-tetrahyrofolate compound to 
homocysteine (Figure 1.1), which ultimately generates methionine (Friso et al., 
2002). This is followed by the conversion of methionine to SAM by methionine 
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adenosyltransferase (MAT), which is used for the methylation of DNA. As an 
essential amino acid, methionine produced via both folate-dependent and 
folate-independent pathways, provides the necessary methyl groups for 
biological DNA methylation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Folate, methyl group and homocysteine metabolism. BHMT = betaine 
homocysteine S-methyltransferase; CBS = cystathionine ß-synthase; GNMT = glycine N-
methyltransferase; MAT = methionine adenosyltransferase; MS = methionine synthase; 
MTHFR = 5,10-methylenetetrahyrofolate reductase; SAM = S-adenosylmethionine; SAH = S-
adenosylhomocysteine; SAHH = SAH hydrolase; THF = tetrahydrofalate (Schalinske and 
Nieman, 2005). 
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As early as 1974, research on alcohol-fed rats described reduced MS activity 
and subsequent reduction of the by-products methionine and SAM 
(Finkelstein, 1974; Barak et al., 1987; Trimble et al., 1993). It has also been 
shown that ethanol appears to enhance the catabolism and loss of methyl 
groups, which in turn disrupts subsequent SAM-dependent transmethylation 
reactions (Schalinske and Nieman, 2005). Cancer related research has 
demonstrated that perturbations to these reactions are known to result in 
hypomethylation of hepatic DNA (Wilson et al., 1984; Bhave et al., 1988; 
Wainfan et al., 1989; Pogribny et al., 2006)  
 
These findings suggest that alcohol has a direct negative effect on the folate 
pathway, but how does it exert this effect? The answer lies in the liver.    
 
1.2.3. Destructive Free Radicals 
 
Folate and methionine metabolism occur in the liver and coincidentally, so 
does that of alcohol. Although the means by which alcohol is able to alter 
SAM levels, is not yet clear, several pathways have been proposed. According 
to the hypothesis by Trimble and colleagues (Trimble et al., 1993), alcohol 
metabolism results in a catabolic pathway whereby homocysteine is degraded 
in order to replenish glutathione levels. They suggest that the oxidation of 
alcohol to acetylaldehyde is accompanied by the release of free radicals, which 
stimulates the cell to redirect homocysteine to a catabolic pathway to 
replenish glutathione, thereby diminishing SAM (Figure 1.1 and Figure 1.2). 
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Alternatively, it has been suggested that the increase in reactive-oxygen 
species (ROS) produced by the oxidation of acetylaldehyde to acetate leads to 
the production of superoxide. The superoxide free radical is then able to 
interact with carbohydrates, proteins, lipids, and nucleic acids, which in turn 
can lead to damage of biomacromolecules involved in the folate pathway 
(Goodlett et al., 2005). Despite the controversies around the exact mechanism, 
it is unanimously agreed that it is the by-products of alcohol metabolism that 
result in the adverse effects on methionine production, whereby the 
concurrent events of both folate and alcohol metabolism within the liver allow 
for the action of free radicals to exert a destructive effect on the folate 
pathway.  
 
 
 
 
 
 
 
 
 
 
   
Figure 1.2: Alcohol metabolism. The metabolism of alcohol results in the production of 
acetylaldehyde, oxygen (free) radicals and hydroxyethyl radicals (www.niaaa.nih.gov). 
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1.2.4. The Free Radical Theory of Development 
 
The free radical theory of development was first conceptualized between 1985 
– 1986 (Sohal and Allen, 1985; Sohal et al., 1986a; Sohal et al., 1986b), and 
hypothesized a role of oxygen free radicals in cellular differentiation. 
Subsequently, in 1989 Allen and Balin developed this hypothesis further and 
formalized the free radical theory of development (Allen and Balin, 1989). The 
central premise of this theory states that “changes in oxygen gradients and an 
alteration in the balance between the formation and the removal of 
metabolically generated oxidants can elicit developmental events” which form 
complex tissues and organ systems (Hitchler and Domann, 2007). They went 
on to suggest that altered gene expression during development can be 
mediated through oxygen gradients and an altered redox state in cells. 
 
In 2007, Hitchler and Domann provided insight into how the redox status of a 
cell could possibly influence development by affecting the production of SAM, 
the cofactor responsible for DNA (and histone) methylation reactions. Central 
to the free radical theory of development is that in order for cells to 
differentiate, the redox potential of a cell must change from a reducing to an 
oxidizing state (Hitchler and Domann, 2007). Glutathione (GSH) is a naturally 
occurring antioxidant found in plants and animals and serves to protect cells 
against harmful oxidizing agents, and thereby ensures the proper functioning 
of various proteins. Thus, if overproduced, GSH is able to inhibit the 
conversion of an oxidative redox state to a reduced state during cellular 
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differentiation and thereby impeding development.  
 
In mammals, elevated levels of GSH production are required during critical 
points in development. These include periods during gametogenesis, after 
fertilization and the interval between fertilization and blastogenesis  (Hitchler 
and Domann, 2007). These increased levels of GSH are required to protect the 
developing embryo from oxidative stress. However, the metabolic cycles of 
GSH and SAM are connected (Figure 1.1). Homocysteine is commonly recycled 
in the methionine pathway where it is converted back into methionine via MS. 
Thus, when increased GSH is required during times of oxidative stress or 
during development, homocysteine’s entry into the transsulfuration pathway is 
favoured, producing GSH (Hitchler and Domann, 2007). This in turn would 
dramatically decrease the level of SAM, and as SAM is pivotal in 
transmethylation reactions, genome-wide DNA hypomethylation occurs 
(Lertratanangkoon et al., 1996; Lertratanangkoon et al., 1997a; 
Lertratanangkoon et al., 1997b).  
 
1.2.5. An integrated model of alcohol metabolism and 
the free radical theory of development 
 
As described previously, alcohol is a well studied teratogen, and one of the 
means by which it can exert these effects is via its metabolism in the body. 
These metabolites have been shown to directly interfere with the folate 
pathway, which is essential for providing the methionine required for 
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transmethylation reactions. The means by which alcohol metabolism achieves 
this is through the release of free radicals. This idea has been supported by the 
free radical theory of development whereby the folate/methionine pathway is 
redirected to produce GSH instead of SAM (the methionine group donor) in 
order to counteract the oxidative stress brought on by free radicals. This 
therefore significantly reduces the methionine available for methylation, 
causing wide-spread DNA hypomethylation. 
 
This has been supported by Garro et al. (1991) who highlighted the concept 
of the indirect effect of alcohol on a developing organism through disruption 
of the cellular environment. They found that maternal ingestion of alcohol 
during pregnancy inhibited foetal DNA methylation in mice. Since DNA 
methylation plays an important role in the regulation of gene expression 
during embryogenesis, ethanol-associated alterations in fetal DNA methylation 
may contribute to the developmental abnormalities seen in FAS. Thus, when 
considering the potential effects of excessive paternal alcohol consumption on 
offspring outcome, it is clear that paternal ingestion of alcohol prior to 
conception cannot exert a direct effect on sired progeny. Instead, the indirect 
action of alcohol’s metabolites on vital transmethylation pathways that guide 
DNA methylation must be investigated.  
 
1.3. The slippery slope of development 
 
If every cell in our body contains the same genetic information, then why 
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don’t we grow hair on our eyes and have brains at our finger-tips? The answer 
lies in a precise orchestration of gene regulation that is tissue specific in both a 
spatial and temporal manner. But how is this achieved? If every cell is 
genetically identical, what is controlling the expression of their genes? The 
most important mediators that turn genes “on” or “off” involve sequence-
specific transcription factors. However, chromatin based regulatory 
mechanisms, in addition to transcription factors, have been implicated as vital 
components in establishing and maintaining transcriptional systems (Mohn 
and Schubeler, 2009). By implication, these programs must therefore be 
functioning independently of the DNA sequence itself. This idea of genetic 
control via external forces was first coined by Conrad Waddington in 1938 as 
“epigenetics” – “the science concerned with the causal analysis of 
development” (Waddington, 1952). His idea was conceptualized in the form 
of a “genetic landscape” (Figure 1.3), whereby his theory of development 
follows the passage of a fertilized egg or cell down a “landscape”. The unique 
path that each cell follows through the landscapes canals will ultimately 
determine its developmental state – a process known as “canalization”. 
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The term “epigenetics” has subsequently been redefined by Robin Holliday as 
the “unfolding of the genetic program for development” (Holliday, 2006), and 
more recently by Adrian Bird as the “structural adaptation of chromosomal 
regions so as to register, signal or perpetuate altered activity states” (Bird, 
2007). 
 
1.3.1. DNA methylation as a form of epigenetics 
 
“Epigenetics” is an umbrella term that encompasses all of the factors 
independent of the DNA sequence itself which are responsible for the 
regulation of gene expression. There are two main epigenetic mechanisms by 
Figure 1.3: Conrad Waddington’s depiction of an epigenetic landscape. The developmental 
possibilities of the genotype follow the passage of a fertilized egg or cell down a landscape. 
The unique path that each cell follows through the landscapes canals will ultimately 
determine its developmental state (Waddington, 1956). 
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which the tissue-specific gene expression patterns are established and 
maintained. These include chromatin modification and chromatin remodeling. 
Chromatin modification and chromatin remodeling is achieved through the 
interaction of various proteins to establish epigenetic marks that define active 
or inactive chromatin conformations. Such epigenetic marks include DNA 
methylation and histone modifications. 
 
As early as 1975, two independent research groups put forward the 
suggestion that DNA methylation was responsible for the stable expression of 
genes throughout subsequent meiotic cell divisions (Riggs, 1975; Holliday and 
Pugh, 1975). Genetic regulation through DNA methylation occurs via a 
number of distinct mechanisms. DNA methylation is able to directly prevent 
transcription regulatory factors from binding to their target sequences, and so 
inhibiting transcription. Secondly, in some instances, instead of being 
repulsive, DNA methylation promotes the binding of methyl-CpG binding 
domain proteins (MBDs) and the methyl-CpG-binding protein MeCP2 
(Jaenisch and Bird, 2003). Together, these methyl-binding proteins function as 
transcriptional silencers. The final mechanism through which DNA methylation 
is able to regulate gene activity is by altering the chromatin structure itself.  
 
Eukaryotic genomes are organized into chromatin, a DNA-protein complex 
that packages the DNA into a highly compact form. 146 base pairs of DNA are 
wrapped around an octamer of histone proteins to form a nucleosome. The 
octamer core consists of two copies of each of the histones, H2A, H2B, H3 
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and H4. Chromatin may consist of various combinations of core histone 
variants, or histones that have undergone post-translational modifications, 
which results in diverse regulation of associated genetic material. These 
modifications include histone acetylation, methylation and phosphorylation. 
 
Histone acetyltransferases (HATs) are enzymes that are able to acetylate the N-
terminal tails of the core histones. This chemical modification leads to the 
neutralization of positively charged histones, which promotes an open 
chromatin conformation, and thereby transcriptional activation (Kuo and Allis, 
1998). Histone terminal tails are also targets of phosphorylation. In particular, 
phosphorylation of serine 10 in the H3 histone has been associated with gene 
activation in mammalian cells. Although the mechanism of phosphorylation is 
not fully understood, HAT activity appears to be linked with phosphorylation. 
It has been noted that acetyltransferases have increased HAT activity on serine 
10 phosphorylated substrates (Lo et al., 2000). This suggests that 
phosphorylation may contribute to transcriptional activation by stimulation of 
HAT activity on the same histone tail (Grant, 2001). 
 
Conversely, the methyl-CpG-binding protein MeCP2 that DNA methylation is 
able to recruit, has been shown to associate with histone deacetylase proteins 
(HDACs). These HDACs deacetylate histone residues associated with the 
nucleosome, which forces the chromatin into a closed conformation, inducing 
transcriptional repression (Heinzel et al., 1997). This interaction with HDACs 
has also been postulated to occur with DNA methyltransferases (DNMTs) to 
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form transcriptionally repressive states (Nowak-Imialek et al., 2008).   
     
1.3.2. DNMTs establish DNA methylation 
 
Methylation occurs primarily at CG dinucleotide sequences (CpG islands), 
where approximately 60% – 90% of the cytosines in these islands are 
modified in mammals, accounting for about 3% - 8% of the total number of 
cytosine residues (Jeltsch, 2002). CpG islands cluster in promoter and first 
exon regions of many genes, where the advent of cytosine methylation 
effectively silences gene expression. Abnormal methylation patterns within 
regions of regulatory importance may therefore result in the irregular 
expression of their associated genes (Jones and Takai, 2001). 
 
DNMTs are the only known enzymes that catalyze the methylation of cytosine 
nucleotides in mammals and are critical modulators of foetal development (Li 
et al., 1992). DNMTs make use of the methionine produced via the folate 
pathway for DNA methylation reactions, which involve the addition of a 
methyl group to the 5’ carbon of a cytosine nucleotide (Rodenhiser and Mann, 
2006).  
 
Various publications have reported that Dnmts are essential for embryonic 
development in mice (Lee et al., 2001; Jeltsch, 2002; Robertson, 2005). Li et 
al. (1992) have shown that inhibiting DNA methyltransferase gene expression 
causes increased embryonic lethality in mice, while reduced levels of these 
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enzymes result in abnormal embryonic phenotypes associated with growth 
and neural defects (Stoger et al., 1997). Okano et al. (1999) provided 
supporting evidence for the vital role of Dnmt3a and Dnmt3b for de novo 
methylation in embryonic development. In their studies, they generated 
Dnmt3-deficient mice from multiple embryonic stem cell lines heterozygous 
for either Dnmt3a or Dnmt3b mutations. Dnmt3a-/- mice developed to term, 
but later became runted and died at about four weeks of age, while Dnmt3b-/- 
embryos showed multiple developmental abnormalities including growth 
impairments and neural tube defects (Okano et al., 1999). Thus, through the 
action of DNMTs, DNA methylation provides a mechanism for maintaining a 
specific state of gene expression and genome stability during development 
(Stoger et al., 1997; Robertson, 2005).  
 
To date there have been three active DNMTs classified in mammals, namely, 
Dnmt1, Dnmt3a and Dnmt3b. Dnmt2 has been identified as a candidate 
protein, but has not been shown to be catalytically active (Jeltsch, 2002). 
Similarly, Dnmt3L has homology to the other members of the Dnmt3 family 
but is missing crucial residues in catalytic motifs, and has not been shown to 
possess enzymatic activity in vitro (Bourc'his et al., 2001).   Dnmt3a and 
Dnmt3b contain a domain called PWWP that occurs in proteins known to play 
a role in cell growth and differentiation (Jeltsch, 2002). These two DNMTs 
have been highlighted as the de novo methyltransferases, and are therefore 
vital components for establishing methylation patterns. Dnmt3L interacts with 
Dnmt3a and Dnmt3b, co-localising these enzymes in cellular nuclei enabling 
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effective establishment of genomic imprints (Hata et al., 2002). Dnmt3L is 
highly expressed during gametogenesis and contributes to the establishment 
of paternally imprinted regions during spermatogenesis (Webster et al., 2005).  
Dnmt1 has been implicated in the maintenance of DNA methylation during 
DNA replication ensuring the propagation of specific methylation patterns 
after each round of cell division, including those of imprinted regions 
(Leonhardt et al., 1992). 
 
1.3.3. Imprinting 
 
In the early 1980’s, a puzzling question shrouded the field of developmental 
biology – why didn’t parthenogenetic embryos develop to term? By activating 
an ovulated oocyte and repressing either the second meiotic or first mitotic 
division, researchers were successfully able to restore the diploid state of the 
oocyte with a full set of chromosomes (Solter, 2006). However, these 
maternally diploid “parthenogenetic” embryos failed to develop, despite 
having a normal number of chromosomes. One hypothesis to explain this 
phenomenon suggested that the “sperm makes an essential physical (non-
genetic) or physiological contribution without which development cannot be 
completed” (Solter, 2006).  
 
In 1984 McGrath and Solter made use of fertilized zygotes to construct 
zygotes that contained either two male (androgenones) or two female 
(gynogenones) pronuclei through pronucleus exchange. This experiment 
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satisfied any possible non-chromosome contributions from the sperm and it 
was therefore expected that both androgenones and gynogenones would 
develop normally. Surprisingly, this was not the case. In both instances, 
development failed soon after implantation – the androgenones showed poor 
embryo proper development, while the gynogenones displayed poor 
development of the extraembryonic membranes, as was the case with the 
parthenogenones (McGrath and Solter, 1984). This group therefore proposed 
that the maternal and paternal genomes are functionally different from one 
another and that both are essential for development. Furthermore, they 
suggested that specific genes are inherited in such a way that one form is 
functional, while the other non-functional, and that this is conditioned during 
gametogenesis. Surani and colleagues (Surani et al., 1984) called this 
“imprinting”, and this has remained as the term used to refer to the process 
whereby the two parental alleles are rendered functionally different.  
 
1.3.4. Evolution of imprinting 
 
To gain insight into the evolution of imprinting, both the molecular events that 
gave rise to imprinted alleles and the selective advantages conferred by this 
advent need to be considered (Wood and Oakey, 2006). A number of theories 
have been put forward in an attempt to explain the phenomenon of genomic 
imprinting. The most popular of these are the ovarian time bomb hypothesis 
and the conflict hypothesis. 
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The ovarian time bomb hypothesis states that imprinting arose as an attempt 
to prevent the development of unfertilized oocytes – a process known as 
parthenogenesis. The importance of imprinting according to this theory was 
demonstrated by Kono et al. (2004) who produced viable mouse offspring 
that were borne through the parthenogenesis of oocytes from mice carrying a 
deletion of the Igf2/H19 imprinting control region (Kono et al., 2004). As 
parthenogenones often display abnormalities, such as malignant trophoblastic 
disease, imprinted genes that prevent parthenogenesis have obvious 
advantages in mammalian development, and have thereby been selected for.  
 
The most prominent theory that explains the evolution of genomic imprinting 
is the kinship theory, more commonly known as the conflict hypothesis (Haig 
and Graham, 1991). This hypothesis states that there is a “conflict” between 
the contributions of each parental allele to the development of offspring. That 
is, the paternal allele favours offspring development at the expense of 
maternal resources; while the maternal allele serves to maximize the 
reproductive potential of the mother’s reproductive lifespan by conserving her 
resources. Evidence for this theory is strongly supported by mouse knockout 
models, which show dramatic over-growth and restricted-growth phenotypes 
(Reik et al., 2003; Ono et al., 2006; Tycko, 2006; Smith et al., 2006).  
 
Imprinted genes play a significant role in the development of the placenta 
(Coan et al., 2005), which suggests that the acquisition of imprinting may 
have been vital for its evolution (Kaneko-Ishino et al., 2003; Reik and Lewis, 
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2005). It has been speculated that the earliest form of mammalian 
placentation evolved over 150 million years ago at the time when early 
placental mammals diverged from the egg-laying monotremes, and coincided 
with the first genes that acquired imprinting (Killian et al., 2001).     
 
 
 
 
 
 
 
 
Imprinting is the mechanism by which X-chromosome inactivation (XCI) is 
achieved in the placenta and embryo of female (XX) marsupials. As marsupials 
are the most primitive of the eutherian mammals, it has been proposed that 
imprinting was the ancestral mechanism by which early eutherians achieve sex 
chromosome dosage compensation (Figure 1.4). The evolutionary acquisition 
of random XCI in the embryonic tissues of eutherian mammals was 
accompanied by mechanistic changes in the maintenance of monoallelic 
silencing, which appeared after the divergence from marsupials (Wood and 
Oakey, 2006). 
Figure 1.4: Evolution of genomic imprinting. Genomic imprinting and the practice of live birth 
coevolved in primitive mammals approximately 180 million years ago. The most ancient of 
mammals is the platypus, an egg-laying monotreme that does not exhibit genomic imprinting. 
The first example of genomic imprinting occurred in an extinct relative of marsupials and 
eutherian (placental) mammals (Jirtle and Skinner, 2007). 
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1.3.5. Dosage compensation 
 
The sex of many organisms is determined by a difference in their sex 
chromosomes. This heterogametic sex determining system, however, poses a 
problem. A difference in genetic material translates into dosage differences 
between sexes. Thus, a dosage compensation system is required in such 
organisms to eliminate these dosage discrepancies, and thereby avoiding any 
possible phenotypic manifestations associated with disparities of genetic 
information between sexes (Hendrich and Willard, 1995).  
 
In mammals, XCI is the mechanism responsible for compensating for X 
chromosome differences between males (XY) and females (XX). XCI is 
achieved by transcriptionally inactivating one of the two X chromosomes 
present in a normal mammalian female during early embryogenesis.  Two X-
linked loci are known to influence XCI. Firstly, the X inactivation centre (XIC) is 
a cis acting regulatory element that is critical for X inactivation, and secondly, 
the X chromosome controlling element (Xce) ensures that XCI occurs 
randomly. Within the XIC, the X-inactive specific transcript or Xist gene is 
known to code for an untranslated RNA, which has been implicated in the 
control of XCI (Hendrich and Willard, 1995). At the start of XCI, Xist 
transcription is up-regulated and coats the future inactive X chromosome. This 
process converts the active, euchromatic X chromosome into a 
transcriptionally silent and highly condensed heterochromatic state, known as 
the Barr body. However, Xist RNA is not essential for the maintenance of the 
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inactive X chromosome. The stable repressive state of this chromosome is 
achieved through DNA methylation and histone deacetylation in somatic cells 
(Li, 2002).        
 
The untranslated RNA transcribed from the Xist locus that is required for X 
chromosome silencing, and thereby dosage compensation of X-linked genes, 
is similar amongst epigenetic systems involving imprinted loci, such as H19. 
The notion has been put forward that both XCI and autosomal imprinting 
evolved out of the necessity to regulate the expression of growth-related 
genes in early eutherian mammals (Wood and Oakey, 2006).  
 
Autosomal dosage compensation in eutherian mammals is achieved through 
genomic imprinting. Imprints are established during gametogenesis (discussed 
in detail later) in a parent-of-origin specific manner, effectively silencing the 
imprinted (hypermethylated) allele. As in XCI, autosomal genomic imprinting 
thereby essentially renders imprinted genes functionally hemizygous and 
dosage compensation is attained.  
 
 
1.3.6. Epigenetic Reprogramming 
 
Upon fertilisation of an egg, the early embryo has the ability to differentiate 
into all the tissues required for embryonic development. At the point of 
fertilisation, the parental genomes are in different stages of the cell cycle and 
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possess very different epigenetic marks and chromatin organisation. A process 
known as epigenetic reprogramming removes established epigenetic marks 
present in the sperm and the oocyte genomes without altering the DNA 
sequence itself, returning the early zygote to an unprogrammed, pluripotent 
state. Subsequently, this process resets these marks which establish specific 
gene expression programmes essential for cellular differentiation and 
embryonic development. This phenomenon involves the reprogramming of 
both histone modifications and DNA methylation. 
 
In mammals, reprogramming DNA methylation is a bimodal event (Figure 1.5), 
occurring during embryo preimplantation and gametogenesis (Reik et al., 
2001). Upon fertilisation, the protamines present in the sperm genome are 
replaced with the histones H3 and H4, while the maternal genome completes 
meiosis. Following the deposition of histones, the paternal genome undergoes 
a genome wide loss of DNA methylation (Santos et al., 2002). This process 
occurs before the initiation of DNA replication and importantly, excludes 
paternally methylated imprinted genes (Olek and Walter, 1997).  
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Further changes in global DNA methylation and histone modifications occur 
once the fertilised egg starts to divide. From the one cell stage of the mouse 
blastocyst, DNA methylation is reduced through a passive mechanism where 
successive rounds of cellular division and DNA replication result in unequally 
methylated sister chromatids. However, imprinted regions escape passive 
demethylation and retain their methylation status in a parent-of-origin specific 
manner and are maintained throughout embryonic development. At the 
morula stage of embryogenesis lineage allocation occurs and the 
Figure 1.5: Epigenetic reprogramming cycle. Epigenetic reprogramming occurs in two phases 
during gametogenesis and preimplantation development. Primordial germ cells (PGCs) arise 
from somatic tissue and give rise to mature gametes. This is followed by genome-wide DNA 
demethylation and includes imprinted genes. Subsequently, gametes are methylated de novo 
and imprints are re-established. Upon fertilisation, during preimplantation a second 
reprogramming event actively and later passively (during cell cycles) demethylates the paternal 
genome but excludes imprinted regions. During the differentiation of the first two cell lineages, 
de novo methylation occurs. PN = pronucleus; TE = trophectoderm; ICM = inner cell mass 
(Morgan et al., 2005).  
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trophectoderm and inner cell mass lineages are defined. At this point, global 
differences in DNA methylation between extraembryonic (placenta) and 
embryonic lineages become apparent.  
 
During embryonic development, primordial germ cells (PGCs) derived from 
epiblast cells migrate to the genital ridge by embryonic day 11.5 (E11.5). These 
PGCs contain epiblast-derived epigenetic marks which are subsequently erased 
through active demethylation by E12.5. Unlike in embryonic somatic tissue, 
genome-wide erasure of DNA methylation in PGCs includes imprinted regions. 
Reprogramming of primordial germ cells is critical as it renders the epigenetic 
state of germ cells of both sexes equivalent. Male PGCs enter mitotic arrest 
until birth when spermatogonial stem cells resume mitosis. Subsequently, 
during gametogenesis where spermatids mature to spermatozoa, a wave of de 
novo methylation by Dnmts re-establishes paternal-specific imprints.  
 
The biological purpose of this reprogramming involves the erasure and re-
establishment of parental genomic imprints in germ cells, but is also a vital 
process that erases and corrects deleterious aberrations of epigenetic marks, 
termed epimutations.  
 
1.3.7. Imprinted genes 
 
The first three imprinted genes were discovered in 1991 in short succession 
(Barlow et al., 1991; Bartolomei et al., 1991; DeChiara et al., 1991). Barlow et 
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al. demonstrated that the insulin-like growth factor-2 receptor (Igf2r) gene is 
only expressed from the maternal chromosome. The insulin-like growth factor 
II (Igf2) gene was then reported by De Chiara et al., who showed that only the 
paternal copy of this gene was expressed. The third imprinted gene, H19, was 
suspected to be imprinted as it lies in an imprinted locus on chromosome 7, 
and indeed Bartolomei et al. demonstrated that H19 was maternally 
expressed. To date there have been over 80 mammalian imprinted genes 
identified.  
 
Imprinted genes are critical regulators of embryonic growth and development. 
The embryos of both mice and humans exhibit a number of imprinted genes, 
some of which are involved in common regulatory pathways (Feil and Berger, 
2007). Chromosomal regions that demonstrated parent-of-origin phenotypic 
effects when inherited uniparentally, were identified using a mouse model 
carrying translocation chromosomes (Choi et al., 2005). The phenotypes 
observed ranged from early embryonic lethality to postnatal effects on growth 
and development. These phenotypes were attributed to the misexpression of 
imprinted genes present within the uniparentally inherited or parent-specific 
duplicated region (Cattanach and Kirk, 1985).  
 
Genes that are imprinted are “tagged” for reduced expression by means of 
cytosine methylation. Imprinting occurs via allele-specific methylation while the 
genomes are separated in their respective germ lines and is parent-of-origin 
specific (Lucifero et al., 2002). This means that only one of the parental alleles 
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is imprinted, while the other remains relatively unmethylated. This results in 
the reciprocal expression of imprinted genes, that is, if a gene is paternally 
imprinted, it is maternally expressed and vice versa.  
 
Although methylation is possible at any CG dinucleotide, DNA methylation of 
imprinted regions occurs at specific regions known as CpG islands. CpG 
islands are genomic regions of approximately 1kb in length which contain a 
series of repeating CG dinucleotides that designate potential methylation sites 
(Robertson, 2005). These islands are commonly found in the promoters (Jones 
and Takai, 2001) of tissue specific genes and if methylated, prevent the 
binding of transcription factors, causing strong and heritable transcriptional 
inhibition (Stoger et al., 1997). The CpG islands of imprinted alleles can occur 
in what are known as differentially methylated regions (DMRs) (Robertson, 
2005).  
 
DMRs can be divided into two classes, namely, primary and secondary DMRs 
(Kobayashi et al., 2006). During either spermatogenesis or oogenesis, primary 
DMRs acquire gamete-specific methylation and maintain this allelic 
methylation difference throughout development. Conversely, secondary DMRs 
establish differential methylation patterns after fertilization. The term 
imprinting control region (ICR) is given to a primary DMR when the loss of that 
primary DMR results in the aberrant expression of its associated imprinted 
genes (Kobayashi et al., 2006). In the hypomethylated state, CpG-islands 
contained within ICRs act as binding targets for proteins, which may result in 
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either transcription or repression of the gene (Rodenhiser and Mann, 2006). 
This form of repression is fairly complex and involves the methylation-
dependent binding of CTCF proteins (Burns et al., 2001).  
 
1.3.8. Locus regulation by CTCF proteins 
 
The CCCTC-binding factor (CTCF) is a zinc finger protein that is able to 
specifically bind nucleotide sequences resulting in either the activation or 
silencing of associated genes. Initially, CTCF was identified as a transcriptional 
repressor in chickens (Baniahmad et al., 1990). Subsequently, the role of CTCF 
has been implicated in enhancer-blocking activity of several vertebrate 
boundary or insulator elements (Bell et al., 1999), where it has been shown to 
be ubiquitously expressed and highly conserved (Gray and Coates, 2005). The 
CTCF consensus sequence is able to bind the insulator protein, which isolates 
downstream enhancers from upstream promoters, creating a boundary 
element, resulting in transcriptional repression.  
 
The insulating property of CTCF is a vital element by which most imprinted loci 
define monoallelic expression of imprinted genes in a parent-of-origin specific 
manner. CTCF binding sites are commonly found in ICRs of imprinted loci and 
bind the protein in a methylation-dependent manner. That is, in a methylated 
state, CTCF is unable to bind to its target sequence abrogating its insulator 
function. Conversely, an unmethylated state allows for CTCF binding, 
preventing communication between gene promoters and downstream 
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enhancers. It is important to note that CTCF binding is not a simple on/off 
switch. While the bound state (unmethylated CTCF binding site) of CTCF 
blocks the interaction of downstream enhancers with the promoter of one 
gene, it allows the enhancer to interact with the promoter of another gene in 
the imprinted cluster. The interaction of the enhancer is reversed in the 
unbound (methylated) state, i.e. the previously suppressed gene is favourably 
acted upon, while the corresponding gene in the cluster is now silenced 
(Figure 1.6). In this vein, the two genes comprising the imprinted cluster are 
reciprocally expressed depending on the methylation state of the parental ICR. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Regulation of imprinted loci. This example of the Igf2/H19 locus demonstrates how 
CTCF regulates most imprinted loci. (a) The Igf2 and H19 locus. Arrows indicate transcription 
start sites. The positions of the imprinted control region (ICR; insulator) and downstream 
enhancer are shown. (b) In the hypomethylated maternal state, the ICR binds CTCF, preventing 
the downstream enhancer from acting on the upstream Igf2 gene, while activating H19. (c) The 
paternal ICR is hypermethylated (Me), preventing CTCF binding. This allows the enhancer to act 
on the upstream Igf2 gene, while H19 is repressed (Wolffe, 2000). 
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1.3.9. Imprinting Disorders 
 
Due to their monoallelic expression, imprinted genes are effectively haploid 
and therefore vulnerable to recessive mutations and epigenetic changes. 
Epimutations that arise from altered methylation or DNA mutations can bring 
about an aberrant change in the genetic regulation of a locus, manifesting in 
developmental disorders and human diseases. 
 
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are two 
developmental disorders associated with the same imprinted region on human 
chromosome 15. PWS is inherited paternally and is associated with short 
stature, hypogonadism, obesity and behavioural abnormalities(Knoll et al., 
1989). Conversely, AS is maternally inherited and is characterised by mental 
retardation, gait ataxia and an inappropriately “happy” demeanour. In both 
cases, there is an imbalance of the inherited imprinted parental signatures of 
the 15q11 – q13 region. This region is maternally imprinted and paternally 
hypomethylated. In PWS, deletion of the paternal 15q11 – q13 region results 
in the loss of genes expressed exclusively from the paternal chromosome, 
allowing for only the expression of genes expressed exclusively from the 
methylated maternal allele. Reciprocally, deletion of this region on the 
maternal allele leads to expression of only the paternal genes within this locus, 
resulting in AS. In addition to this large deletion, PWS may also be the result of 
maternal uniparental disomy (UPD), where both copies of chromosome 15 are 
maternally inherited; and in some cases aberrant methylation of the paternal 
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chromosome (Polychronakos and Kukuvitis, 2002).  
 
The incorrect establishment of DNA methylation can occur as a result of 
mutations in the DNMT genes. In patients with ICF (immunodeficiency, 
centromeric instability and facial anomaly), reactivation of genes on the 
inactive X chromosome occurs due to inadequate methylation as a result of 
deleterious mutations in DNMT3B, a vital de novo methytransferase (Okano et 
al., 1999; Hansen et al., 2000).  Aberrantly methylated promoter-region CpG 
islands have been associated with cancer development, where 
hypermethylation of promoter regions silences tumour suppressor genes in 
rodent tumours, lung cancer and metastasis. Beckwith-Weidemann syndrome 
(BWS) is an imprinting disorder associated with a high risk of embryonal 
Wilm’s tumours as a result of the loss of an unidentified tumour suppressor 
gene (Polychronakos and Kukuvitis, 2002). In paternal UPD cases, the 
paternally expressed gene IGF2, which codes for a foetal growth factor, is 
expressed at levels twice that of the normal state explaining the overgrowth 
and cancer phenotypes associated with BWS.  
 
Hypomethylation of the H19 ICR has also been associated with the features of 
asymmetry and growth retardation seen in Silver-Russell syndrome (SRS) 
patients (Bliek et al., 2006). These aberrations at the ICR have been associated 
with reduced methylation and increased CTCF binding and therefore 
enhancer-blocking activity, which results in the biallelic expression of H19 
(Gicquel et al., 2005).  
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1.4. An epigenetic model of FAS 
 
DNA methylation is a vital regulator of gene expression. At imprinted loci, it 
determines the binding of the insulator protein CTCF, which in turn regulates 
the expression of associated genes within the locus in a parent-of-origin-
specific manner. Aberrations to the imprints, and in particular ICRs, have been 
associated with developmental disorders, including AS, PWS and BWS, which 
are associated with abnormal growth phenotypes and neurological deficits.  
 
The cause of aberrant DNA methylation at ICRs, such as that of H19 in SRS, 
remains largely unknown. However, several environmental factors have been 
associated with decreased methylation. Heavy metals (Aina et al., 2004), 
pesticides (Anway and Skinner, 2006), cigarette smoke (Kaplan et al., 2003), 
dietary folate deficiencies (Friso and Choi, 2002) and alcohol have all been 
associated with DNA methylation disruption. Alcohol and dietary folate intake 
have been linked with cancer, where alcohol-fed rats displayed disruption of 
the folate, methyl group and homocysteine metabolism pathway, with 
subsequent reduction of the by-products essential for DNA methylation 
(Finkelstein, 1974; Barak et al., 1987; Trimble et al., 1993). Perturbations to 
these metabolic pathways result in hypomethylation of hepatic DNA, and is 
associated with hepatomas in the rat liver (Bhave et al., 1988; Wainfan et al., 
1989). Low folate/high alcohol intake has been associated with sporadic 
colorectal cancer (Giovannucci et al., 1995; van Engeland et al., 2003), upper 
alimentary and liver cancer (Poschl and Seitz, 2004).  
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Not only does alcohol affect methylation in cancers, but also alters methylation 
involved in developmental pathways. Prolonged levels of maternal alcohol 
exposure during pregnancy have been implicated in a range of unfavourable 
foetal outcomes, such as FAS. Investigations using a mouse model into the 
effects of alcohol on the methylation signatures of imprinted genes have 
revealed that excessive exposure resulted in global hypomethylation of fetal 
DNA, providing a link between loss of methylation and FAS (Garro et al., 
1991). The implication of this and other similar studies is significant as DNA 
methylation plays a vital role in the regulation of gene expression during 
embryogenesis, particularly at imprinted loci. 
 
Epigenetic reprogramming during gametogenesis provides a vulnerable 
window for environmental factors to exert their effect. In particular, alcohol is 
able to decrease the methylation available for transmethylation reactions vital 
for establishing imprints. When paternally ingested, alcohol is able to exert a 
negative effect on the establishment of such imprints at paternally imprinted 
loci, where it was shown that chronic alcohol use in men was correlated with 
demethylation of normally hypermethylated regions in sperm DNA (Ouko et 
al., 2009).   
 
To date, three paternally methylated DMRs/ICRs have been described 
(Kobayashi et al., 2006). The H19 ICR, Rasgrf1 ICR and IG-DMR (ICR) are 
primary DMRs whose methylation is established during gametogenesis and are 
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representative of three separate loci that contain genes vital to embryonic/fetal 
development.  
 
Developmentally significant genes are typically organized into functional pairs 
and are co-expressed at specific loci (Takada et al., 2000). Located distally on 
mouse chromosome 7, the Igf2/H19 locus contains two genes and is regulated 
by the H19 ICR. Igf2 encodes an embryonic mitogen, while H19 produces a 
non-coding RNA of unknown function. Igf2 is strongly expressed in the mouse 
placenta and in homologous structures of the human placenta, where it 
promotes placental and fetal growth (Redline et al., 1993). 
 
The IG (intergenic)-DMR is encompassed in the Dlk1/Gtl2 locus on the distal 
portion of mouse chromosome 12. Dlk1 has been reported to be homologous 
to the Notch-Delta family of developmentally regulated signalling molecules 
(Takada et al., 2002). The Delta-Notch signalling pathway is essential in 
determining cell fate, proliferation, and apoptosis of the vascular system in 
embryo and adult tissue. This pathway also plays a crucial role in the 
vertebrate nervous system through the regulation of molecular signals that 
promote cellular differentiation in a spatial and temporal manner (Edlund and 
Jessell, 1999). Dlk1 encodes a transmembrane protein that is extensively 
expressed in the developing embryo, while Gtl2 encodes an untranslated RNA 
(Schmidt et al., 2000). DLK1 is thought to be involved in development and 
differentiation of the adrenal medulla, adipocytes, haempoietic progenitor 
cells and osteoblasts (Fukuzawa et al., 2005). 
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Ras protein specific guanine nucleotide-releasing factor 1 or Rasgrf1, is located 
distally on mouse chromosome 9. Rasgrf1 is paternally imprinted at a domain 
30kb 5’ of its transcription start site. Rasgrf1 is exclusively expressed in the 
neonatal brain where it functions to couple Ras protein activation to signal 
transduction processes mediated by Ca2+ (Plass et al., 1996; Yoon et al., 2005). 
Rasgrf1 knock-out mouse models have shown that Rasgrf1 deficiency is highly 
correlated with reduced postnatal growth and memory defects (Brambilla et 
al., 1997; Fernández-Medarde et al., 2002).  
 
Given the importance of these imprinted genes in foetal development and the 
negative impact of alcohol on DNA methylation, this study aims to investigate 
the effect of excessive paternal alcohol intake on the imprinting status of these 
three paternally imprinted loci in mice. It is hypothesised that alcohol will 
decrease methylation at these paternally methylated ICRs in sperm DNA, 
particularly at the CTCF binding sites. Moreover, we aim to investigate 
whether any DNA methylation aberrations observed in these imprinted regions 
will be inherited by the offspring sired by ethanol treated males and whether 
the treatment of these sires will impact on the outcome of their progeny.  
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Chapter 2 
2. Materials and Methodology 
Preparation of solutions marked with * are available in Appendix B. 
 
2.1. Sample collection 
 
2.1.1. Male mouse model for excessive paternal 
alcohol consumption 
 
A group of 15 male C57BL/6JOlaHsd mice ranging from seven to eight weeks 
of age were selected for the study. Ethics clearance was obtained from the 
Animal Ethics Committee, University of the Witwatersrand (Appendix A). Mice 
were imported by the National Health Laboratory Service (Sandringham) from 
Harlan UK Limited (originally from the Jackson Labs).  The weights of the male 
mice ranged from 24g – 28g, and were monitored throughout the 
experiment. Eight male mice were selected for treatment with 7.5µl/g of a 
50% solution of ethanol*. This concentration was specifically chosen as it has 
been shown to significantly inhibit DNA methylation (Garro et al., 1991) and 
results in excessively high blood alcohol concentrations (Livy et al., 2004). The 
control group consisted of seven males treated with an isocaloric solution of 
7.5µl/g of a 0.704g/ml solution of sucrose*. Both the treatment and control 
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groups were orally gavaged with a blunt-ended needle and syringe. Oral 
gavaging was carried out over a five week period, during which the frequency 
of feeding was progressively increased to allow the mice to become 
accustomed to the new diet. A five week gavaging period was chosen as this 
encompasses a complete round of spermatogenesis in the mouse (Abel and 
Moore, 1987). Male mice were orally gavaged three times during the first 
week (every second day from Monday to Friday); for five days consecutively 
during the second week (Monday to Friday); and daily from week three to five. 
Mice were housed at the Central Animal Service (CAS), situated at the 
University of the Witwatersrand’s Medical School, for the duration of the 
experiment. All health and dietary needs were attended to by the CAS 
veterinary and support staff. Food and water were given ad lib for the 
duration of the experiment. 
 
2.1.2. Mating of alcohol fed males 
 
Once the five week treatment regimen of the male mice was complete, all 
males were separated into separate cages with two untreated C57BL/6 
females. Mating was allowed for a period of 24 hours. Males were 
subsequently removed and females were monitored for the formation of 
vaginal plugs. Once vaginal plugs and/or pregnancies were confirmed by 
veterinary staff at the CAS, females were placed in separate cages, where they 
were allowed to give birth and care for their young. Both male and female 
mice were tagged with metal ear tags with unique identification numbers. 
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2.1.3. Harvesting of sperm 
 
Male mice were anaesthetised in a CO2 chamber and their testes were 
removed surgically immediately following the 24 hour mating period. All male 
mice had their testes surgically removed at this point, regardless of whether 
the presence of vaginal plugs was confirmed in their mates. Briefly, the body 
cavity was opened by using an incision from the abdomen into the testicle 
region. Each testis was pulled from the body cavity using forceps. Using a pair 
of scissors, each testicle and associated epididymus was removed and placed 
in phosphate buffered saline (PBS)*. The epididymus was then punctured 
several times and transferred to tube containing 1ml PBS. This “swim out” 
protocol allows the mature motile spermatozoa to swim out of the epididymus 
into the PBS. The swim out selection was carried out for 60 – 90 minutes at 
30oC to facilitate sperm motility. The sperm was then separated from the 
cellular debris by centrifuging for 5 minutes at 2000xg. Following this, a wet-
mount slide was prepared to check for successful swim out, indicated by the 
abundance of motile sperm (Figure 1.7a). Once the presence of sperm was 
confirmed, the sperm solution was placed in a cryo-tube and flash frozen 
using liquid nitrogen (stored at -80oC).    
 
2.1.4. Offspring measurements 
 
Offspring sired by alcohol treated and control (sucrose treated) males were 
monitored from birth. Offspring weights and anatomical measurements were 
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recorded at two days of age, and reassessed every two days subsequently over 
a period of 30 days. Thereafter, weights and anatomical measurements were 
recorded weekly for a further five weeks. The measurements taken for each 
offspring included crown-rump length, head length and the distance between 
the eyes.  
 
Offspring were not assessed from birth as it is common for females to 
cannibalize new-born offspring (Gandelman et al., 1971), which is 
exacerbated by human contact (Marques-de-Araujo and Cardoso, 1999). Pups 
were uniquely marked with a non-toxic felt tip pen on their backs using a 
scoring system, and later a ringing system was used to mark their tails when 
bodily hair started developing. When the pups were four weeks old, the ear 
punch method was used to permanently mark each pup.  
 
2.1.5. Offspring tail biopsies 
 
Tail biopsies were obtained from 13 of the 17 offspring sired by EtOH treated 
sires, and 23 of the 29 offspring sired by control males at four weeks of age. 
In instances of still-births and partly cannibalised pups, tail biopsies were 
obtained immediately post-mortem. Four-week old (viable) offspring were 
anaesthetized with Isofor and 1cm of tail was removed using a scalpel. After 
the biopsy, the tip of each mouse’s tail was quarterised so as to prevent 
further bleeding. The tail biopsies were placed in 500µl PBS and stored at -
20oC. 
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2.2. DNA extractions 
 
2.2.1. Sperm DNA extraction 
 
In order to extract DNA from sperm obtained from the “swim out” protocol, it 
is essential to separate the contaminating epithelial cells from the desired 
spermatozoa. The Differex™ System (Promega) served to enrich for sperm cells 
in the presence of an excess of epithelial cells (Gill et al., 1985).    
 
The Differex™ System makes use of Proteinase K digestion in conjunction with 
phase separation and differential centrifugation in order to separate sperm 
from epithelial cells. Proteinase K* digests epithelial cells and sperm tails, while 
the resilient sperm head remains intact. Through density gradient 
centrifugation, cellular DNA and debris are differentially separated from the 
intact sperm heads, from which DNA is later extracted.  
 
Sperm samples stored at -80oC were rapidly thawed to 37oC. The Differex™ 
System was then carried out according to the manufacturer’s protocol from 
steps 1 – 11. The only change to this protocol occurred at step 3, where the 
incubation at 56oC was extended to two hours. This digests the contaminating 
epithelial cells, along with the sperm tails, but leaves the sperm heads intact 
(Figure 1.7b). At this point, separation of the sperm heads from the epithelial 
cells is complete. 
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Figure 1.7a: Undigested sperm with head (arrow) and tail intact. 
Figure 1.7b: Image of intact sperm head after digestion with Proteinase K. Note that only the 
head is intact (denoted by the black arrow), while the tail and surrounding epithelial cells have 
been digested. 
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An intermediate protocol bridges the Differex™ System with the extraction of 
DNA from the sperm heads using QIAamp DNA Micro Kit (QIAGEN) protocol. 
This was obtained via personal communication with Dr Tsukada (Appendix C). 
Steps 9 – 14 of the QIAamp DNA Micro Kit Handbook were followed 
according to the manufacturer’s protocol. Sperm DNA was eluted in 50µl of 
buffer AE. This was concentrated down to a volume of about 25µl due to very 
low initial DNA concentrations. The final concentrations of the sperm DNA 
ranged from 1ng/µl to 30ng/µl and were stored at -20oC. 
 
2.2.2. Tail biopsy DNA extraction 
 
The QIAamp DNA Micro Kit (QIAGEN) was used to extract DNA from offspring 
tail biopsies. The protocol used was based on isolation of genomic DNA from 
tissues. 5mm of mouse tail was used for each extraction. The protocol was 
followed as per the manufacturer’s specifications. DNA was eluted in 50µl of 
Buffer AE and stored at -20oC. DNA yields ranged from 268ng/µl to 
1160ng/µl. 
 
 
2.3. Bisulfite modification 
 
In principle, bisulfite modification results in the deamination of all 
unmethylated cytosine bases and converts them to uracil bases, while 
methylated cytosines (5-methylcytosines) remain unchanged (Figure 1.8). Thus, 
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the sequence of the treated DNA will differ from that of its original 
composition at unmethylated cytosines. During subsequent PCR reactions, 
uracil bases are complemented with adenosine bases, which are in turn used 
as a template for thymine complementation. Thus UpG dinucleotides of the 
bisulphite modified sample strand are converted to TpG. Primers for PCR are 
specifically designed based on the chemically-modified sequence, which can 
be further analysed by sequencing. 
 
 
 
 
 
 
 
 
 
 
 
DNA samples were bisulfite modified in duplicate using the EpiTect® Bisulfite 
Kit (QIAGEN) as per the manufacturer’s specifications. The protocol used was 
based on the sodium bisulfite conversion of unmethylated cytosines in DNA 
from solutions with low concentrations of DNA. 500ng of DNA was used for 
the bisulfite conversion of tail DNA samples, while the maximum volume of 
Figure 1.8: DNA treatment with 
sodium bisulfite. Methylated 
cytosines (mC) remain as Cs, while 
unmethylated Cs are converted to 
uracil (U) and subsequently to 
thymine (T) during PCR (England 
and Petterson, 2005). 
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DNA allowed by the kit was used for conversion of the low-concentration 
sperm DNA. 
 
 
2.4. Polymerase chain reaction (PCR) 
 
All PCR amplification protocols were optimized and performed using nested 
PCR. Nested PCR involves two consecutive rounds of amplification, where the 
first round uses external primers, and the second uses internal or nested 
primers. The first round amplifies the target region as in a typical PCR reaction, 
while in the second round, the nested primers anneal to sequences internal to 
the product of the first round PCR. The rationale behind this method is to 
maximize amplification of the highly degraded bisulfite modified genomic 
DNA and/or DNA of relatively low quantity (as in sperm DNA). 
 
Primer sets were obtained/designed to amplify a specific region within the ICR 
of each of the four imprinted loci under investigation (A19-Rasgrf1, Igf2-H19, 
Dlk1-Gtl2 and Snrpn; Table 1.1). These ICRs are located between two genes 
within each locus, and are referred to in terms of the gene downstream of the 
ICR. That is, the ICRs of Rasgrf1, H19 (also H19 DMR), IG (intergenic region of 
Dlk1/Gtl2; also IG-DMR), and Snrpn. The Rasgrf1 ICR amplified region is 
located on contig AC102545.9 and contains 29 CpG sites. This region also 
contains a CTCF binding site that spans CpG sites 20 – 27. The H19 ICR region 
locates to contig AC13548.13 and contains 16 CpG sites. The entire H19 DMR 
contains four CTCF binding sites. The region amplified in the present study 
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contained two of these CTCF binding sites. These two CTCF sites were 
selected as small changes to DNA methylation at these binding sites are able 
to switch the Igf2/H19 domain from a paternally hypermethylated epigenotype 
to a maternally hypomethylated genotype (Engel et al., 2004). The first CTCF 
site contains six CpGs, and the second contains five. The IG-DMR (or ICR) 
maps to contig AC107681.15 and the region amplified contains 29 CpG sites. 
However, this ICR does not contain a CTCF binding site.  
 
As the aim of the present study is to investigate methylation patterns of the 
hypermethylated paternal allele, it is essential that potentially contaminating 
somatic DNA (containing the maternally imprinted allele) is ruled out. The 
Snrpn ICR is hypomethylated on the paternal allele, and methylated or 
hypermethylated on the maternal allele. This imprinted region was therefore 
included in this study as a control region to detect maternal allele 
contamination. The amplified region of this ICR contains 16 CpGs, located on 
contig AC167813.4 with no reported CTCF binding sites. 
 
Table 1.1: Primers used for nested PCR.  
Primer Sequence 5’ Æ 3’ 
Amplicon 
size Reference 
Rasgrf1 F  TAGAGAGTTTATAAAGTTAG 
Rasgrf1 R  ACTAAAACAAAAACAACA 
284bp 
(Yoon et al., 
2002) 
H19 out F GAGTATTTAGGAGGTATAAGAATT 
H19 out R ATCAAAAACTAACATAAACCCCT 
474bp 
H19 in F GTAAGGAGATTATGTTTATTTTTGG 
H19 in R CCTCATAAAACCCATAACTAT 
423bp 
(Tremblay et 
al., 1997) 
IG out F GTTGYGGTATTGTTAYGTGGT 997bp This study 
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IG R TAATCCCATTCCCAATCTATAA 
IG in F GGAGATGTGTTGTGGATTT 
IG R TAATCCCATTCCCAATCTATAA 
466bp 
Snrpn out F 
TATGTAATATGATATAGTTTAGAAATT
AG 
Snrpn out R 
AATAAACCCAAATCTAAAATATTTTA
ATC 
529bp 
Snrpn in F 
AATTTGTGTGATGTTTGTAATTATTTG
G 
Snrpn in R 
ATAAAATACACTTTCACTACTAAAAT
CC 
420bp 
(Li et al., 2004) 
 
Out = external or outer primer; in = internal or inner primer; F = forward primer; R = reverse 
primer. 
 
Both the H19 DMR and the Snrpn ICR were PCR amplified using conventional 
nested PCR. However, due to the high thymine content of bisulfite modified 
DNA it was not possible to design nested PCR primers for both the IG-DMR 
and the Rasgrf1 ICR. An external and internal forward primer and a single 
degenerate reverse primer were designed for the IG-DMR. One set of primers 
was used for the amplification of the Rasgrf1 ICR, which were used in two 
successive rounds of PCR using the first round product as the starting template 
for the second round. 
 
All PCR reactions were performed in duplicate using a GeneAmp 2720 thermal 
cycler (Applied Biosystems). The annealing temperatures (TaoC) for 
amplification of the ICRs were as follows: IG-DMR, 59oC; H19, 55oC; Rasgrf1, 
59oC; and Snrpn, 59oC. The reaction conditions for all PCR reactions were 
performed as per Table 1.2. 
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Table 1.2: PCR reaction conditions. 
Reagents Round 1 Round 2 Cycle (IG-DMR) 
ddH20 30.8µl 29.8µl 95
oC 5min   
Buffer 10x 5µl 5µl 95oC 15s 
MgCl2 4µl 4µl Ta
oC 30s 
dNTP Mix* 5µl 5µl 72oC 15s 
x 50 cycles 
Primer F (10µM) 2µl 2µl 72oC 5min  
Primer R (10µM) 2µl 2µl 4oC ∞   
Taq pol (5U/µl) 0.2µl 0.2µl    
DNA 1µl 2µl* 
round 1
      
  50µl 50µl       
Note: * 
round 1
 = PCR product from first round of PCR. 
 
 
2.5. PCR product cloning 
 
PCR products obtained from duplicate nested PCRs were cloned using the 
pGEM®-T Easy Vector System (Promega) in conjunction with DH5α competent 
Escherichia coli (E.coli) bacterial cells. Cloning was only performed on the 
sperm DNA of the treated males.   
 
2.5.1. pGEM®-T Easy Vector ligations 
 
Following successful PCR amplification, products were ligated into pGEM®-T 
Easy Vectors in preparation for cloning. This vector system contains a multiple 
cloning site within the coding region of the β-galactosidase enzyme, which is 
able to metabolize the colourless substrate X-gal (5-bromo-4-chloro-3-indolyl-
[beta]-D-galactopyranoside), converting the substrate to a bright blue colour. 
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When a PCR product is incorporated (ligated) into the multiple cloning site β-
galactosidase gene expression is interrupted preventing the conversion on the 
chromogenic substrate X-gal from white to blue. Therefore, vectors that have 
successfully incorporated a PCR fragment (insert) will result in colonies that 
remain white, while those that have not incorporated an insert will convert the 
colourless X-gal blue. This method is known as blue-white colony 
selection/screening. The ampicillin resistance gene contained within the 
pGEM®-T Easy Vector aids in colony selection. Vector ligations were setup and 
performed as per the pGEM®-T Easy Vector System protocol. Ligation reactions 
were incubated over night at 4oC to increase ligation efficiency. 
 
2.5.2. Preparation of competent E.coli cells 
 
Competent cells were prepared from DH5α E.coli stocks (Appendix D). 
 
2.5.3. Transformations 
 
Once PCR products were successfully ligated, competent DH5α E.coli cells 
were used for transformations (Appendix E). These E.coli cells are high 
efficiency competent cells with a transformation efficiency of >1x108 cfu/µg 
DNA, and are compatible with blue/white colony screening and standard 
ampicillin selection. 
 
2.5.4. Bacterial minipreps 
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After transformed bacterial cells were plated and grown overnight at 37oC, 
individual white colonies were selected for miniprep cultures. Colonies were 
individually picked from agar plates with a pipette tip and placed into a 
centrifuge tube containing Luria broth* (1µl/ml ampicillin* (50mg/ml). This 
was allowed to grow overnight at 37oC at 200rpm in a shaking incubator. 
Tubes were left half a turn open so as to allow for gaseous exchange. 
 
2.5.5. Isolation and purification of plasmid DNA from 
E.coli 
 
Isolation and purification of plasmid DNA from E.coli was carried out 
according to the Plasmid Quickprep protocol (Schneitz Lab, University of Zurich 
Institute of Plant Biology (Sambrook et al., 1989) (Appendix F). The presence 
of an insert was determined by digesting plasmid DNA using EcoRI.  
 
2.5.6. Cycle sequencing 
 
Prior to capillary electrophoresis, plasmid DNA samples were cycle sequenced 
using BigDye® (ABI) and an M13 Reverse primer (tcatagctgtttcctgtgtga). The 
Montage SEQ96 Sequencing Reaction Cleanup Kit (Millipore) (Appendix H) was 
used for cycle sequencing product clean up and preparation. Cycle sequencing 
was optimized using the 1/2 reaction as per Table 1.3. 
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Table 1.3: Cycle sequencing conditions. 
1/2 Reaction Cycle 
Plasmid DNA (400-1000ng/µl) 5µl 96oC 30s 
BigDye® 1µl 50oC 15s 
BigDye® Buffer 1.5µl 60oC 4min 
    
    x 25 cycles 
Primer (M13 Reverse; 10µM) 1µl 24oC ∞   
ddH20 1.5µl     
 10µl     
 
Note: BigDye® is light sensitive and samples must be placed in a black bag or container after 
cycle sequencing. 
 
2.5.7. Sequencing of sperm DNA clones 
 
Sequencing was performed on an Applied Biosystems (ABI) 3130xl Genetic 
Analyser. ABI sequence files were converted to FASTA format using ABI 2 
FASTA Converter (Heracle Software). 
 
2.5.8. DNA sequence analysis 
 
DNA methylation data from bisulfite sequenced clones was analysed from 
FASTA sequence files using BiQ Analyzer (Bock et al., 2005). This programme 
aligns clones using a clustal W alignment. Inclusion criteria for clone sequence 
data included: 90% bisulfite conversion or greater; and 80% sequence 
identity or greater with the reference sequence. To avoid inclusion of 
identical/same clone sequences, all sequences are required to differ in at least 
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one of the genomic sequence’s aligned C positions. Sequences that are 
identical are excluded from further analysis. 
 
2.6. PyrosequencingTM for quantitative DNA analyses 
 
PyrosequencingTM technology can be adopted as a sensitive method for the 
analysis of CpG methylation. This technology makes use of a light-emitting 
reaction that allows allele quantification at individual CpG sites. In this case, 
the alleles will either be a C (mCpG) or T (TpG) for each CpG site that has the 
potential to be either methylated or unmethylated.  
 
Briefly, a sequencing primer is hybridized to a single-stranded DNA fragment 
and incubated with an enzyme cocktail containing DNA polymerase, ATP 
sulfurylase, luciferase and apyrase, together with the substrates adenosine 5’ 
phosphosulfate and luciferin. dNTPs are then added in a pre-defined 
dispensation order and via DNA polymerase catalysis, are incorporated 
sequentially into the growing strand. When a dNTP is incorporated, 
pyrophosphate is released in a quantity that is equimolar to the amount of 
incorporated nucleotide. Through the interaction of the accompanying 
enzymes, a visible light reaction is generated. This light emission is detected by 
a charge coupled device camera and recorded as a peak in a PyrogramTM, 
where the peak height is proportional to the number of nucleotides 
incorporated. Apyrase finally degrades unincorporated dNTPs and stops the 
light-emitting reaction, and the dNTP incorporation cycle is continued. 
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2.6.1. Pyrosequencing assay design 
 
Pyrosequencing assays were designed using PSQ Assay Design Software 
(Biotage). This software specifically designs an assay to amplify a region of 
interest that contains a number of single nucleotide polymorphisms (SNPs). In 
this instance, the cytosine nucleotide contained within a CpG dinucleotide, 
that will either remain as a cytosine if methylated, or converted to a thymine 
(through bisulfite modification) if unmethylated, is in essence the 
“polymorphism”, being C/T (IUPAC code, Y). However, in the case of DNA 
methylation, the C (methylated):T (unmethylated) ratio at a given CpG within 
a specific DNA sample may vary, and is therefore unlike a traditional SNP 
where a sample is simply heterozygous or homozygous. Thus, the C and T 
alleles are quantified and subsequently expressed as a percentage. 
 
Once the reference sequence containing the IUPAC code for each CG (YG) has 
been imported and a target region of approximately 100bp selected, the assay 
design software generates a series of potential primer sets to amplify the 
region. In addition to this, a sequencing primer is also generated for each 
primer set that will be used during the Pyrosequencing reaction. 
 
Primer sets were obtained for each of the four ICRs under investigation (Table 
1.4). 100bps is the optimal target region length and was centred on the CTCF 
binding sites of those ICRs where this is present. As mentioned previously, the 
H19 ICR has two CTCF binding sites, where both were analysed by 
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pyrosequencing; and the Rasgrf1 region contains a single binding site. As the 
Snrpn ICR does not contain a CTCF binding site, a random 100bp site was 
selected containing 7 CpG sites.  
 
The technique of pyrosequencing in conjunction with the Pyro Q-CpG 
methylation software (Biotage) has a distinct advantage over cloning in that it 
is highly sensitive, accurate and therefore reproducible (Huse et al., 2007) and 
quantifies the DNA methylation of a sample by analysing all amplicons within 
a pooled PCR sample, and is therefore regarded as being more accurate. 
Selecting colonies for sequencing introduces selection bias and cloning limits 
the number of clones that can be selected for sequencing due to financial and 
time constraints.  
 
Table 1.4: Primers sets used for pyrosequencing. 
ICR Primer sequence 5’ Æ 3’ Amplicon 
region length
Annealing 
Temperature 
H19 (CTCF 1)   
F AGGAGGTATAAGAATTTTGTAAGG 
R(Bio) TTAAATAACCCACAACATTACCAT 
S GGAATTAGTTGTGGGGTT 
180bp 60.3 oC 
H19 (CTCF 2)   
F TTGTGTGTAAAGATTAGGGTTGTT 
R(Bio) AACTAACATAAACCCCTAACCTCA 
S GTGTAAAGATTAGGGTTGTT 
146bp 66oC 
Snrpn   
F TGGTAGTTGTTTTTTGGTAGGATA 
R(Bio) TCCACAAACCCAACTAACCTT 
S GTGTAGTTATTGTTTGGGA 
240bp 66oC 
Rasgrf1   
F GTTATAGTTGAGTTATAATTATTA 
R(Bio) ACTAAAACAAAAACAACACTACAAC 
S CCAAATACCACAACAACAA 
121bp 50.1 oC 
Note: F= forward primer; R = reverse primer; S = sequencing primer; Bio = 5’ biotin label. Amplicon lengths exclude 
the 23bp 5’ biotin label. 
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2.6.2. Pre-pyrosequencing PCR 
 
Pre-pyrosequencing PCR utilised first round PCR products as a starting 
template for a second PCR using the primers designed by the Assay Design 
Software. The method of pyrosequencing employed here requires the addition 
of a 5’ biotinylated tag on either the forward or reverse pre-pyrosequencing 
PCR primer (Table 1.4). To eliminate the need for a unique biotin-labelled 
primer for each primer set, a universal biotin-labelled primer was used to 
generate labelled DNA fragments (Colella et al., 2003). The pre-
pyrosequencing PCR primer that has been designated to be biotin labelled 
(Bio-; Table 1.4) requires a complimentary tail or tag off of which the universal 
primer can prime. This is achieved by adding the 23bp complimentary tag, 5’-
GACGGGACACCGCTGATCGTTTA -3’, to the 5’ end of the specified primer  
Thus, each pre-pyrosequencing PCR contained three primers – a normal, 
tagged (tail), and universal primer (Table 1.5).  
 
Table 1.5: Pre-pyrosequencing reaction conditions. 
 
 
 
 
  
 
 
Reagents Volume Cycle 
ddH20 33.1µl 95
oC 5min  
Buffer 10x 5µl 95oC 15s 
MgCl2 4µl Ta
oC 30s 
dNTP Mix* 2.5µl 72oC 15s 
x 45 
Primer Normal (10 µM) 1µl 72oC 5min  
Primer Tagged (1 µM) 1µl 4oC ∞  
Primer Universal (10 µM) 1µl    
Taq pol (5U/µl) 0.4µl    
DNA (~100ng) 2µl    
  50µl TaoC = annealing temperature 
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2.6.3. Pyrosequencing preparation and run 
 
Pyrosequencing was performed using the PSQ 96MA System (Biotage) 
(Appendix G). Before commencing with pyrosequencing, pre-pyrosequencing 
PCR samples were loaded into a 96-well PCR plate. Briefly, through the 
interaction with the biotin-labelled universal primer, the pre-pyrosequencing 
PCR product is immobilized on streptavidin-coated Sepharose beads. 
Subsequently, the Sepharose beads are captured on the 96 probe Vacuum 
Prep Tool. The beads (bound to the PCR product) are then washed in 70% 
ethanol, Denaturation solution, Washing buffer, and ddH2O for twelve 
seconds each. This process separates the DNA strands, leaving only the biotin-
labelled strand attached to the captured Sepharose bead. Once the wash steps 
are completed, the Vacuum Prep Tool probes are lowered into a PSQ 96 Plate 
Low pre-filled with the sequencing primer and Annealing buffer, releasing the 
Sepharose beads. The PSQ 96 Plate Low is then heated to 80oC and allowed to 
cool, allowing for the sequencing primer to anneal. A reagent cartridge is then 
filled with the required amount of enzyme, substrate and dNTPs. The PSQ 96 
Plate Low is then placed into the PSQ 96MA instrument along with the 
reagent cartridge, and the run is commenced. 
 
2.6.4. Pyrosequencing data analysis 
 
Pyrosequencing data was analysed using the Pyro Q-CpG Software (Biotage). 
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2.7. Statistical analyses 
 
2.7.1. Descriptive statistics  
 
To assess the methylation status of the paternal ICRs, each CpG dinucleotide 
was scored as being either “methylated” or “unmethylated”, represented by 
either a CG or TG, respectively, in the bisulphite modified genomic sequence.  
 
With respect to clone data, each CpG site is scored to determine the overall 
methylation status of individual clones. Every methylated site is scored as ‘1’, 
while unmethylated sites are scored as ‘0’. In this binary fashion, the total 
number of methylated sites per clone are calculated and divided by the total 
number of CpG sites and recorded as a percentage as the “total methylation” 
of the clone. In this manner, the total methylation of clones obtained from the 
treated males’ sperm samples was calculated.  
 
The conversion rate of the bisulphite modification process is important as 
unmethylated cytosines that are not correctly converted to thymines will give 
rise to false methylation positive sites. The bisulphite conversion error rates 
were calculated for each DNA sample using the BiQ Analyzer software (Bock 
et al., 2005), where clones with non-converted non-CpG cytosine content 
>5% were discarded. 
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In conjunction with clone data, pyrosequencing data was collected for the 
treated male sperm samples, while only pyrosequencing data was collected for 
the offspring.  Pyrosequencing assays were designed for H19, Rasgrrf1 and 
Snrpn, and concentrated on a smaller number of CpG sites than those 
obtained for their corresponding clone data. Two assays were designed for 
H19, centred on the two CTCF binding sites. 
 
The descriptive statistics data for the treated male sperm DNA and offspring 
tail DNA methylation levels are reported. These data are described in terms of 
central tendency (mean levels) and variation (standard deviation) and 
presented graphically in the form of box-plots. 
 
 
2.7.2. Hypothesis testing 
 
In this present study, it is predicted that excessive ingestion of ethanol by a 
male mouse will (1) cause a reduction in sperm DNA methylation at ICRs, (2) 
will be inherited paternally as an epimutation by sired offspring, (3) will cause 
growth retardation in these offspring. To measure these effects, Mann-
Whitney U tests, Wilcoxon two sample tests and hierarchical linear modelling 
were used to test predictions (1) and (2). Mediation was used to test 
prediction (3). P-values of 0.05 and lower were considered to be significant, 
while p-values significant at the 10% level (p<0.1) were regarded as showing 
a trend. 
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2.7.2.1. Mann-Whitney U tests and one-way ANOVAs 
 
The nature of the data presented here is continuous and distributed into two 
treatment groups, i.e. EtOH and sucrose. Traditionally, this type of data would 
be analysed using the t-test. However, the t-test assumes that the data is 
normally distributed and usually requires a sample size ≥20.  
 
Due to the small sample size of male sperm samples (n=13) and the lack of 
normal distribution, the non-parametric Mann-Whitney U and One-way 
ANOVA (Wilcoxon) tests, which do not assume normality, were employed for 
sperm DNA methylation analyses. Furthermore, one-tailed tests were used, as 
it was predicted that EtOH will cause a reduction in DNA methylation. 
Similarly, the DNA methylation profiles of offspring sired by EtOH treated 
males were compared with those sired by the sucrose treated males using the 
one-tailed Mann-Whitney U and Wilcoxon tests, as our hypothesis predicts 
that EtOH will cause growth retardation. 
 
Mann-Whitney U tests were performed using GraphPad Prism® version 5 
(GraphPad Software, Inc.), while one-way ANOVA Wilcoxon two sample tests 
were performed in Enterprise Guide 4 (SAS Institute Inc.). 
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2.7.2.2. Correlations between treatment, DNA 
methylation and weight 
 
The direct relationships between treatment, DNA methylation and weight 
were assessed non-parametrically using the Spearman’s correlation. These 
correlations determine whether one variable outcome is associated with that 
of another in a relationship that is either positive or negative. For example, 
whether treatment is associated/correlated with a decrease in offspring 
weight; if treatment is correlated with reduced DNA methylation; and if DNA 
methylation is correlated with offspring weight.  These analyses were 
performed using SAS 9.1 (SAS Institute Inc.). 
 
2.7.2.3. Mediating effect of DNA methylation on the 
relationship between treatment and offspring 
weight 
 
According to the hypothesis of this study, it is predicted that EtOH will cause a 
reduction in DNA methylation in the sperm, which will subsequently be 
inherited by their offspring, whose DNA methylation will be reduced (when 
compared to the control group), which in turn will result in growth 
retardation. Thus, the only manner by which EtOH can exert this negative 
effect on the offspring would be indirectly through the sperm. Therefore, to 
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test this indirect effect, mediation was employed to determine whether the 
effect of treatment on offspring weight is mediated by DNA methylation. The 
amount of mediation that is brought about by the mediator is called the 
indirect effect. 
 
The mediation model below (Figure 1.9) describes the relationship between an 
independent variable (IV), the mediator variable (M) and the dependent 
variable (DV or outcome variable). In this study, the IV is treatment; M is DNA 
methylation; and the DV is offspring weight.  
 
 
 
 
 
 
 
 
Before one can assess the degree of mediation by M, the paths a, b, c and c’ 
must be estimated (Figure 1.9). These paths initially test correlations between 
the three variables (IV, DV and M). The first step is to show that treatment is 
Figure 1.9: Mediation model. This model determines the amount of mediation that the 
mediator variable (M – DNA methylation) exerts on the relationship between the 
independent variable (IV - treatment) and the dependent variable (DV – offspring weight). 
The correlation between two variables is determined by paths a, b and c; while path c’ 
establishes the mediating effect of IV on DV, controlling for M. 
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correlated with offspring weight (path c); secondly, a correlation of treatment 
with DNA methylation (path a) must be shown; thirdly, show that DNA 
methylation affects offspring weight (path b); and lastly, establish that DNA 
methylation mediates the relationship between treatment and offspring 
weight (path c’). These analyses were performed in SAS 9.1 using the least 
trimmed squares (LTS) method of robust regression (SAS Institute Inc.) (for 
script details see Appendix J). 
 
 
2.7.2.4. Multilevel/hierarchical regression modelling 
 
The mediation model above does not consider the hierarchical structure of the 
data of this study; that is, offspring are nested within mothers, and mothers 
are nested within males. These observations are therefore not independent. 
That is, offspring that come from the same male are related. 
Multilevel/hierarchical regression modelling was performed in STATA 10 
(StataCorp) for two time periods: day 30-39 and day 40-63 where the treated 
males/sires were used as the grouping variable. Furthermore, two analyses 
were performed for each time period at the region specific level (H19 CTCF 1, 
H19 CTCF 2, Rasgrf1 CTCF and Snrpn) and at the level individual CpG sites 
using pyrosequencing data.  The purpose of this was to determine which CpG 
sites and/or regions contributed to the overall relationship between treatment 
and offspring weight, the significance of which was assessed by Wald chi-
square tests. 
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Chapter 3 
3. Results 
The primary objective of this study was to assess the effect of excessive ethanol 
ingestion on the methylation status of paternally imprinted genes, where it is 
predicted to (1) reduce DNA methylation profiles of these genes in mouse sperm 
(paternal allele); (2) be inherited by sired offspring; and (3) result in growth 
retardation of offspring.  To test these predictions, the methylation status of the 
three paternal ICRs – H19, IG-DMR and Rasgrf1 – were analysed from sperm DNA 
of treated (EtOH and sucrose) males. Subsequently, methylation profiles of these 
imprinted regions were analysed in the tail DNA of sired offspring. Weight data 
of offspring was analysed over a 63 day period. 
 
3.1. Mouse model 
 
A total of 13 (six EtOH treated, seven sucrose treated) C57BL/6 male mice were 
used who, when mated with two female C57BL/6 mice each, sired a total of 46 
offspring (17 sired by EtOH treated males, 29 sired by sucrose treated males).   
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3.1.1. Mouse identification numbering system 
 
Unique identification numbers were assigned to each mouse used in the study, 
and is employed as the standard nomenclature from here forth. The 13 males 
and their respective treatment group are shown (Table 3.1a). Although each 
treated male was mated with two females, only those females that produced 
offspring were recorded. Each offspring is uniquely identified by the number 
assigned to their mother (also used as the “litter” number), and a number 
ranging from one to nine. For each offspring, the sex and treatment of the father 
was also recorded (Table 3.1 b). In cases where offspring died shortly after birth 
or were cannibalised by their mothers, sex could not be determined (indicated as 
“?”). Offspring sired by EtOH or sucrose treated males are referred to as “EtOH 
offspring” and “sucrose offspring”, respectively. Male mice 64 and 67 showed 
adverse effects to alcohol ingestion during the feeding regime and were omitted 
from the study. From here on, treated male mice/fathers are referred to as 
“sires”, and female mates/mothers are referred to as “dams”. 
 
Table 3.1a: Identification numbering system for male mice. 
Sire Treatment
60 EtOH 
61 Sucrose 
62 EtOH 
63 EtOH 
65 EtOH 
66 EtOH 
68 EtOH 
69 Sucrose 
70 Sucrose 
71 Sucrose 
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72 Sucrose 
73 Sucrose 
74 Sucrose 
 
 
Table 3.1 b: Identification numbering system for dams and offspring. 
Dam Offspring Sire / Treatment 
Offspring 
Sex 
1 63 /  EtOH F 
2 63 /  EtOH M 
3 63 /  EtOH M 
4 63 /  EtOH F 
82 
5 63 /  EtOH M 
1 63 / EtOH F 
2 63 / EtOH F 
3 63 / EtOH M 
4 63 / EtOH M 
83 
5 63 / EtOH M 
87 1 66 / EtOH ? 
1 68 / EtOH ? 
2 68 / EtOH ? 
3 68 / EtOH ? 
4 68 / EtOH M 
5 68 / EtOH F 
89 
6 68 / EtOH F 
1 70 / Sucrose F 
2 70 / Sucrose M 
3 70 / Sucrose M 
4 70 / Sucrose M 
5 70 / Sucrose M 
90 
6 70 / Sucrose F 
1 71 / Sucrose F 
2 71 / Sucrose F 
3 71 / Sucrose F 
4 71 / Sucrose M 
91 
5 71 / Sucrose F 
1 72 / Sucrose ? 
2 72 / Sucrose ? 95 
3 72 / Sucrose ? 
1 74 / Sucrose F 
2 74 / Sucrose F 
3 74 / Sucrose F 
4 74 / Sucrose F 
5 74 / Sucrose F 
98 
6 74 / Sucrose F 
1 72 / Sucrose F 
2 72 / Sucrose M 
3 72 / Sucrose F 
4 72 / Sucrose M 
5 72 / Sucrose M 
100 
6 72 / Sucrose M 
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7 72 / Sucrose ? 
8 72 / Sucrose ? 
9 72 / Sucrose ? 
 
Note: M = male; F = female; ? = sex unknown. 
 
3.2. CpG methylation analyses of the three paternally 
imprinted ICRs 
 
Analysis of ICR DNA methylation profiles of the three paternally imprinted 
genes (H19, Rasgrf1 and IG) and the maternally imprinted gene Snrpn were 
conducted at three levels. Firstly, “total methylation analyses” assessed 
methylation of the entire ICR containing up to 31 CpG sites. These analyses 
are based exclusively on clone sequence data obtained from sperm DNA 
samples of the sires (Appendix I and Appendix M). Secondly, methylation was 
analysed at the level of a selected region which contained a defined number 
of CpG sites. In the case of H19 and Rasgrf1, the selected regions 
encompassed CTCF binding sites, while seven consecutive CpG sites were 
selected in the Snrpn ICR. These analyses were based on pyrosequencing data 
and performed in duplicate for sperm samples and in triplicate for offspring 
samples, with the exception of the Snrpn ICR, which was performed in 
duplicate for both sperm and offspring samples. In some cases additional 
pyrosequencing data was obtained and was included in the analyses 
(Appendix K). The third analysis assessed DNA methylation at the level of 
individual CpG sites and made use of both clone sequences and 
pyrosequencing data. CpG site numbers are consistent across clone and 
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pyrosequencing data.  
 
3.2.1. Sperm DNA methylation analyses of sires 
 
A total of 600 clone sequences were obtained for the four ICRs from sire 
sperm samples (H19 n=168, Rasgrf1 n=159, IG-DMR n=119, Snrpn n=154). 
Clone data could not be obtained for H19 ICR for mouse 60 (H19 60), and 
the IG-DMR of mouse 60 and mouse 61 (IG-DMR 60 and 61). Furthermore, 
despite having sufficient numbers of clones for analyses, the stringent BiQ 
Analyzer inclusion criteria excluded all clone sequences for IG-DMR 69, 70 
and 74. After satisfying all sequence data inclusion criteria, a total of 278 
sequences remained for subsequent analyses (H19 n=92, Rasgrf1 n=85, IG-
DMR n=51, Snrpn n=50). 
 
3.2.1.1. Detection of somatic DNA contamination in 
sperm samples 
 
The Snrpn ICR was initially assessed to detect the presence of somatic cell 
(reflected by the presence of a maternally imprinted allele) contamination in 
sperm samples. Samples that exceeded 10% mean total methylation were 
regarded as contaminated. According to clone sequence data, none of the 
sperm samples exceeded this threshold (Figure 3.1). However, the number of 
clone sequences obtained for each sample ranged from 2 to 11, with a mean 
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number of 3.8 clones per sample. Considering the small sample size, there is a 
strong possibility that this may not be a true representation of the total 
methylation for these samples. 
 
 
 
 
 
 
 
 
 
 
Pyrosequencing revealed that sample Snrpn 69 exceeded the 10% threshold 
(Figure 3.2), and considering the sensitivity of pyrosequencing when 
compared with cloning, was excluded from further sperm DNA methylation 
analyses. After excluding all clones pertaining to sperm sample 69, a total of 
261 clones were available for subsequent analyses (H19 n=87, Rasgrf1 n=79, 
IG-DMR n=51, Snrpn n=44) (Figure 3.3).  
 
 
 
 
 
Figure 3.1: Clone sequence data of the total methylation of sperm samples at the Snrpn ICR.  
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3.2.1.2. Total methylation analyses of sperm DNA 
 
Clone sequence data obtained from the sire sperm samples revealed no 
statistically significant differences between the two treatment groups with 
Figure 3.2: Pyrosequencing data of the total methylation of sperm samples at the Snrpn ICR. 
Figure 3.3: Distribution of clone sequences among the four ICRs under investigation. 
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respect to the three paternally imprinted ICRs and the maternally imprinted 
Snrpn ICR (Figure 3.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Total methylation of ICRs from sire sperm DNA clone data. The total methylation of each 
sire sperm sample was quantified for the three paternally methylated ICRs (H19 n=87, Rasgrf1 n=79, 
IG n=51). Total methylation was quantified for the maternally imprinted ICR (Snrpn n=44), which 
served as a control for somatic contamination. 
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3.2.1.3. Region specific analyses of sperm DNA 
 
Clone and pyrosequencing data were analysed to assess whether there was 
evidence of region-specific reduction of DNA methylation at the H19 CTCF 
binding sites (CTCF 1 and 2), the Rasgrf1 CTCF binding site and the seven-CpG-
site region within the Snrpn ICR (Table 3.2). No significant differences in total 
DNA methylation were observed in both data sets between the two treatment 
groups for all regions, with the exception of H19 CTCF 1, which was significant 
at the 1% level. 
 
Table 3.2: Region-specific sperm DNA methylation analyses. 
Imprinted Region 
Clone / 
Pyrosequencing 
data 
CpG Sites Ethanol Median (%) 
Sucrose 
Median (%) 
Mann-
Whitney U 
      
H19 ICR  Clone 1 - 16 100.0 99.4 14.5 
H19 CTCF 1  Clone 100.0 100.0 14.0 
H19 CTCF 1  Pyro 
2 - 7 
96.28 97.3 8.5
a
 
H19 CTCF 2  Clone 100.0 100.0 14.0 
H19 CTCF 2  Pyro 
11 - 15 
97.65 98.10 17.5 
      
Rasgrf1 ICR  Clone 1 - 29 96.8 98.2 13.5 
Rasgrf1 CTCF  Clone 96.92 99.11 13.0 
Rasgrf1 CTCF  Pyro 
20 - 26 
85.92 87.62 14.0 
      
IG-DMR Clone 1 - 31 97.4 96.7 5.0 
      
Snrpn ICR Clone 1 - 16 0.6 0.0 17.5 
Snrpn Pyro 6 - 12 2.7 3.7 13.5 
           
a
p<0.1 
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3.2.1.4. Analysis of individual CpG sites in sperm DNA 
 
In addition to region specific analyses, methylation levels of individual CpG sites 
were assessed (Table 3.3 and 3.4). No significant findings were observed at any 
of the CpG sites in the H19 ICR clone sequence data. However, a trend was 
noted at sites 6 and 11 where the EtOH group demonstrated lower methylation 
profiles. Pyrosequencing data revealed a significant reduction in methylation at 
CpG site 7 (p= 0.0244) in the H19 CTCF 1 region of the EtOH group, but no 
significant differences in CTCF 2. Clone sequence data obtained for the IG-DMR 
revealed no significant findings, and observations were inconsistent as some CpG 
sites showed reduced methylation in the EtOH group, while a number of CpG 
sites showed lower methylation levels in the sucrose group.  The Rasgrf1 ICR 
clone sequence data revealed a hypomethylation trend at CpG sites 17 and 22 
(p<0.1) in the EtOH group, while pyrosequencing data for the Rasgrf1 CTCF 
region showed a significant reduction in the EtOH group at CpG 26 (p=0.014) 
and no significant observations in CpGs 20 – 25. As expected, Snrpn ICR CpG 
methylation was low in the clone sequence data, since this region is maternally 
imprinted, while pyrosequencing data from the seven-CpG-site region showed 
CpG site 10 to be significantly less methylated in the EtOH group (p=0.003). 
Furthermore, a definite trend was observed in the pyrosequencing data at all 
Snrpn CpG sites (6 – 12) which showed reduced methylation in the EtOH group, 
with sites 6 and 9 approaching significance (p=0.090 and 0.063, respectively).  
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Table 3.3: Clone data of sperm samples. 
Region EtOH Mean (%) Sucrose Mean (%) Wilcoxon Standardised Statistic 
     
clone_H19CpG1 100.00 98.33 0.730  
clone_H19CpG2 100.00 97.22 0.730  
clone_H19CpG3 100.00 96.67 0.730  
clone_H19CpG4 100.00 100.00 0.000  
clone_H19CpG5 100.00 98.33 0.730  
clone_H19CpG6 86.06 95.00 -0.529  
clone_H19CpG7 100.00 100.00 0.000  
clone_H19CpG8 100.00 100.00 0.000  
clone_H19CpG9 98.34 96.67 0.583  
clone_H19CpG10 100.00 100.00 0.000  
clone_H19CpG11 93.34 100.00 -0.913  
clone_H19CpG12 100.00 98.33 0.730  
clone_H19CpG13 100.00 98.33 0.730  
clone_H19CpG14 100.00 100.00 0.000  
clone_H19CpG15 96.66 100.00 -0.913  
clone_H19CpG16 98.34 100.00 -0.913  
clone_Rasgrf1CpG1 100.00 97.92 0.833  
clone_Rasgrf1CpG2 100.00 100.00 0.000  
clone_Rasgrf1CpG3 97.92 91.25 0.632  
clone_Rasgrf1CpG4 100.00 100.00 0.000  
clone_Rasgrf1CpG5 100.00 100.00 0.000  
clone_Rasgrf1CpG6 98.33 100.00 -0.833  
clone_Rasgrf1CpG7 100.00 86.25 1.787 * 
clone_Rasgrf1CpG8 100.00 97.22 0.833  
clone_Rasgrf1CpG9 100.00 100.00 0.000  
clone_Rasgrf1CpG10 83.33 95.13 0.315  
clone_Rasgrf1CpG11 98.33 97.22 0.000  
clone_Rasgrf1CpG12 96.67 97.22 0.000  
clone_Rasgrf1CpG13 98.33 100.00 -0.833  
clone_Rasgrf1CpG14 100.00 97.92 0.833  
clone_Rasgrf1CpG15 100.00 100.00 0.000  
clone_Rasgrf1CpG16 100.00 97.22 0.833  
clone_Rasgrf1CpG17 91.97 100.00 -1.354 a 
clone_Rasgrf1CpG18 98.33 100.00 -0.833  
clone_Rasgrf1CpG19 95.83 100.00 -0.833  
clone_Rasgrf1CpG20 100.00 96.67 0.833  
clone_Rasgrf1CpG21 97.92 100.00 -0.833  
clone_Rasgrf1CpG22 81.25 100.00 -1.354 a 
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clone_Rasgrf1CpG23 100.00 97.22 0.833  
clone_Rasgrf1CpG24 95.83 100.00 -0.833  
clone_Rasgrf1CpG25 96.97 97.92 0.000  
clone_Rasgrf1CpG26 100.00 97.22 0.833  
clone_Rasgrf1CpG27 94.88 97.22 -0.525  
clone_Rasgrf1CpG28 96.25 95.13 0.191  
clone_Rasgrf1CpG29 100.00 97.22 0.833  
clone_SnrpnCpG1 5.55 0.00 0.833  
clone_SnrpnCpG2 0.00 0.00 0.000  
clone_SnrpnCpG3 0.00 4.17 -0.833  
clone_SnrpnCpG4 11.67 19.32 -0.095  
clone_SnrpnCpG5 0.00 0.00 0.000  
clone_SnrpnCpG6 0.00 0.00 0.000  
clone_SnrpnCpG7 0.00 1.52 -0.833  
clone_SnrpnCpG8 0.00 0.00 0.000  
clone_SnrpnCpG9 0.00 1.52 -0.833  
clone_SnrpnCpG10 0.00 1.52 -0.833  
clone_SnrpnCpG11 0.00 0.00 0.000  
clone_SnrpnCpG12 0.00 0.00 0.000  
clone_SnrpnCpG13 0.00 0.00 0.000  
clone_SnrpnCpG14 0.00 0.00 0.000  
clone_SnrpnCpG15 0.00 0.00 0.000  
clone_SnrpnCpG16 0.00 0.00 0.000  
clone_IGCpG1 100.00 100.00 0.000  
clone_IGCpG2 100.00 100.00 0.000  
clone_IGCpG3 100.00 100.00 0.000  
clone_IGCpG4 90.00 95.83 0.000  
clone_IGCpG5 100.00 100.00 0.000  
clone_IGCpG6 96.00 87.50 -0.390  
clone_IGCpG7 97.78 100.00 0.516  
clone_IGCpG8 100.00 91.67 -1.033  
clone_IGCpG9 100.00 100.00 0.000  
clone_IGCpG10 100.00 100.00 0.000  
clone_IGCpG11 100.00 95.83 -1.033  
clone_IGCpG12 96.00 87.50 -0.390  
clone_IGCpG13 92.00 83.33 -0.390  
clone_IGCpG14 100.00 100.00 0.000  
clone_IGCpG15 100.00 100.00 0.000  
clone_IGCpG16 100.00 100.00 0.000  
clone_IGCpG17 92.22 100.00 0.976  
clone_IGCpG18 80.00 100.00 0.516  
clone_IGCpG19 93.34 100.00 0.516  
clone_IGCpG20 97.78 100.00 0.516  
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clone_IGCpG21 100.00 100.00 0.000  
clone_IGCpG22 100.00 100.00 0.000  
clone_IGCpG23 97.78 100.00 0.516  
clone_IGCpG24 100.00 100.00 0.000  
clone_IGCpG25 100.00 100.00 0.000  
clone_IGCpG26 100.00 95.83 -1.033  
clone_IGCpG27 100.00 100.00 0.000  
clone_IGCpG28 100.00 100.00 0.000  
clone_IGCpG29 100.00 100.00 0.000  
clone_IGCpG30 97.78 87.50 -0.390  
clone_IGCpG31 100.00 100.00 0.000  
          
a
p<0.1, *p<0.05 
 
Table 3.4: Pyrosequencing data of sperm samples. 
Region EtOH Mean 
(%) 
Sucrose 
Mean (%) 
Wilcoxon Standardised 
Statistic 
     
sire_H19CpG2 95.33 94.92 -0.518  
sire_H19CpG3 98.83 99.00 -0.604  
sire_H19CpG4 100.00 100.00 0.000  
sire_H19CpG5 96.92 97.50 -0.407  
sire_H19CpG6 94.67 98.83 -0.804  
sire_H19CpG7 91.92 93.67 -1.974 * 
sire_CTCF1 96.28 97.32 -1.446 a 
sire_H19CpG11 99.00 95.58 -0.417  
sire_H19CpG12 96.25 94.33 1.557 a 
sire_H19CpG13 97.42 95.75 0.739  
sire_H19CpG14 96.58 99.08 -0.982  
sire_H19CpG15 96.50 98.25 -0.809  
sire_CTCF2 97.15 96.60 0.000  
sire_Rasgrf1CpG20 90.25 93.25 -0.887  
sire_Rasgrf1CpG21 84.75 91.42 -0.643  
sire_Rasgrf1CpG22 69.00 79.33 -1.044  
sire_Rasgrf1CpG23 83.75 75.75 1.205  
sire_Rasgrf1CpG24 99.58 99.58 0.315  
sire_Rasgrf1CpG25 75.50 74.00 0.000  
sire_Rasgrf1CpG26 98.58 100.00 -2.197 * 
sire_Rasgrf1 85.92 87.62 -0.561  
sire_SnrpnCpG6 2.11 3.14 -1.363 a 
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sire_SnrpnCpG7 5.42 5.75 -0.646  
sire_SnrpnCpG8 4.94 5.22 -0.241  
sire_SnrpnCpG9 1.25 2.06 -1.529 a 
sire_SnrpnCpG10 0.72 2.92 -2.666 ** 
sire_SnrpnCpG11 3.72 4.86 0.000  
sire_SnrpnCpG12 2.53 2.69 -0.081  
sire_Snrpn 2.96 3.81 -0.721  
          
a
p<0.1, *p<0.05, **p<0.01 
 
3.2.2. Offspring tail DNA methylation analyses 
 
The methylation statuses of the H19 CTCF binding sites 1 and 2, the Rasgrf1 
CTCF binding site and the Snrpn seven-CpG-site region were quantified using 
pyrosequencing from the 46 offspring tail biopsy samples (EtOH offspring n=17, 
sucrose offspring n=29). Pyrosequencing was performed in triplicate for each 
sample. “Average methylation per CpG site” was calculated by averaging the 
triplicate values for each site within a given sample. “Average methylation per 
CpG site” values for each CpG were then averaged across sites to give the total 
methylation of the sample. A non-parametric one-way ANOVA was performed to 
determine differences in DNA methylation levels of the four ICRs under 
investigation between the EtOH and sucrose treated offspring groups.  
 
3.2.2.1. Region specific DNA methylation analyses in 
offspring 
 
Region specific DNA methylation analyses were conducted for offspring samples 
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using pyrosequencing data (Table 3.5). The total methylation of the H19 CTCF 1 
of the EtOH offspring was significantly lower than those of the sucrose offspring 
(p=0.0017). Similarly, the H19 CTCF 2 region was highly significant (p=0.0007), 
with the EtOH offspring demonstrating a reduced DNA methylation profile.  No 
differences in total DNA methylation were observed at the Rasgrf1 CTCF binding 
site and Snrpn seven-CpG-site region between the two treatment groups. 
However, Wilcoxon tests revealed that the Snrpn region is approaching 
significance (p=0.08). Contrary to findings in the H19 CTCF binding sites, the 
Snrpn region appeared to be more methylated in the EtOH group. 
 
Table 3.5: Pyrosequencing data of mean offspring DNA methylation of the three ICRs. 
Region EtOH Mean 
(%) 
Sucrose Mean 
(%) 
Wilcoxon 
Standardised Statistic 
     
H19 CTCF1 68.61 75.51 -2.92 ** 
H19CpG2 66.89 73.84 -2.95 ** 
H19CpG3 68.90 75.95 -3.03 ** 
H19CpG4 76.07 82.08 -2.45 ** 
H19CpG5 67.04 73.41 -2.54 ** 
H19CpG6 68.95 75.75 -2.79 ** 
H19CpG7 63.83 72.04 -2.79 ** 
     
H19 CTCF2 75.23 83.87 -3.20 *** 
H19CpG11 71.84 84.06 -2.82 ** 
H19CpG12 70.59 81.28 -3.04 ** 
H19CpG13 66.08 81.51 -3.12 *** 
H19CpG14 84.46 86.69 -0.56  
H19CpG15 83.16 85.82 -1.46 
a 
     
Rasgrf1 68.08 65.36 0.82  
Rasgrf1CpG20 74.91 72.62 0.94  
Rasgrf1CpG21 71.84 65.33 0.98  
Rasgrf1CpG22 52.38 49.66 0.31  
Rasgrf1CpG23 54.50 53.48 -0.42  
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Rasgrf1CpG24 86.84 80.95 1.17  
Rasgrf1CpG25 49.00 46.95 1.30 
a 
Rasgrf1CpG26 87.06 88.53 -0.95  
    
 
Snrpn 63.42 60.65 1.38 
a 
SnrpnCpG6 60.71 59.21 1.10  
SnrpnCpG7 64.62 62.41 1.31 
a 
SnrpnCpG8 78.74 74.03 2.28 * 
SnrpnCpG9 50.00 53.41 -1.69 * 
SnrpnCpG10 61.74 58.72 1.06  
SnrpnCpG11 66.53 59.48 2.43 ** 
SnrpnCpG12 61.65 57.26 1.22  
       
a
p<0.1, *p<0.05, **p<0.01, ***p<0.001   
 
 
3.2.2.2. DNA methylation analysis of individual CpG sites 
of offspring 
 
Analysis of individual CpG sites (Table 3.5, Figure 3.5) of the H19 CTCF 1 
revealed that all of the sites (1 – 6) were significantly less methylated in the EtOH 
offspring (p<0.01). A similar analysis of the H19 CTCF 2 showed that CpG sites 
11 and 12 were significantly different (p=0.0024 and 0.0012, respectively) and 
site 13 was highly significant (p=0.0009), while sites 14 and 15 were not 
statistically different. However, these sites in the EtOH offspring showed a lower 
methylation trend, with site 15 tending towards significance (p=0.072). Analysis 
of the Rasgrf1 CTCF binding site revealed only CpG site 25 to be reaching 
significance (p=0.096). The seven-CpG-site region of the Snrpn ICR revealed 
significant differences at CpG sites 8, 9 (p=0.011 and 0.0459, respectively) and 
CpG 11 was highly significant (p=0.0077). However, mixed observations were 
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noted at these CpG sites. DNA methylation at CpG 9 was decreased in the EtOH 
group, while CpG sites 8 and 11 showed increased DNA methylation in the EtOH 
offspring.  
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Figure 3.5: DNA methylation of individual CpG sites of offspring from pyrosequencing data. 
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3.3. Parturition analyses 
 
To ascertain whether the treatment of each sire had an impact on the pregnancy 
outcome of mated dams, pregnancy success rates (Table 3.6); total number of 
offspring (Table 3.7); litter sizes (Table 3.8) and offspring sex ratios (Table 3.9) 
were assessed.  
 
3.3.1. Pregnancy success rate 
 
To assess the success rate of impregnation, each sire was allocated a score out of 
two, representative of the potential pregnancies of the two dams mated (Table 
3.6). A successful impregnation was indicated by the presence of a vaginal plug, 
and successful fertilisation was indicated by pregnancy and birth of offspring.  
 
The EtOH treated males (n = 6) had an overall impregnation success rate of 
33.3% or four pregnancies of a possible 12. Similarly, the sucrose treated males 
(n = 7) showed an overall success rate of 35.71% or five of a potential 14 
pregnancies. 
 
Table 3.6: Overall success rates of pregnancies by treated males. 
Sire Treatment 
No. successful 
pregnancies (n = 2 
females) 
Total no. 
pregnancies 
Overall success rate 
60 EtOH 0 
62 EtOH 0 
63 EtOH 2 
65 EtOH 0 
66 EtOH 1 
4 33.33% 
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68 EtOH 1 
61 Sucrose 0 
69 Sucrose 0 
70 Sucrose 1 
71 Sucrose 1 
72 Sucrose 2 
73 Sucrose 0 
74 Sucrose 1 
5 35.71% 
 
 
3.3.2. Total number of sired offspring 
 
The total number of offspring sired in each treatment group was calculated for 
each successful pregnancy, and included those offspring that were cannibalised 
after birth. The four pregnancies of the EtOH treated males produced a total of 
17 offspring, while the five pregnancies of the sucrose treated males totalled 29 
(Table 3.7). 
 
 Table 3.7: Total number of offspring sired by treated males. 
Sire Treatment No. offspring 
sired 
Total no. offspring 
sired per treatment 
group 
63 EtOH 10 
66 EtOH 1 
68 EtOH 6 
17 
70 Sucrose 6 
71 Sucrose 5 
72 Sucrose 12 
74 Sucrose 6 
29 
 
 
3.3.3. Litter sizes 
 
The average litter size of the EtOH treated males was 4.25, which was marginally 
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smaller than that of the sucrose treated group with an average of 5.8 
pups/offspring per litter (Table 3.8) and not statistically significant (Wilcoxon two-
sample test; p=0.1874). 
 
Table 3.8: Average size of litters sired by treated males. 
Sire Treatment Dam Litter size Average litter size 
63 EtOH 82 5 
63 EtOH 83 5 
66 EtOH 87 1 
68 EtOH 89 6 
4.25 
70 Sucrose 90 6 
71 Sucrose 91 5 
72 Sucrose 95 3 
72 Sucrose 100 9 
74 Sucrose 98 6 
5.8 
 
 
3.3.4. Sex ratios of sired offspring 
 
To determine whether the treatment of each male group had an impact on the 
sex ratio of male and female offspring, the number of each sex in each group 
was analysed (Table 3.9). These data excluded cannibalised pups as their sex 
could not be determined. The EtOH group had a male to female sex ratio of 
1.6:1; while that of the sucrose group was 1:2.3, respectively. The total number 
of each sex was not significant between the two treatment groups (Wilcoxon 
two-sample test; p=0.4715).     
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Table 3.9: Sex ratios of sired offspring. 
Sex ratio Total 
ratio Sire Treatment Dam 
M F M F 
63 EtOH 82 3 2 
63 EtOH 83 3 2 
68 EtOH 89 2 1 
8 5 
70 Sucrose 90 4 2 
71 Sucrose 91 1 4 
72 Sucrose 100 2 4 
74 Sucrose 98 0 6 
7 16 
M=male; F=female 
 
3.4. Mouse weight data 
 
3.4.1. Offspring growth rates 
 
The growth rates of offspring sired by the treated (EtOH and sucrose) male mice 
were analysed over a 63 day period. Initially weight measurements were taken 
every second day until 30 days of age, and recorded weekly thereafter (20 time 
points).  
 
3.4.1.1. Overall growth rates 
 
The overall growth rate of offspring sired by EtOH treated males (n=17) was 
compared with that of those sired by sucrose treated males (n=29) over the 63 
day period. No significant difference was observed between these two groups 
(p=0.9461; Mann-Whitney U test; Figure 3.6). 
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3.4.1.2. Male pup vs. female pup growth rates 
 
The growth rates and adult weights of male and female C57BL/6 mice vary 
greatly, where male mice grow more rapidly and weigh more as adults. Thus, 
pooling the growth rates of the two pup sexes would inaccurately represent such 
data, which is skewed when sex bias is present within a sample. Taking this into 
consideration, the growth rate and weight at the 20 time points of each sex in 
both treatment groups was compared separately using a non-parametric one-way 
ANOVA (Table 3.10). 
  
No significant difference in growth rates between the two female offspring 
Figure 3.6: Growth rate of EtOH and sucrose offspring over the 63 day period. 
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groups was observed, while that of the male offspring tends towards significance 
(p=0.0844). However, there was a notable trend between these groups with both 
EtOH male and female offspring exhibiting a lower growth rate compared to their 
sucrose counterparts (Figure 3.7).  This trend is most pronounced after day 30. 
Upon further investigation of offspring weight on a day-by-day basis revealed 
that the divergence of sucrose male offspring from EtOH male offspring was 
significant at days 35, 42 and 49 (p=0.0221, 0.0356 and 0.0356, respectively), 
with day 56 approaching significance (p=0.0503). Similarly, female EtOH 
offspring showed lower weights than their sucrose counterparts at days 35 and 
42 (p=0.0196 and 0.0196, respectively), with days 49 and 56 approaching 
significance (p=0.052 and 0.087, respectively).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Growth rate of EtOH and sucrose offspring separated by sex over the 63 day period. 
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Table 3.10: Comparison of offspring growth rate and weight over the 63 day period. 
Offspring 
Sex 
Growth variable EtOH Mean 
Weight (g) 
Sucrose Mean 
Weight (g) 
Wilcoxon 
Standardised 
Statistic 
Growth_Rate 0.38 0.40 -1.38
a
 
Day2 1.32 1.33 -0.11 
Day4 2.09 2.11 0.00 
Day6 3.07 2.99 0.11 
Day8 4.12 4.09 -0.32 
Day10 5.06 4.94 0.00 
Day12 5.90 5.81 -0.42 
Day14 6.73 6.66 -0.53 
Day16 7.20 7.18 -0.42 
Day18 7.42 7.56 -0.85 
Day20 7.96 8.06 -0.74 
Day22 8.68 8.72 -0.85 
Day24 10.06 10.00 -0.37 
Day26 11.50 11.29 0.42 
Day28 12.93 13.53 -1.06 
Day30 14.71 15.29 -0.69 
Day35 18.59 19.95 -2.01* 
Day42 20.87 22.11 -1.80* 
Day49 22.36 23.96 -1.80* 
Day56 23.73 24.89 -1.64
 a 
Male 
Day63 25.17 26.27 -1.27 
Growth_Rate 0.29 0.30 -0.66 
Day2 1.37 1.38 -0.33 
Day4 2.16 2.25 -0.78 
Day6 3.13 3.17 -0.62 
Day8 4.21 4.12 0.29 
Day10 5.16 5.14 0.04 
Day12 6.03 5.96 -0.08 
Day14 6.83 6.77 -0.37 
Day16 7.16 7.30 -0.37 
Day18 7.28 7.60 -0.62 
Day20 7.85 7.97 -0.87 
Day22 8.44 8.47 -0.78 
Day24 9.80 9.69 0.04 
Day26 11.04 10.73 0.87 
Day28 11.90 11.93 -0.33 
Day30 13.08 13.28 -0.37 
Day35 15.53 16.85 -2.06* 
Female 
Day42 17.37 18.03 -2.06* 
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Day49 18.17 18.73 -1.63
 a 
Day56 18.76 19.46 -1.36
 a 
Day63 19.95 20.41 -0.75 
       
a
p<0.1, *p<0.05 
 
 
3.4.1.3. Litter analyses 
 
Offspring from smaller litters generally weigh more at birth than those born from 
larger litters (Reading, 1966). If litter size is a significant underlying factor, it may 
confound data analyses.  
 
 In order to assess whether this bias was present within the seven litters analysed 
in this study (the remaining two litters from mothers 87 and 89 were cannibalised 
shortly after birth and therefore could not be included) and whether this 
influenced offspring growth rates, the “birth” weight (weight at first time point, 
day 2) and growth rate of each litter was correlated with litter size. Analyses were 
further grouped by sex and treatment. Spearman’s correlations revealed no 
significant correlations in the sucrose male, EtOH male and EtOH female offspring 
groups (p>0.05). However, a significant negative correlation with the sucrose 
female offspring group was observed (Spearman correlation coefficient= -
0.69754; p=0.0055). 
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3.5. Correlation analyses – direct relationships between DNA 
methylation and offspring weight  
 
The relationship between DNA methylation and offspring weight was analysed in a 
correlation matrix. Analyses were conducted on offspring DNA methylation profiles 
at the region specific level (including the H19 CTCF binding sites 1 and 2, Rasgrf1 
CTCF, the Snrpn seven-CpG-site region) and at the level of individual CpG sites, 
which were correlated with offspring growth rate and weight at each of the 20 time 
points (day 2 – day 63) (Appendix N).  
 
DNA methylation at the H19 CTCF 1 region was significantly correlated with 
offspring weight at day 35 (p=0.0348), and approaching significance at day 42 
(p=0.0966). At the level of individual CpG sites, a general pattern of significance was 
observed for all CTCF 1 CpG sites (2 – 7) around days 30 – 42 (p<0.05). The H19 
CTCF 2 region was significantly correlated with offspring weight at days 14 – 22 
(p<0.05) and again at days 30 – 56 (p<0.05). However, at the CpG level, no 
significant correlations were seen at days 14 – 22 for any of the sites, while 
significance was only noted for all CpG sites (11 – 15) at day 35 (p<0.05). 
 
DNA methylation at the Rasgrf1 CTCF region was significantly correlated with 
offspring weight at day 6 (p=0.0193), with days 2 and 4 approaching significance 
(p=0.0877 and 0.0633, respectively). Correlation at these days was a general trend 
for all CpG sites (20 – 27), with the exception of CpG 25, which showed no 
correlation with offspring weight.  
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The DNA methylation profile of the seven-CpG-site Snrpn region showed a weak 
correlation with the overall growth rate of the offspring (p=0.0854), and significant 
correlations at days 35 and 56 (p=0.0477 and 0.038, respectively). Similarly, CpG 
sites 9 and 10 were significantly correlated with offspring growth rate (p=0.0171 
and 0.0454, respectively), with sites 7 and 12 approaching significance (p=0.0665 
and 0.0516, respectively). Significant correlations were noted at days 35 for CpG 
sites 9, 10 and 12, and day 56 for sites 7, 9, 10 and 12. 
 
The correlations described above were all found to be positive. That is, the 
relationship between DNA methylation and offspring weight was directly 
proportionate – when DNA methylation increases, weight tends to increase, and vice 
versa. 
 
Overall, significant correlations between DNA methylation and offspring weight 
occurred in unique block-like patterns. That is, DNA methylation profiles of H19 
(CTCF 1 and 2) were highly correlated with offspring weight at days 28 – 56, Rasgrf1 
CTCF with days 2 – 6, and Snrpn with days 35 and 56. These patterns seemed to be 
maintained in a strict day-specific manner, and significant observations rarely 
occurred outside of these well defined “correlation blocks”. 
 
3.6. Mediation analyses 
 
The relationship between DNA methylation and offspring weight has thus far been 
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established, where correlations were observed in strict blocks. Furthermore, it has 
been shown that EtOH exposure (through the sire) is able to decrease both 
methylation and weight of the offspring. It is now required to determine whether 
treatment (EtOH) of the offspring sires is responsible for the variation in offspring 
weight, but mediated by DNA methylation, otherwise known as the “indirect effect” 
of treatment (Appendix O).  
 
Direct effect and indirect effect (PATHAB when DNA methylation of each region was 
controlled for - PATHBEST) of treatment on offspring weight was calculated at days 
30 – 56. When these two effects are added, the total effect of treatment on average 
offspring weight is calculated.  
 
Analyses revealed only two regions that significantly mediate the effect of EtOH on 
decreased offspring weight, albeit it at the 10% level. The direct effect of treatment 
(EtOH) decreased the average mouse weight by 1.5g and the indirect of EtOH 
decreased average mouse weight by 0.36g when mediated through the H19 CTCF 1 
region at day 35, therefore decreasing the average weight of offspring by an overall 
of 1.90g (1.54g + 0.36g).  Similarly, the direct effect of EtOH on average offspring 
weight is a decrease of 1.75g, and an indirect effect of a 0.13g decrease when 
mediated through H19 CpG12 at day 35, giving a total decreased effect on average 
offspring weight of 1.88g. Although not significant at the level of mediation 
(PATHAB), the total effect of treatment (EtOH) at all CpGs/regions was negative, 
except for H19 CpG 3. 
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Results of the mediation analyses also revealed that the direct effect of EtOH at all 
methylation regions was negative; that is, that the effect of treatment of the sire 
with EtOH reduced the average offspring weight at all CpG sites. Furthermore, day 
35 predominantly ranked among the top 10 total effects in decreasing average 
offspring weight. These included H19 CTCF 2, along with the CpG sites which 
comprise this region that were shown to be significantly demethylated in the EtOH 
offspring group (CpG 11, 12, 13 and 15). H19 CTCF 1 demonstrated high reductions 
in average offspring weight at days 30, 35, 42 and 49, which is consistent with 
findings of significantly reduced growth in offspring around this period.  
 
Despite demonstrating a decreased direct effect on average offspring weight at all 
five days (days 30, 35, 42, 49 and 56), the mediating effect (PATHAB) of treatment 
through Snrpn CpG sites showed a trend in increasing average offspring weight 
(PATHAEST) and/or DNA methylation (PATHBEST) at all five days.  
 
3.7. Multilevel modelling  
 
In order to determine the effect of treatment on offspring weight in a hierarchical 
fashion, multilevel regression was performed (Appendix L). This was assessed using 
offspring weight as the outcome variable once each region/CpG site was controlled 
for in the model. Analyses revealed that when the data is hierarchically structured, 
the effect of sire treatment with EtOH (treatment~1) decreases the average offspring 
weight (indicated by a negative coefficient (Coef.) value) by approximately 1.2g and 
1g at the day 30 – 39 and day 40 – 63 period, respectively at both the region specific 
- R e s u l t s -  
 
 
 112
and individual CpG site level. These results were insignificant, with the period day 40 
– 63 at the region specific level approaching significance (p<0.01).  
 
Region specific analyses confirmed that females (sex_1) weighed significantly less 
than males at both time periods. Females were 2.4g and 4.8g lighter at day 30 – 39 
(p=0.001) and day 40 – 63 (p<0.001), respectively.  
 
However, all regions and individual CpG sites insignificantly affected average 
offspring weight. At the region specific level, treatment with EtOH marginally 
decreased the average offspring weight (day 30 – 39 = 0.01g, day 40 – 63 = 0.03g) 
when the H19 CTCF 1 (ctcf1) region was controlled for, while other regions seemed 
to marginally increase average offspring weight (indicated by a positive coefficient 
value). At the level of individual CpG sites, similar conflicting results were noted, with 
some CpGs within each region demonstrating a slight decrease in average offspring 
weight, while others seemed to increase offspring weight.          
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Chapter 4 
4. Discussion 
 
4.1. Outline of discussion 
 
The findings of this study are consistent with the prediction that treatment of 
male mice with EtOH has an adverse effect on sired offspring. This includes both 
a reduction in DNA methylation and growth retardation.  
 
At the level of offspring DNA methylation, strong evidence was observed at the 
H19 ICR, at both CTCF binding sites, while the Rasgrf1 CTCF binding site and the 
Snrpn ICR demonstrated less dramatic effects. Furthermore, pronounced growth 
retardation was observed in offspring of EtOH treated sires from approximately 
days 35 to 56. In addition, strong positive correlations of offspring DNA 
methylation at the H19 CTCF 1 and CTCF 2 binding sites with offspring weight 
were evident around days 35 to 56. Although sire treatment was significantly 
correlated with offspring DNA methylation and weight, mediation analyses 
revealed that offspring DNA methylation was not a significant mediator of the 
relationship between sire treatment and offspring weight. That is, the growth 
retardation observed in the EtOH offspring group was not shown to be mediated 
through the reduction in offspring DNA methylation.  
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These findings would suggest that treatment of male mice with EtOH prior to 
conception alters sperm in an unknown manner, postulated as possibly an 
alteration to DNA methylation, which in turn is inherited by their offspring, 
accounting for the observed reduction in offspring DNA methylation within this 
group. Surprisingly however, no significant reduction in sperm DNA methylation 
profiles was evident in the EtOH treated male group. 
 
The discussion that follows explores the implications of each of these findings. 
Firstly, the evidence (or lack thereof) of decreased DNA methylation in sperm and 
offspring as a result of excessive paternal EtOH exposure will be assessed in 
accordance with the hypothesis of this study. Secondly, possible mechanisms 
accounting for the altered epigenome evident in the EtOH offspring group and 
their implications will be explored. Thirdly, the relationships between sire 
treatment, offspring DNA methylation, and offspring growth are explored. And 
lastly, the implications of the loss of imprinting observed in the offspring of EtOH 
exposed sires in conjunction with their adverse outcome will be explored in terms 
of epigenetic control of imprinted loci.  
 
4.2. Rationale for inclusion of the maternally 
imprinted Snrpn ICR in methylation analyses 
 
Despite including maternally imprinted Snrpn in this study for the sole purpose of 
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detecting somatic DNA contamination in sperm samples, the Snrpn region was 
analysed along with the paternally imprinted regions of the offspring. The reason 
for this was because during analyses for somatic DNA contamination detection 
(primarily based on pyrosequencing data), it was noted that this ICR was not 
completely devoid of methylation on the paternal allele, but instead was 
hypomethylated. That is, a low level of “basal” methylation was detected. 
Moreover, on closer inspection, when the levels of “basal” Snrpn DNA 
methylation on the paternal allele were compared between the two treatment 
groups, there seemed to be a trend for lower levels of methylation across the 
EtOH group. As this finding seemed to support the hypothesis of the current 
study, it was decided to include the Snrpn ICR in subsequent analyses. 
 
4.3. The effect of excessive EtOH exposure on sperm 
DNA methylation 
 
In the present study, the exposure of male mice to 7.5µl/g of a 50% EtOH 
solution over a period of five weeks did not appear to cause dramatic effects in 
sperm DNA methylation profiles. Sequence data showed that of all the CpG sites 
contained within the four ICRs (H19, IG, Rasgrf1 and Snrpn), only three out of 
the 92 showed significantly altered DNA methylation, all of which were contained 
within the Rasgrf1 ICR. In accordance with our hypothesis, Rasgrf1 CpGs 17 and 
22 showed a reduction in DNA methylation in the EtOH group (p<0.1). However, 
contrary to the current hypothesis, the sucrose group demonstrated a lower level 
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of methylation at Rasgrf1 CpG 7, where the largest difference in the level of DNA 
methylation was observed (p<0.05). These conflicting findings may be explained 
by the fact that the number of clones analysed were very limited. The reduced 
level of methylation at Rasgrf1 CpG 7 is primarily derived from three sperm 
samples (61, 71 and 73). In particular, sample 61 showed a 50% level of 
methylation at this CpG. However, this value was quantified from only six clone 
sequences. Similarly, CpG 7 methylation levels of samples 71 and 73 were 80% 
and 87.5%, respectively, but were the result of only a single clone in each sample 
being unmethylated. Thus, the dramatic decreases in DNA methylation observed 
in these samples was merely due to limited clones, where a single unmethylated 
site within one clone could result in a 20% decrease in DNA methylation at a 
CpG for a particular sample (e.g. 71). This could therefore be argued not to 
accurately represent the level of DNA methylation. The same argument could be 
made for the reduced levels of methylation observed at CpG 22. However, the 
decrease in methylation at CpG 17 could be an accurate representation of the 
sample, as this level of methylation was quantified from a larger number of 
clones (n=22). There therefore seems only to be reliable evidence for a reduction 
in the level of DNA methylation at Rasgrf1 CpG 17 in the EtOH treated group 
based on sequence (clone) data. 
 
Visual inspection of sequence data did not appear to show any distinct patterns 
of reduced DNA methylation at linked CpGs. According to the literature discussed 
previously, EtOH (through the metabolite, acetaldehyde) reduces the availability 
of the methyl group donor (SAM) required for DNA methylation reactions by the 
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Dnmt enzymes (Halsted et al., 2002a). We might therefore expect that if 
transmethylation reactions were hampered, large “blocks” of unmethylated 
regions would be observed in sequence data of aligned clones, where a number 
of consecutive CpGs would have been unsuccessfully methylated. This was not 
observed in our data. Instead, the very few CpGs that were unmethylated 
seemed to be distributed randomly and it was very rare to observe two 
consecutively unmethylated CpGs, while more than this was never seen. 
 
Similar to the sequence data, pyrosequencing data revealed only a select number 
of CpGs with significantly reduced levels of methylation. Although more than 
two consecutive significantly unmethylated CpGs were not observed, affected 
CpG sites did tend to cluster, often being within one or two CpGs from each 
other. Although this trend is based on very few observations, it is more consistent 
with a model where EtOH disrupts Dnmt activity, resulting in stretches of 
unmethylated CpG sites. 
 
However, unlike the sequence data, reduced methylation was observed across all 
three of the ICRs (pyrosequencing data was not obtained for the IG-DMR), 
including the Snrpn ICR. Due to the robust quantification of pyrosequencing, 
these data probably reflect the DNA methylation profiles of the three ICRs more 
accurately. Thus, the decreased level of methylation observed at H19 CpG 12 in 
the sucrose group is likely to be genuine and is therefore contrary to our 
hypothesis. However, this is an isolated CpG site and on its own does not provide 
evidence compelling enough to disregard the validity of the hypothesis put 
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forward in this study.  
 
In summary, large-scale demethylation induced by excessive EtOH exposure was 
not evident in the sperm of treated male mice. However, significant effects were 
noted at the level of individual CpG sites which generally showed lower levels of 
methylation in the EtOH treated male group, which agrees with previous findings 
(Ouko et al., article in press). Moreover, there was some evidence that affected 
CpG sites tended to cluster, suggesting possible disruption in the DNA 
transmethylation pathway as a result of EtOH exposure. 
     
4.3.1. Ethanol-induced DNA demethylation may be 
masked in sperm samples 
 
Based on the empirical findings of this study where no significant, large-scale 
differences were observed in the paternal sperm DNA methylation profiles as was 
anticipated, one can only speculate on potential mechanisms that could account 
for the growth retardation phenotype and significant reductions in DNA 
methylation observed in the EtOH sired offspring. 
 
Although a trend at the H19 CTCF 1 region and significantly lower levels of DNA 
methylation at H19 CpG 7 and Rasgrf1 CpG 26 were observed in the EtOH 
group, it is interesting to note that the Snrpn region contained three CpG sites 
significantly affected by EtOH. Although two of these sites were only significant 
at the 1% level (CpGs 6 and 9), Snrpn CpG 10 displayed the most dramatic 
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decrease in methylation (p<0.004) of all the CpGs of the three ICRs in sperm 
DNA. The implications of this finding may suggest that because unlike H19 and 
Rasgrf1, the Snrpn ICR is maternally imprinted and therefore hypomethylated 
(not imprinted) in male germ cells, it may escape mechanisms that ensure the 
correct establishment of paternal imprints during spermatogenesis. Being 
unchecked, the effects of EtOH may be more pronounced at this region, 
accounting for the higher frequency of altered CpG methylation levels at the 
Snrpn ICR, as well as the highly significant reduction observed at Snrpn CpG 10. 
By implication, this theory also suggests that if these regulatory mechanisms that 
ensure the correct establishment of paternal imprints during spermatogenesis do 
exist, then aberrations (losses) in paternal DNA methylation at imprinted loci as a 
result of EtOH exposure may be corrected at later stages of spermatogenesis and 
would therefore be unobserved in mature spermatozoa. Alternatively, this 
regulatory mechanism may make these regions more resistant to changes in DNA 
methylation. By way of one or both of these scenarios this regulatory mechanism 
would act to safe-guard and maintain the integrity of paternal imprints in 
spermatozoa. This theory may explain the lack of observed significant, wide-
spread decreases in DNA methylation in the sperm of male mice exposed to EtOH 
in this study. 
 
In addition, the sperm samples obtained from the treated males contain a 
population of mature spermatozoa that have been exposed to EtOH metabolites, 
but would also be representative of individual spermatozoa that have been 
affected to varying degrees. Thus each sperm could potentially represent a 
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uniquely altered epigenetic profile, which may be unobservable when quantifying 
the “total” or average methylation for a particular sperm sample which is 
comprised of a milieu of potentially divergent epigenomes. Furthermore, the 
negative effects of EtOH on DNA methylation may only impact on a fraction of 
the total sperm population, while the vast majority of the spermatozoa maintain 
“normal” DNA methylation profiles, masking the altered epigenomes. This 
argument may account for the lack of reduced DNA methylation observed in the 
EtOH treated male sperm samples. 
 
4.4. The effect of paternal treatment on offspring 
outcome and development 
 
The difficulty with studying the effect of alcohol on spermatozoa is that 
treatment often renders the sperm inactive or damages it to such an extent that it 
is unable to penetrate and fertilize the ovum (Stockard, 1913). However, these 
severe effects are noted almost exclusively in chronic alcoholics who have been 
abusing alcohol over many years, resulting in atrophy of the testicles and 
spermatogonia (Stockard, 1913). This is an important consideration as the aim of 
this study was to determine the effect of alcohol on sperm DNA methylation, an 
epigenetic factor, and not its cytotoxic effects. The male mice used in this study 
were treated with either alcohol or sucrose over a 35 day period. This ensured 
that treatment was performed for the duration of a single complete cycle of 
mouse spermatogenesis. The dosage of alcohol administered mimicked chronic 
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alcoholism in humans, but over a period that was short enough so as to avoid 
severe cytotoxic effects (Stockard, 1913).   
 
4.4.1. The effect of sire treatment on fecundity 
 
4.4.1.1. Pregnancy success rates 
 
The results of this study demonstrated very low pregnancy success rates of dams 
by both EtOH and sucrose treated sire groups (33.33% and 35.71%, 
respectively). Contrary to these findings, previous studies on paternal 
preconception alcohol exposure have reported rates of approximately 20 - 44% 
and 90 - 100% in EtOH and sucrose groups, respectively (Stockard, 1913; 
Anderson and Willis, 1981; Abel and Tan, 1988; Cicero et al., 1994a). However, 
in agreement with the findings of this study Cicero (1990) and Abel (1989) did 
not find significant differences in success rates between the two treatment 
groups. 
 
4.4.1.2. Litter sizes 
 
The average litter sizes of the EtOH and sucrose dam groups were relatively low 
in this study, with no significant differences between the two (4.25 and 5.8, 
respectively). The average litter size of female C57BL/6 mice is around seven 
pups. However, a female mouse’s first pregnancy generally yields a smaller litter 
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than subsequent pregnancies, which may account for the findings of this study as 
nulliparous females were used. Whether the findings of the current study agree 
with those of others is difficult to determine as varying concentrations of EtOH, 
exposure periods and rodent species were used, which is further confounded 
with often opposing results in studies with similar methodologies. However, both 
rodent models (mouse and rat) seem to suggest that paternal exposure to EtOH 
(despite being administered at different concentrations and exposure periods) 
does not affect litter size (Anderson and Willis, 1981; Abel and Tan, 1988; Abel 
and Lee, 1988; Abel, 1989b; Abel, 1993). Evidence to the contrary stems from 
studies using only rat models (Cicero et al., 1990; Cicero et al., 1994a), and may 
reflect species specific differences. Paternal alcohol exposure may have 
paradoxical effects in mice and rats (Abel and Bilitzke, 1990) as the offspring of 
alcohol exposed male mice were more immobile than the offspring of male rats 
exposed to alcohol, which showed decreased immobility in swimming tests. The 
opposite behavioural phenotype observed in this study provides evidence for 
species specific paternally-mediated effects. This may, in part, explain the findings 
of our study where a mouse model was employed.  
 
4.4.1.3. Total number of offspring 
 
The effect of preconception paternal alcohol exposure on the total number of 
offspring sired by treated males differs between rodent models. Findings of this 
study suggest that despite a relatively equal pregnancy success rates and litter 
sizes between the two treatment groups, far fewer offspring were obtained from 
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the EtOH group when compared to the sucrose control group (n=17 and 29, 
respectively). Livey et al. (2004) found no differences in the total number of 
offspring between the two treatment groups using a C57BL/6 mouse model. 
However, this study used a 3g/kg dosage of alcohol (equivalent to 6µl/g), while 
the current study used a higher dosage (7.5µl/g). Findings of the present study 
agree with those of Cicero (1994), who exposed male rats to alcohol doses of 
5g/kg (equivalent to 10µl/g) and observed a significant decrease in total offspring 
in the EtOH group (n=30) when compared to the control group (n=60). It could 
be argued that the alcohol concentration used in this study is closer to that of 
Livey (2004) – only 1.5µl/g higher – while Cicero (1994a) used a concentration 
2.5µl/g higher than the present study. However, Livey (2004) exposed male mice 
for 60 days with no effect, while the present study exposed males for only 35 
days with a significant effect on offspring numbers. This suggests that an alcohol 
dose of 6µl/g may be insufficient in mediating a significant effect, while doses of 
7.5µl/g and 10µl/g are significant, even over a shorter exposure period. It is also 
important to note that Cicero (1994) observed significant reduction in total 
offspring numbers by only exposing male rats to a single dose of 10µl/g 24 hours 
prior to conception. This once-off, high dose of alcohol is synonymous to binge-
like behaviour observed in human alcoholics.   
 
4.4.1.4. Postnatal mortality rates 
 
Stockard (1913) observed that male guinea pigs chronically treated with alcohol 
gave rise to defective embryos or weakened offspring that died shortly after birth. 
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This has been corroborated by Cicero (1994a) who noted a 2.5% postnatal 
mortality rate in the control group, while this was doubled in the EtOH group. In 
the present study, similar postnatal mortality rates in both offspring groups were 
observed (sucrose = 20.7%; EtOH = 19.0%). In agreement with this study, others 
observed equal postnatal mortality rates in both groups (Anderson and Willis, 
1981; Abel and Moore, 1987; Abel and Lee, 1988; Abel, 1989a; Cicero et al., 
1990; Abel, 1993). 
 
4.4.1.5. Sex ratios 
 
The effect of paternal alcohol exposure on sex ratios has been observed in a 
number of studies. Findings have been mixed with studies showing significantly 
decreased male to female ratios in litters sired by alcohol exposed fathers (Abel, 
1993), while others demonstrate dramatic increases in females (Anderson et al., 
1978; Anderson and Willis, 1981). However, the majority of findings report no 
changes in sex ratios between the two groups (Klassen and Persaud, 1978; 
Randall et al., 1982; Leichter, 1986; Abel and Tan, 1988; Abel, 1989a; Cicero et 
al., 1990). Contrary to all of these findings, the present study observed relatively 
equal sex ratios in the EtOH group (M:F = 8:5), while more than double the 
number of females were present in the control group (M:F = 7:16). This unusual 
finding may be a consequence of a combination of factors resulting in a highly 
skewed sex ratio. Firstly, the total number of offspring obtained for the sucrose 
group was relatively small in comparison to previous studies that obtained 
roughly 60 offspring (Anderson and Willis, 1981) or approximately 25 litters for 
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analyses. Secondly, the sex of six offspring from the sucrose group could not be 
determined; accounting for 20% of the group, and thus male offspring might 
have been overlooked. Lastly, considering the small sample size, sex ratio would 
have been dramatically biased by litter number 98, where all six pups were 
female. Thus, the control group may reflect an unrealistic representation of sex 
ratio. Furthermore, due to the smaller sample size in the EtOH group and missing 
sex data for four pups (23.4% of the total EtOH offspring), sex ratio in this group 
may also not be truly representative.   
 
4.4.1.6. Offspring growth 
 
Although there was no significant difference in the growth rates of offspring 
sired by EtOH or sucrose treated sires observed, there was a definite trend 
demonstrating the growth rates of pups sired by EtOH treated males to be 
weaker than those sired by sucrose treated males. This trend was observed from 
approximately day 28 onwards, where days 35 to 56 showed significantly 
reduced weights of EtOH offspring when compared to controls. 
 
It has been shown that a single dose of alcohol orally administered to a male 24 
hours prior to conception tends to result in lower body weights of their sired 
offspring (Cicero et al., 1994b). Longer exposure periods (three months) of males 
to alcohol prior to breeding have also reported decreased birth weights in 
offspring (Ledig et al., 1998). However, no significant differences were observed 
in birth weight in our study, even when separated by sex. A number of studies 
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using rodent models support our findings (Anderson and Willis, 1981; Abel and 
Tan, 1988; Abel and Lee, 1988; Abel, 1989a; Abel, 1993), which has also been 
reported in humans (Passaro et al., 1998). 
 
The growth rate data of this study agrees with that of Stockard and Papanicolaou  
(Stockard, 1913; Stockard and Papanicolaou, 1916b; Stockard and Papanicolaou, 
1916a) who observed that the growth rate of the control offspring (sired by 
sucrose treated males) was superior to that of offspring sired by alcohol treated 
males. Studies on alcoholic men also noted significant decreases in the postnatal 
growth of their children (Abel and Sokol, 1983; Little and Sing, 1987) 
 
4.4.1.7. Physical development 
 
It was found that male guinea pigs who were treated with alcohol fumes and 
subsequently mated with healthy females, gave rise to offspring that were 
defective (Stockard and Papanicolaou, 1916b). These defects were present from 
the F1 generation (the first litter sired by the alcohol treated males) and included 
increased mortality rates and deformities of the eyes and brain. In the present 
study, anatomical measurements (crown-rump length, head length and the 
distance between the eyes) as well as visual observations of eye condition were 
recorded for each pup from day 2 to day 63.  
 
No gross abnormalities of the eyes or any other organ were observed, while 
anatomical measurements were difficult to record accurately and were thus 
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unreliable (data not shown). However, no obvious anatomical differences were 
noted between the offspring of the two treatment groups. This agrees with 
previous findings which reported no significant difference in the crown-rump 
length (Livy et al., 2004) and the lack of gross abnormalities in offspring of EtOH 
exposed sires  (Anderson and Willis, 1981; Cicero et al., 1994a). Although the 
findings of this study are not consistent with those of Stockard and Papanicolaou 
(1916a) it must be noted that these researchers used a larger sample size (90 
matings, producing over 50 litters). 
 
4.4.2. Summary of findings of the outcome offspring 
sired by EtOH treated males  
 
Together, these findings suggest that frequency of exposure and alcohol dosage 
(volume intake) prior to conception are significant factors that can influence 
offspring outcome. Furthermore, binge-like behaviour can have dramatic and 
perhaps a more pronounced deleterious effect on offspring.  
 
Data from the current study revealed that exposure of male mice for five weeks 
preconception does not have a significant impact on the birth weight of 
offspring, but does result in significantly fewer offspring who show significant 
growth retardation from approximately days 35 to 56. The implication of this 
finding suggests that the deleterious effects of paternal alcohol exposure prior to 
conception affect genetic or epigenetic elements in the sperm that are active 
during postnatal development, particularly during the five to eight week period. 
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4.5. The effect of paternal alcohol exposure on offspring 
imprints 
 
Despite the absence of large-scale, alcohol-induced demethylation at imprinted 
loci in the sperm of males, the offspring of the EtOH treated sires displayed 
significantly reduced DNA methylation at paternally imprinted regions. In 
particular, the H19 CTCF binding sites appeared to be most affected. Overall, the 
methylation content of H19 CTCF 1 was significantly reduced (p<0.05), which 
was echoed at each of the six CpG sites that comprise the region (CpG sites 2 – 
7). H19 CTCF 2 was most affected (p<0.001), but inspection of individual CpGs 
revealed that only CpG 11 to 13 were significantly hypomethylated when 
compared to the sucrose control group. Conversely, although significance was 
observed at Rasgrf1 CpG 25, Rasgrf1 CTCF region appeared to be largely 
unaffected in offspring.  
 
4.5.1. Gain of methylation at the paternally 
hypomethylated Snrpn ICR 
 
Interestingly, although site-specific reductions in DNA methylation were observed 
at the Snrpn seven-CpG-site region in sperm, methylation levels were increased 
on the paternal allele in offspring. This finding was further confirmed in 
mediation data, where treatment (EtOH) caused increases in offspring DNA 
methylation at Snrpn CpG sites. Similar findings have been reported (Haycock 
- D i s c u s s i o n -  
 
 
 129
and Ramsay, 2009) which found gains in DNA methylation on the maternal allele 
at the H19 ICR when embryos were exposed to EtOH during the preimplantation 
period. As discussed previously, regulation of imprinted loci involves the interplay 
of the CTCF insulator protein with its binding site. When bound, CTCF maintains 
a hypomethylated state by actively preventing DNA methylation (Fedoriw et al., 
2004). Therefore, loss of methylation at paternally methylated CTCF binding sites 
would increase demands for CTCF, reducing the pool of factors available for 
normally unmethylated maternal alleles. This in turn may result in decreased 
binding of CTCF on hypomethylated ICRs, allowing for de novo methylation 
(Engel et al., 2006). In conjunction with our findings of significantly reduced 
methylation at the paternal H19 ICR, this may explain the gain of methylation 
observed at the normally hypomethylated Snrpn region. However, despite the 
plausibility of this mechanism, a CTCF binding site has not been reported in the 
Snrpn region, but may suggest the presence of a putative CTCF binding site.   
 
4.5.2. Evidence of inherited reduced methylation in 
offspring 
 
A significant reduction of DNA methylation in EtOH sired offspring was observed 
at the H19 CTCF 1 region, H19 CpG 7 and H19 CpG 13. This was also evident at 
these regions in the sperm of EtOH treated sires. This correlation suggests that 
the loss of methylation induced by EtOH exposure in the sperm may be inherited 
as an altered epimutation by sired offspring.  
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However, although DNA methylation at Rasgrf1 CpG 26 was significantly 
reduced in the sperm, a significant reduction was not observed at the 
corresponding site in offspring. Furthermore, one would expect that CpG 
sites/regions in the offspring showing the most significant reductions in DNA 
methylation to be correlated in the sperm, even if at lower significance. This was 
observed at H19 CpG 12, but not at the H19 CTCF 2 region and H19 CpG 13, 
which showed a highly reduced level in the offspring, but was not significant in 
the sperm.  
 
These findings show an imbalance of reduced DNA methylation at corresponding 
sites in the sperm and sired offspring. Sperm profiles show only a few regions of 
significant losses in DNA methylation, which for the most part, are also significant 
in the offspring. Conversely, offspring show highly significant reductions at 
regions that are insignificant in the sperm. 
 
As previously proposed, the presence of a minor pool of epigenetically altered 
spermatozoa may be undetected in the overall sperm sample due to the presence 
of unaffected/normal sperm which make up the majority. It would therefore be 
plausible that a single sperm, whose epigenome has been altered as a 
consequence of EtOH exposure, could fertilize an oocyte and give rise to an 
embryo/offspring that would inherit the “mutant” paternal epigenotype. Thus, 
when DNA methylation is quantified at a particular locus in both the sire and 
offspring, the profile of the father’s sperm sample may appear unaffected, while 
the offspring show reduced DNA methylation (as observed in this study). This is 
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supported by Abel (1993) who found an increased frequency of runts sired by 
EtOH exposed male rats, suggesting that alcohol had an effect on individual 
sperm as opposed to affecting entire sperm production. 
 
However, according to the above argument, it would follow that if only a fraction 
of the sperm population would be affected by EtOH exposure and that this effect 
would be limited to such an extent that it is undetected in sperm samples; then 
only a very small proportion of the offspring would have inherited the altered 
epigenotype. Considering the small sample size of the EtOH sired offspring in this 
study, this effect would be virtually undetected. On the contrary, reduced DNA 
methylation profiles in the offspring of the EtOH treated males were observed at 
significant levels. While the few CpG sites that were altered in the sperm seemed 
to correlate with significantly reduced levels at the corresponding site in the 
offspring, the majority of CpGs in the sperm showed no significant changes in 
DNA methylation despite their corresponding sites in the offspring being 
significantly altered. Because a reduction in offspring DNA methylation isn’t 
always correlated with a reduction in the corresponding site in the sperm, it 
suggests that something other than DNA methylation itself influences offspring. 
What other paternal factors could account for the observed effect in EtOH sired 
offspring?   
 
4.6. Alternative mechanisms of epigenetic inheritance 
 
Sequence data obtained from sperm samples confirmed that EtOH did not alter 
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the DNA sequence itself or methylation of the DNA. Thus, the paternal factors 
inherited by EtOH sired offspring that resulted in an altered pheno- and 
epigenotype would most likely be epigenetic in nature. Besides DNA methylation, 
two other epigenetic mechanisms exist in mammals that regulate gene 
expression: RNA species and chromatin remodelling through histone 
modifications. 
 
4.6.1.  RNA species 
 
The mature sperm head is commonly thought to contain the tightly condensed 
haploid paternal genome which is transcriptionally inert. However, several RNA 
species have been found in spermatozoa that are both known and unknown 
protein-coding and non-coding RNAs. It is argued that the RNA species in 
spermatozoa are so few in number when compared to the abundance of RNAs 
found in oocytes, that they may be considered remnants and unlikely to play a 
significant role in embryonic development. However, the transmission of these 
RNAs from the sperm to the oocyte has been confirmed (Ostermeier et al., 2004), 
and raises the possibility that these and other spermatozoal RNAs do in fact play 
a unique role in zygotic development.  
 
Transcripts unique to male germ cells play a role in embryonic stem cell 
differentiation. mRNA transcripts have been identified in sperm that are known to 
participate in fertilization and embryonic development, but which are absent in 
the oocyte (Geijsen et al., 2004). In addition to mRNAs, approximately 68 siRNAs 
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have been identified in human spermatozoa, with 13 of these showing similarities 
with siRNAs known to function in gene regulation (Ostermeier et al., 2005). This 
implies the possibility of early regulation of parental genes through selective RNA 
degradation. Human and mouse sperm is also enriched with microRNAs (miRNAs) 
that have the capacity to epigenetically alter the phenotype of offspring through 
“paramutation”. Disruption of the Kit gene in a mouse model yielded a non-
lethal white tail phenotype. However, the mutated allele was not detected by 
genotyping. Instead, varied transcript lengths of the Kit gene were observed in 
later spermatogenic cells. Injection of this RNA into fertilised oocytes yielded the 
paramutation phenotype, as did exogenous miRNAs targeting the Kit gene. This 
further supported the idea that sperm RNA can possess a function, and 
furthermore, that it can act as an epigenetic modifier in the early embryo 
(Rassoulzadegan et al., 2006).   
 
4.6.2. Influence of histones on gene expression 
 
Somatic RNAs are associated with the nuclear matrix that lies interior to the 
nuclear envelope. The nuclear matrix dynamically organises DNA into loop 
domain structures on the matrix (Ward et al., 1989), which provides a platform 
for transcription and replication (Tsutsui et al., 2005). The integrity of this nuclear 
matrix is vital in mouse fertility (Ward et al., 1999; Ward et al., 2000). Like 
somatic RNAs, the RNA contained within spermatozoa is integrated into the 
nuclear matrix. The retention and preferential packaging of sperm RNA at the 
nuclear matrix is paralleled in the sperm nuclear DNA. Central to the formation of 
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the mature male gamete is the replacement of histones with protamines to form 
a highly condensed inert conformation. The replacement of histones with 
protamines was thought to be a complete process. However, emerging evidence 
has revealed that the haploid sperm genome is not entirely protamine-bound, 
with some regions of the genome retaining and associating with core histones 
(Ooi and Henikoff, 2007). In humans, approximately 15% of sperm DNA is 
retained in histone bound structures (Gatewood et al., 1987).  
 
Like RNA packaging at the nuclear matrix, differential packaging of sperm DNA 
with histones suggests functional significance. The ß-globin gene family analysed 
in human sperm demonstrated that gene products active in the embryonic sac 
preferentially associated with histones, while those that remain silent in the yolk 
sac associate with protamines (Gardiner-Garden et al., 1998). The maternally 
imprinted IGF2 gene has also been confirmed to be differentially packaged with 
histones (Wykes and Krawetz, 2003). These studies suggest that histone retention 
is not only a non-random event, but is linked with gene activity. Furthermore, 
packaging of DNA with protamines results in a conformation that is more tightly 
compact than that with histones, and it is hypothesised that the less tightly 
condensed genetic regions associated with histones may allow genes important 
in development to be rapidly transcribed during early embryonic stages.  
 
The extent of histones in regulating gene expression extends beyond their 
association with genes that are merely active in early embryo development to 
those specifically associated with imprinted regions. Comparative genome 
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hybridisation has shown preferential packaging of DNA with histones with CTCF 
factor binding sites (Lalancette et al., 2008). As mentioned previously, CTCF sites 
are found extensively in the ICRs of imprinted regions, which through binding of 
the CTCF protein, acts as an insulator, regulating imprinted gene expression in a 
parent-of-origin specific manner.  CTCF is a nuclear matrix associated factor and 
the nuclear matrix is the site at which histone bound DNA (and RNA) containing 
genes actively transcribed in early embryogenesis localises. From this, it has been 
speculated that CTCF may play a role in coordinating chromatin repackaging, so 
that the 15% histone content in sperm is ‘reserved’ for coding and regulatory 
elements of the paternal genome (Lalancette et al., 2008). The question raised 
here is why there is a need to segregate the coding from the non-coding regions 
of the paternal genome if protamines are rapidly replaced with histones after 
fertilisation. Again, this group speculated that by excluding most genes from 
protamine packaging, the paternal genome delivers an epigenetic blue-print to 
the oocytes of all coding genes to ensure compatibility.  This may be critical for 
imprinted genes for example, which are monoallelically expressed, and biallelic 
expression of these genes results in deleterious phenotypes. Lalancette et al. 
(2008) go on to suggest that the RNA present in spermatozoa may act to 
suppress transcription of those regions that ‘escape’ compact protamine 
conformations through an RNA-mediated mechanism similar to RNAi.  
 
It has also been suggested that the resistance of vital genomic imprinting regions 
to genome-wide demethylation of the paternal genome may be mediated by 
histone modifications (Ooi and Henikoff, 2007). Furthermore, the role of histones 
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in maintaining gene expression is exemplified by evidence that a 60% reduction 
in DNA methylation had no influence on gene expression. 
 
4.6.3. The effect of ethanol on histone modifications and 
RNA species 
 
4.6.3.1. Ethanol disrupts H3K9 trimethylation 
 
As described previously, chromatin is comprised of nucleosomes which consist of 
DNA wrapped around an octamer of histone proteins. These histones can be 
chemically modified to open and close the chromatin structure, regulating 
transcription and thereby gene activity. Histone modifications include, among 
others, acetylation and methylation of lysine (K) residues of the histone N-
terminal tail. Histone methylation is mediated by histone methyltransferases 
(HMTases). Identical to DNMTs, HMTases make use of the methyl group donated 
by S-adenosyl-methionine (SAM).  During cellular differentiation or metabolism, 
changes in gene expression are achieved through global epigenetic modifications 
that include histone acetylation and methylation, and DNA methylation (Shukla et 
al., 2008). Methylation of histone lysines H3K9, H3K27 and H4K20 are related to 
gene silencing, whereas H3K4 and H3K79 are associated with gene activation.  
 
EtOH metabolism has been shown to cause significant biological effects by 
altering histone modifications (Shukla et al., 2008). Studies have revealed 
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selective acetylation of H3K9 in rat hepatocytes (Park et al., 2003; Kim and 
Shukla, 2005), as well as the lung, spleen and testes (Kim and Shukla, 2006) as a 
consequence of EtOH exposure. As a result of H3K9 acetylation, a decrease in 
methylation at the same lysine residue was observed. Concurrently, H3K4 
methylation increased, and was associated with increased gene expression (Pal-
Bhadra et al., 2007). Furthermore, altered histone H3K9 methylation has been 
shown to result in the epigenetic silencing of tumour necrosis factor α (TNFα), 
which is suspected to be involved in endotoxin-mediated inflammatory processes 
(El Gazzar et al., 2007). 
 
As evidenced in the present study, although no differences were observed in 
sperm DNA methylation, a decrease in DNA methylation was observed in the 
EtOH offspring. If EtOH had induced site specific modifications of sperm DNA 
histones in this study but not caused a significant decrease in sperm DNA 
methylation, a role for histones in mediating DNA methylation may be implied.   
 
Evidence for the interaction between DNA methylation and histone methylation 
was first observed in the fungus, Neurospora crassa (Tamaru and Selker, 2001). 
Mutations in the dim-5 gene that encodes a H3K9 methyltransferase resulted in a 
complete loss of all DNA methylation. Similar findings demonstrated that 
mutations in the Arabidopsis thaliana H3K9 methyltransferase, kryptonite, 
abolished DNA methylation of CpNpG sites (Jackson et al., 2002). This is thought 
to be regulated by the A.thaliana heterochromatin protein 1 (HP1), which binds 
to methylated H3K9 and recruits a DNA methyltransferase to target CpNpG sites. 
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This mechanism is also evident in mouse embryonic stem cells (Lehnertz et al., 
2003). Pericentric heterochromatin in mice is characterised by H3K9 
trimethylation and high levels of DNA methylation. H3K9 trimethylation is 
mediated by the histone methyltransferases Suv39h1 and Suv39h2 via 
heterochromatin protein 1 isoforms HP1α and HP1ß to stabilise heterochromatic 
domains. Lehnertz et al. (2003) showed that Suv39h-mediated H3K9 
trimethylation recruits Dnmt3b (a de novo Dnmt) to heterochromatic regions, 
guiding DNA methylation (Figure 4.1). Furthermore, increased histone acetylation 
and decreased DNA methylation are associated with increased gene expression, 
indicating a reciprocal relationship between these two modifications.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Histone and DNA 
methylation pathways at 
mammalian heterochromatin. 
The pathways of histone and 
DNA methylation pathways at 
satellite regions in the mouse 
are depicted. The putative 
Dnmt3a/Dnmt3b-Hp1α/Hp1ß 
complex is recruited via Suv39h-
dependent H3 K9 trimethylation 
to direct DNA methylation at 
satellite regions. There also 
exists a Suv39h-independent 
pathway where the Suv39h-
unrelated HMTase which is 
hypothesized to mediate H3 K9 
dimethylation, and interacts 
with Dnmt3b to establish a 
silent chromatin domain. Dnmt1 
is also speculated to play a role 
in directing DNA methylation 
independently of H3 K9 
methylation in a currently 
unknown manner (Lehnertz et 
al., 2003). 
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4.6.3.2. Ethanol induces differential microRNA expression 
 
MicroRNAs comprise approximately 1% of mammalian genes (Berezikov et al., 
2005) and are estimated to regulate the expression of 30% of the human 
genome (Lewis and Redrup, 2005) and are therefore abundant regulators of gene 
expression. They are vital in embryonic development (Yu et al., 2007) and 
perturbations to miRNAs have been associated with disease states and birth 
abnormalities.  
  
Based on prenatal ethanol exposure models, the effects of ethanol on miRNAs 
have only been recently explored with seemingly conflicting results. A sub-set of 
miRNAs have been identified in the cortical neurons of mice in vitro that are 
aberrantly down-regulated as a consequence of EtOH exposure (Sathyan et al., 
2007). A bioinformatic analysis of global gene expression data obtained from 
ethanol exposed embryos was used to detect potential cis-acting elements that 
may underlie the biological effects of alcohol (Wang et al., 2008). In contrast to 
the findings of Sathyan et al. (2007), analyses revealed that alcohol treatment 
stimulated expression of miRNAs, as detected by increased levels of miRNA 
binding sites (3’-UTRs). Wang et al. (2009) used a similar in utero mouse model 
and analysed the expression of 509 miRNAs in foetus brains using a miRNA 
microarray, which was verified using northern blot and quantitative real-time PCR 
techniques. They found that of the miRNAs screened, six were found to be up-
regulated, while eight were down-regulated. These findings were congruent with 
significant decreases in litter size and weight observed in the ethanol exposed 
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foetuses (Wang et al., 2009).  
 
Together, these findings demonstrate that ethanol has the ability to both up- and 
down-regulate miRNAs. Considering the vast number, the diverse functions and 
intricate mechanisms of miRNA expression and gene regulation, these results may 
not be surprising or in conflict. What is important however is that ethanol has a 
significant impact on the regulation of miRNAs in biological models based on 
prenatal ethanol exposure. 
 
4.7. Implications of altered epigenetic mechanisms 
 
The effect of EtOH to decrease miRNA levels may have a direct link with a loss in 
DNA methylation. RNA-directed DNA methylation was first observed in plants, 
where RNA virus infection triggered methylation at identical DNA sequences 
(Wassenegger et al., 1994). Similarly, RNA species in mammals are able to direct 
DNA methylation. X inactivation in the female mouse relies on the Xist RNA to 
coat the X chromosome to be inactivated in cis. This association has been 
demonstrated to trigger cytosine methylation (Heard et al., 2001; Lee, 2003). By 
implication, the loss of Xist would result in the inability to inactive the X 
chromosome through RNA-directed DNA methylation.  
 
The apparently minimal EtOH-induced loss of sperm DNA methylation yet 
pronounced decreases observed in offspring in this study may be explained by 
disruption of miRNA in the sperm prior to conception. As in X chromosome 
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inactivation, miRNA species responsible for directing DNA methylation at 
imprinted loci may be down-regulated during spermatogenesis as a consequence 
of alcohol exposure. Upon fertilisation, a deficiency of sperm-specific miRNAs 
responsible for RNA-directed DNA methylation may be introduced to the embryo, 
with subsequent failure to establish correct imprinting marks.  
 
Ethanol’s ability to decrease H3K9 methylation provides another mechanism that 
could account for the dramatic loss of DNA methylation observed in offspring. 
During spermatogenesis, EtOH-induced increased acetylation and subsequent loss 
of H3K9 histone methylation in mature spermatozoa may be present at 
significant levels globally, and thereby at regions of DNA whose 
methylation/imprints have already been established. Thus, normal imprinting 
marks would be present at these regions, but concurrently harbouring altered 
histone modifications. These aberrant histone modifications would be conveyed 
through the affected sperm to the fertilised oocyte. During the onset of DNA 
replication initiation, H3K9 acetylation marks would actively prevent DNA 
methylation, repressing imprint establishment.  
 
The proposed “conflict” chromatin mark model, whereby chromatin harbours 
both DNA methylation (a repressive chromatin mark) and histone acetylation (an 
active chromatin mark) has not been extensively explored in the literature. 
However, investigations into methylation mechanisms in Neurospora identified an 
unmethylated DNA region that was histone H4 hypoacetylated {selker 2002}. As 
active chromatin is conventionally associated with unmethylated DNA and 
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hyperacetylation of histone H4, this finding supports evidence a “conflicting” 
chromatin state. Furthermore, the erythroid-specific carbonic anhydrase II (CAII) 
promoter has been shown to possess active histone modifications () localised 
around the transcription start site, while concurrently harbouring high levels of 
CpG methylation directly upstream of these active marks {Brinkman 2007}. This 
“bipartite” epigenetic code, in part, also appears to support evidence of a 
chromatin state that contains opposing marks. 
 
However, the mechanisms of reduced miRNAs and altered histone modifications 
in sperm accounting for losses of DNA methylation in subsequent offspring still 
require much investigation. 
 
 
 
4.8.  Epigenetic switching: a mechanism for growth 
retardation 
 
In the original hypothesis of the current study, it is proposed that exposure of male 
mice to alcohol would induce a loss of DNA methylation at the H19, IG and 
Rasgrf1 ICRs in sperm DNA. The implications of this would have a significant 
impact on the parent-of-origin reciprocal imprinting of these loci, in which the 
maternal allele is normally hypomethylated and the paternal allele 
hypermethylated. The loss of methylation at a paternal ICR would be carried as an 
aberrant methylation imprint in the nucleus of mature sperm. Subsequently, each 
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of these loci would become actively regulated in the embryo after fertilization. 
According to the proposed model by which imprinted loci are regulated, the 
hypomethylated state of an ICR allows for the binding of the CTCF protein, as in 
the maternal allele. Binding of CTCF to the maternal ICR insulates the downstream 
common enhancer from accessing the upstream paternally-expressed gene 
promoter, while the downstream maternally-expressed gene promoter is selectively 
acted upon.  
 
The data of this study confirm the ability of ethanol to reduce DNA methylation to 
some extent in the sperm of exposed males, but significantly impacts imprinted 
regions of the paternal allele in their offspring. This loss of imprinting on the 
paternal allele, especially at the H19 ICR (CTCF 1 and 2), would allow CTCF 
binding at the ICR, essentially switching the allele to a maternal epigentotype. This 
would result in the expression of the normally silent maternal H19 gene from the 
paternal (sperm) allele, while silencing the paternally expressed Igf2 gene. 
Concurrently, the maternal allele still possesses normal regulation and gene 
expression, resulting in double expression of the maternally expressed H19 gene 
and repression of the paternal Igf2 gene from both alleles. Support for this stems 
from findings whereby the inhibition of Dnmts resulted in decreased methylation 
at the Igf2/H19 locus and subsequent activation of H19 from the paternal allele (Li 
et al., 1992). 
 
This has significant implications according to the conflict hypothesis, which states 
that paternally expressed genes from imprinted regions use maternal resources to 
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promote embryonic growth and development; while maternally expressed genes 
endeavour to conserve maternal resources. As mentioned previously, the Igf2/H19 
locus is vital in embryonic development. The paternally expressed Igf2 gene is a 
potent mitogen promoting offspring growth while the maternally expressed H19 
gene negatively regulates Igf2 expression. 
 
The observed switch in epigenotype from a heavily methylated (imprinted) paternal 
allele to a hypomethylated “maternal” allele state, as observed in the offspring at 
the H19 ICR, has significant implications on embryonic growth. Suppression of the 
paternally expressed growth-promoting Igf2 gene and enhanced activity of the 
maternally expressed H19 gene would in effect hamper offspring growth.  
 
 
 
4.9. The three-way tryst – treatment, DNA methylation and 
offspring development 
 
Thus far, it has been shown that paternal exposure to EtOH influences both the 
weight and DNA methylation profiles of sired offspring. The question that must 
be asked is whether treatment (EtOH) causes the observed growth retardation in 
offspring through decreases in DNA methylation. In other words, does the EtOH-
induced decrease in offspring DNA methylation (via the sire) dysregulate 
imprinting control and establishment and thereby cause aberrant regulation of its 
associated gene, resulting in the stunted growth phenotype. 
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Correlation analyses of the level of offspring DNA methylation at particular 
regions/CpG sites with offspring weight at each of the 20 time points were 
assessed. The findings of this study demonstrated that the level of methylation at 
the H19 regions (CTCF 1 and 2) were highly correlated with days 28 to 56. 
Furthermore, these correlations appeared in a “block”, where correlations were 
rarely observed outside of this. Similarly, but not as obvious, Rasgrf1 CTCF 
methylation correlated with days 2, 4 and 6 while Snrpn correlated primarily with 
days 35 and 56. This demonstrates that the level of DNA methylation is correlated 
with offspring weight at specifically grouped days in a positive relationship. That 
is, low levels of DNA methylation correlate with low weights (and vice versa for 
higher levels of methylation). This therefore suggests a functional relationship 
between DNA methylation and offspring weight. 
 
To investigate this relationship further, mediation analyses and multilevel 
modelling were conducted to establish whether treatment influenced offspring 
weight via DNA methylation. Multilevel modelling revealed insignificant results at 
all regions and individual CpG sites investigated. Furthermore, results seemed to 
be in conflict as some regions and CpG sites appeared to marginally decrease 
average offspring weight, while others slightly increased offspring weight. This 
conflict and lack of significance can be attributed to the fact that a small male 
sample size was employed (n=13, two males excluded from the study). All 
offspring data is nested within females/dams, which in turn are nested within the 
13 males. This hierarchical structure therefore decreases the sample size used for 
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analyses to essentially 13 data points, which is further separated into the two 
treatment groups. This would therefore provide inadequate power to detect 
significant differences.  
 
Mediation analyses revealed only two regions that significantly mediated a 
decrease in offspring weight (CTCF 1 and H19 CpG12) at day 35. In conjunction 
with the significant decrease in offspring DNA methylation at these regions and 
the strong correlation of these regions with decreased offspring weight at day 
35, these mediating effects strongly support a functional role of DNA methylation 
in offspring growth. 
 
 
4.10. Strengths and limitations of the present study 
 
4.10.1. Limitations 
 
The limited sample size of both treated males and subsequently the number of 
offspring obtained were a significant limitation to this study in terms of statistical 
analyses. Primary of which included mediation and hierarchical/multilevel 
modelling analyses, which failed to detect significance due to lack of power as a 
consequence of undersized samples. Furthermore, mediation analyses were not 
based on a hierarchically structured model and thus analyses may not have been 
accurate in terms of a nested data set structure.   
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The current study focused on a single maternal ICR, namely Snrpn. Conclusions 
regarding the observed demethylation and gain of methylation in the sperm and 
offspring, respectively, cannot therefore been be generalised to other maternally 
imprinted regions.   
 
Although pyrosequencing is a highly effective method of quantifying DNA 
methylation, it has the distinct disadvantage in that it does not allow for 
qualitative assessment. Qualitative analyses, such as clonal bisulfite sequencing, 
enable the assessment of DNA methylation at a site-specific level of individual 
clones. This analysis allows for patterns in the loss of DNA methylation to be 
observed (as performed in sire sperm analyses). That is, one can assess whether 
losses of DNA methylation at individual CpG sites occur in “blocks”, or whether 
they are randomly distributed across clones. These “patterns” may have 
important implications for the binding efficiency of certain proteins, such as 
CTCF, and the proposed allele-switching mechanism. As this study only examined 
DNA methylation in offspring tail biopsies quantitatively via pyrosequencing, the 
resolution of DNA methylation could not be analysed qualitatively at the level of 
individual clones.  
 
Lastly, the lack of significant EtOH-induced loss of DNA methylation observed in 
the sperm of treated males suggests that the treatment regimen employed in this 
study may not have been performed over a sufficient period of time. Greater 
EtOH concentrations and/or longer exposure of males to EtOH may be more 
appropriate to detect EtOH-induced epigenetic aberrations at imprinted loci. 
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Furthermore, significant decreases in DNA methylation in the offspring of EtOH 
treated males suggest that other epigenetic mechanisms are affected by EtOH 
exposure. These include RNA species and histone modifications, which have been 
shown to be altered by EtOH, but were however beyond the scope of this study.  
 
4.10.2. Strengths 
 
The major strength of this study was that it included all three of paternal ICRs 
known to date that spanned separate and distinct imprinted loci. Without this 
range, it may have been concluded that imprinting loci in offspring sired by EtOH 
treated males are significantly demethylated based on findings of the H19 ICR. 
However, as evidenced in the present study, the extent of aberrant methylation 
varies significantly between loci.  
 
Another clear strength of this study was the inclusion of the Snrpn ICR. This locus 
not only served to determine somatic (maternal allele) contamination, but 
provided further evidence of EtOH-induced loss of methylation in sperm DNA and 
increased levels of methylation in offspring. 
 
4.11. Future studies 
 
As outlined in the study limitations above, future studies are required to focus 
primarily on the functional implications of loss of imprinting. This would provide 
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further insight into the role of imprinting as a mechanism of EtOH-induced 
growth retardation in offspring. Such studies would assess the status of 
methylation at imprinted loci in relation to the relative expression of their 
associated genes. Furthermore, it may be advisable to explore various tissue types 
as some imprinted genes show tissue-specific expression, where they may be 
biallelically expressed in some tissues, and monoallelically expressed in others 
(Wilkins, 2006). Tissues that demonstrate strict imprinting and monoallelic 
expression of imprinted genes include epithelial tissues (such as those obtained 
from tail biopsies), hepatic, muscle and neural tissues. Quantification of gene 
expression could be achieved using quantitative real-time PCR or gene expression 
arrays. In addition, techniques such as chromatin immunoprecipitation should be 
employed to quantify the level of CTCF binding at ICRs and correlate these 
findings with levels of methylation and gene expression.  
 
The role of primary DMRs (ICRs) in determining the methylation status of 
secondary DMRs and promoter regions would require further studies to expand 
the repertoire of imprinted loci to include paternal secondary differentially 
methylated regions, such as the Igf2 DMR and the H19 promoter. As 
demonstrated by the loss and gain of methylation at the Snrpn ICR in sperm and 
offspring, respectively, maternally differentially methylated regions should also be 
investigated.  
 
As highlighted previously, the duration and dosage of the EtOH regimen may 
have significant impacts on offspring development and methylation at imprinted 
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loci. It is therefore suggested that future studies investigate the effects of 
paternal EtOH exposure over varied time periods and include a range of EtOH 
concentrations.   
 
Lastly, the effect of EtOH exposure on other epigenetic mechanisms, such as 
regulation of gene expression via RNA species and histone modifications should 
be explored in both sperm and in sired offspring. A variety of techniques can be 
employed to assess histone modifications, including western blotting and 
immunofluorescence. However, these immunoassay methods are often fraught 
with problems, including cross-reactivity, variable specificity and epitope 
occlusion. For these reasons, mass spectrometry is often favoured to quantify 
histone modifications (Garcia et al., 2007). RNA array platforms (including micro 
RNA arrays), in conjunction with quantitative reverse transcription PCR (qRT-PCR) 
enable the detection of RNAs, and facilitate the analysis of global RNA expression 
profiles (Tang et al., 2006). These findings should be further correlated with levels 
of methylation and gene expression of associated regions.  
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Chapter 5 
5. Conclusion 
 
The findings of this study suggest that exposure of sires to EtOH for a five week 
period prior to conception has a limited ability to reduce DNA methylation at ICRs 
in sperm DNA but has the ability to negatively influence the epigenetic state of 
these ICRs of developmentally significant imprinted genes in sired offspring. 
 
Findings of EtOH-induced loss of methylation in sperm DNA were confined to 
specific CpG sites which spanned all four ICRs, albeit to a very limited degree. 
This agreed only in part with our hypothesis, where it was predicted that this loss 
would occur on a larger scale. The minimal decrease in DNA methylation 
observed in sperm DNA of EtOH-exposed males suggests that exposure time of 
males to EtOH and/or the dosage utilised may not have been sufficient to induce 
significant epigenetic effects. It is also suggested that methylation in sperm DNA 
may be more resistant to the deleterious effects of EtOH. However, this 
mechanism can only be hypothesised as no such mechanism has been 
scientifically explored or identified to date.  
 
In contrast, a severely reduced methylation status was observed at the H19 ICR, 
which included both the CTCF binding site regions. This was in accordance with 
the prediction that treatment of sires with EtOH would adversely affect the 
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methylation pattern of imprinted loci in offspring.  
 
Due to the large effects noted at the H19 ICR in the offspring of the EtOH-
exposed males and the limited significant findings in sire sperm, it is proposed 
that other epigenetic mechanisms are more susceptible to the effects of EtOH or 
other teratogenic agents. These epigenetic alterations may involve histone 
modifications and/or aberrant effects on RNA species which are transferred 
through the mature spermatozoa to the oocyte. 
 
It was further noted that the offspring of EtOH-treated males displayed growth 
retardation during postnatal development. Correlation analyses revealed that the 
reduced levels of DNA methylation at the H19 ICR in EtOH offspring coincided 
with this period of growth retardation. Furthermore, the effects of EtOH on 
reduced offspring weight were shown to be mediated through DNA methylation, 
supporting the predication that lowered levels of DNA methylation (as a 
consequence of paternal EtOH exposure) in the offspring would negatively affect 
their growth.  
 
Overall, the excessive exposure of male mice prior to conception for at least the 
duration of one cycle of spermatogenesis impacts negatively on offspring DNA 
methylation at imprinted loci and weight. Furthermore, the effect of EtOH on 
offspring growth retardation appears to be mediated through reduced levels of 
DNA methylation at the H19 ICR. The growth retardation phenotype observed in 
the offspring was proposed to involve an ethanol-induced epigenetic switch. It is 
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proposed that reduction in the DNA methylation patterns of the H19 ICR on the 
paternal allele switches the epigenotype to a hypomethylated maternal allele 
state. This in turn, promotes the binding of the CTCF enhancer-blocking protein 
at the paternal H19 ICR reducing expression of Igf2 and consequently resulting in 
offspring growth retardation.  
 
In conclusion, EtOH-induced demethylation of paternally methylated ICRs in the 
sperm of treated males was not significant. However, large-scale reduction in 
DNA methylation was observed in their offspring, demonstrating that excessive 
exposure of male mice to EtOH impacts on the epigenetic state of their progeny, 
and is associated with a growth retardation phenotype. This mechanism may 
have important implications in the aetiology of FAS, where pre- and postnatal 
growth retardation is observed. Although the effect of paternal treatment with 
EtOH on growth retardation appears to be mediated through DNA methylation, 
further studies are required to determine the effect of reduced methylation at the 
H19 ICR on the expression levels of H19 and Igf2. 
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Appendix B 
Solution Preparations 
dNTP Mix      
 dATP (10mM) 10µl     
 dTTP (10mM) 10µl     
 dCTP (10mM) 10µl     
 dGTP (10mM) 10µl     
 ddH2O 760µl     
  800µl     
       
 dNTPs are comercially available from Roche Diagnostics   
       
3% Agarose Gel      
 Agarose 12g     
 1 x TBE* 400ml     
 EtBr* (10mg/ml) 12µl     
       
 EtBr (Ethidium Bromide: 3µl EtBr/100ml 1 x TBE)    
       
10 x TBE      
 Tris 216g     
 Boric acid 110g     
 EDTA 14.88g     
       
 Make up to 2 litres with dH2O      
       
TE Buffer (10mM Tris-HCl, pH7.4; 0.1mM EDTA)    
 2M Tris-HCl (pH7.4)* 0.5ml     
 EDTA (pH 8.0)* 20µl     
 dH2O 99.48ml     
  100ml     
       
 Autoclave and store at room temperature    
       
2M Tris-HCl pH7.4      
 Tris base 242.2g     
 dH2O 700ml     
 Final volume (H2O) 1L     
       
 pH was adjusted by adding ~140µl concentrated HCl and autoclaved  
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0.5M Ethylenediamine Tetra-acetic Acid (EDTA)    
 Na2EDTA.2H2O 93.05g     
 dH2O 300ml     
 Final volume (H20) 500ml     
       
 pH adjusted to 8.0 with 10M NaOH* and autoclaved   
       
Luria Broth      
 NaCl 6g     
 Tryptone 6g     
 Yeast extract 3g     
 Final volume (dH2O) 1L     
       
 pH was adjusted to 7 using 5M NaOH, auoclaved and stored at 4oC  
       
Luria Agar Plates      
 dH2O 500ml     
 NaCl  5g     
 Tryptone 5g     
 Yeast extract 2.5g     
 Agar 10g     
       
 pH was adjusted to 7.0 using 5M NaOH*, autoclaved and 500µl (50mg/ml) ampicillin was added 
 This was then poured into 100mm petri-dishes    
       
Ampicillin (50mg/ml)      
       
10M NaOH      
 NaOH pellets 4g     
 dH2O 10ml     
       
 Caution: this is an extremely caustic base     
       
Lysis Solution (freshly prepared)      
 ddH20 7.35ml     
 50% Glucose 2ml     
 0.25M EDTA 0.4ml     
 1M Tris.HCl (pH8.0) 0.25ml     
  10ml     
       
 Glucose solution was filter sterilized using a 0.45µm filter prior to use and stored at 4oC 
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Alkaline SDS      
 ddH2O 8.33ml     
 10% SDS 1ml     
 3M NaOH 0.67ml     
  10ml     
       
High Salt Solution (3M NaOAc)      
 NaOAc 4.1g     
 ddH20 50ml     
       
 pH corrected to 5.2 with concentrated HCl    
       
RNase A Solution       
 ddH2O 500µl     
 RNase A stock (7000u/ml) 10µl     
  510µl     
       
Ethidium Bromide (EtBr)      
 EtBr powder 10mg     
 dH2O 1ml     
       
 EtBr is light sensitive and must be stored in a dark bottle.   
 This reagent is also commercially available from Sigma Aldrich  
       
100 bp Molecular Weight Marker (100ng/µl)    
 Ficoll* 1µl     
 100bp DNA stock (1µg/µl) 1µl     
 ddH2O 8µl     
  10µl     
       
 100bp molecular weight marker is available from Invitrogen   
       
Proteinase K (10mg/ml)      
 Proteinase K stock (100mg/ml) 100mg     
 ddH2O 10ml     
       
 Proteinase K stock is available from Roche Diagnostics   
       
Ficoll-bromophenol Blue Loading Dye (Ficoll)    
 50% Sucrose crystals 50g     
 0.5M EDTA (pH 7.0) 0.1ml     
 0.1% Bromophenol blue dye 0.1g     
 10% Ficoll powder 10g     
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 Final volume (ddH2O) 100ml     
       
Phosphate Buffered Saline      
 Tablet x 1     
 ddH2O 100ml     
       
 Allow tablet to dissolve in water      
 Note: PBS tablet Oxid Cat. No. BR14a)     
       
70% Ethanol (EtOH)      
 100% Ethanol 70ml     
 ddH2O 30ml     
  100ml     
       
90% Ethanol      
 100% Ethanol 90ml     
 ddH2O 10ml     
  100ml     
       
50% Ethanol       
 100% EtOH 50ml     
 ddH2O 50ml     
  100ml     
       
TFB I Buffer (per 200ml)      
 Potassium acetate 0.588g     
 Rubidium chloride 2.42g     
 Calcium chloride 0.294g     
 Manganese chloride 2.0g     
 Glycerol 30ml     
       
 Make up to 200ml with ddH2O      
 Adjust pH to 5.8 with dilute acetic acid and filter sterilise   
       
TFB II Buffer (per 100ml)      
 MOPS 0.21g     
 Calcium chloride 1.1g     
 Rubidium chloride 0.121g     
 Glycerol 15ml     
       
 Make up to 100ml with ddH2O      
 Adjust pH to 6.5 with 5M NaOH and filter sterilise    
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Sucrose solution (0.704g/ml)      
 dH2O 1000ml     
 Sucrose 704g     
       
 Dissolve sucrose in dH2O at RT      
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Appendix C 
DifferexTM System to QIAamp DNA Mirco Kit bridging protocol 
 
 
 
1. Add 100µl of Buffer ATL to the Separation Solution to obtain a final volume of 
approximately 200µl. 
2. Add 7µl of 1M DTT*, and add 20µl of Proteinase K*. 
3. Close the lid and mix by pulse-vortexing, and briefly spin down the solution.  
4. Add 200µl of Buffer AL and mix by pulse-vortexing for 15s. 
5. Place the tube into an orbital incubator at 56oC at 900 rpm overnight. 
6. Spin down and add 200µl of 100% EtOH, close the lid and mix thoroughly by pulse-
vortexing for 15s. 
7. Incubate for 3 min at RT. 
8. Spin down and place entire contents of tube into a QIAamp spin column. 
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Appendix D 
Preparation of competent DH5α E.coli cells 
 
 
1. 20µl of stock DH5α E.coli was plated onto a LA* plate containing no antibiotic, and 
left to incubate overnight at 37oC. 
2. A single colony was then removed from the plate and inoculated into 5ml of LB 
medium* in a 50ml flask and incubated overnight at 37oC. 
3. 1ml of this overnight culture was then inoculated into a 500ml flask containing 100ml 
LB, and incubated at 37oC with aeration to A600 = 0.48. 
4. Once the required absorbance reading was achieved, the flask was immediately 
placed on ice for 15min. Note: cultured cells were kept cold from this step forward. 
5. 50ml of the culture medium was then placed in a 50ml centrifuge tube and pelleted 
at 3500rpm for 5min. 
6. The resulting supernatant was then discarded and 0.4 volume of TFB I buffer* was 
added to gently re-suspend the pellet. This was then incubated on ice for a further 
15min. 
7. Cells were then pelleted at 3500rpm for 5min. 
8. Once again, the supernatant was discarded and the pellet re-suspended in 0.04 
volume of TFB II* (0.04 of the culture volume). The solution was then kept on ice for 
15min. 
9. 500µl aliquots of the bacterial solution were prepared and flash frozen in liquid 
nitrogen and stored at -80oC.  
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Appendix E 
Transformation protocol 
 
 
1. Competent DH5α E.coli cells were stored at -80oC and thawed on ice immediately 
prior to use. 
2. 25µl of DH5α E.coli cells was added to a 1.5ml microfuge tube for each sample. 
3. 5µl of (~200ng/µl) the ligation product was then added to the cells. The remaining 
5µl was stored at -20oC as backup stock. 
4. The transformation solution was then placed in ice for 15min. 
5. Subsequently, the solution was heat-shocked for 90s at 42oC. 
6. This was then placed on ice for a further 25min. 
7. Following this, 700µl of luria broth (LB) was added to each sample. Note: this is a 
“rescue” LB, which contains no antibiotics.  
8. Samples were then incubated at 37oC for 1 hour. This time allows the bacteria to 
initiate expression of the ampicillin resistance gene. 
9. After the 1 hour incubation, each sample was centrifuged for 1 min at 3500 rpm. This 
pellets the transformed bacterial cells. 
10. The bacterial pellet was then pipetted out along with 500µl of the LB medium. This 
was then plated on luria agar (LA) plates containing 1µl/1ml Ampicillin (Amp; 
50mg/ml).  
11. Plates were left to absorb the 500µl of LB culture medium for 1 hour at 42oC. 
12. Plates were then inverted and incubated overnight at 37oC. 
 
Note: plates were prepared for blue/white screening an hour prior to use by spreading 
50µl 100mM IPTG* and 50µl 2% X-gal* onto each LA plate.  
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Appendix F 
Protocol for isolation and purification of plasmid DNA from 
E.coli 
 
 
1. Overnight minipreps were spun down at 4 000 rpm for 1min in a microfuge to pellet 
the bacterial cells. 1ml of culture along with the bacterial pellet was removed and 
pipetted into a 1.5ml microfuge tube. This was spun for 30-40s in a centrifuge at 14 
000 rpm to re-pellet the cells. Note: this step was modified from the original protocol. 
Miniprep cultures were pelleted as opposed to being resuspended (as stated in the 
original protocol). This was performed so as to obtain a greater number of bacterial 
cells for higher yields of plasmid DNA. 
2. Supernatant was decanted and the pellet was resuspended in 100µl Lysis Solution*. 
3. 200µl Alkaline SDS* was added to each tube and vortexed well. 
4. Tubes were then incubated in an ice water bath for 5min. 
5. 150µl of High Salt Solution* was then added to each sample and vortexed well. 
6. Tubes were then incubated in the ice water bath for 10min. 
7. These were spun for 10min at 14 000 rpm. 
8. 400µl of the supernatant from each sample was removed and transferred to a new 
1.5ml microfuge tube pre-filled with 400µl 100% isopropanol. 
9. Samples were vortexed well and kept in the ice water bath for 10min. 
10. Tubes were spun at 14 000rpm for 10min. 
11. The supernatant was then discarded. 
12. 500µl 70% EtOH* was added to each tube and briefly vortexed to wash the pellet. 
13. Samples were then re-pelleted for 3min at 14 000 rpm. 
14. EtOH was removed by inverting each tube onto clean paper towel. 
15. Tubes were then placed in a heating block at 50oC for two hours to dry the pellets of 
excess EtOH.  
16. 50µl ddH2O (not 100µl TE* as per protocol) with 4µg/ml RNase A* was added to each 
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sample to resuspend the pellet, and incubated at 42oC for 20min. 
17. 1µl of this was used for restriction enzyme digestion. 
18. Plasmid DNA was stored at -20oC.  
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Appendix G 
Pyrosequencing preparation protocol 
 
 
The following protocol was been taken from Biotage’s sample preparation guidelines: Sample 
preparation guidelines for PSQTM 96 and PSQ 96MA systems. 
 
1) Immobilization of PCR product to beads:  
 
• For all samples, run 5µl of pre-pyrosequencing PCR on a 3% agarose gel to check for 
strong PCR products.  
• Place samples in a 96-well PCR plate. 
• Vigorously shake the bottle of streptavidin Sepharose beads until a homogenous 
solution is obtained. 
• Make up a master mix of Sepharose and Binding buffer by adding 3µl of Sepharose 
and 40µl of Binding buffer for each sample. 
• Aliquot 43µl of the Sepharose/binding buffer mix to each sample. 
• Place the 96-well plate on a shaker for 10min so as to ensure that the beads remain 
in solution and don not settle. 
• Prepare the PSQ 96 Plate Low well plate with the sequencing primer and Annealing 
buffer. For each sample add 1.6µl of 10µM sequencing primer to 38.4µl of Annealing 
buffer. Make a master mix if required and aliquot 40µl into each well of the PSQ 96 
Plate Low.  
 
2) Strand separation of products: 
 
• Place the four troughs on the Vacuum Prep Workstation in the order shown in the 
diagram in the manual pg. 5. 
• Fill each trough up with the following:  
1) 70% Ethanol – 180ml  
2) Denaturation Buffer – 120ml 
3) Washing Buffer – 180ml    
4) ddH20 – 180ml 
• Turn the vacuum pump on and apply vacuum. Capture the beads and immobilized 
templates on the filter probes by lowering the Vacuum Prep Tool into the 96-well PCR 
plate. (Note: this must be done within 3min of agitation terminated so that beads do 
not settle. Also, re-suspend the samples with a pipette after agitation on the shaker.) 
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• Make sure all the Sepharose beads have been captured onto the filter probes. Place 
the Vacuum Prep Tool for 12sec into: 1) 70% ethanol 2) Denaturation buffer 3) 
Washing buffer. Hold the vacuum prep tool up at 90º to allow for all the liquid to 
completely drain from it for a few seconds and return to horizontal position. 
• Turn the pump off to release the vacuum. 
• Place the PSQ 96 Plate Low plate on the workstation and release the beads from the 
filter probes onto the plate by shaking the vacuum prep tool while allowing the filter 
probes to rest on the bottom of the wells.  
 
4.   Primer Annealing: 
 
• Heat the PSQ 96 Plate Low plate with the sequencing primer and Annealing buffer on 
a heating block at 80ºC for 3min.  
• Allow to cool to room temperature. 
 
6. Cartridge preparation:  
 
• Add the required volume of enzyme, substrate, and dNTPS into the reagent cartridge 
as specified by the software. This volume is sample number and assay design-
dependent.  
• Place the PSQ 96 Plate Low and cartridge into the PSQ 96MA instrument and start the 
run. 
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Appendix H 
Montage SEQ96 Sequencing Reaction Cleanup Kit protocol 
 
 
1. Cycle sequencing samples were diluted with 20µl Injection Solution (provided) and 
mixed gently by pipetting up and down 3-5 times. 
2. Diluted samples were then transferred into the bottom of a SEQ96 plate wells.  
3. The SEQ96 plate was then placed on the vacuum manifold (-15.in Hg) for 8min. 
4. After the vacuum is turned off, the bottom of the plate is blotted dry with paper 
towel. 
5. 30µl of Injection Solution was the added to each well and the SEQ96 plate placed back 
on the vacuum manifold. 
6. The vacuum was applied for a further 8min. 
7. Once the vacuum was switched off, the bottom of the plate was once again blotted 
dry. 
8. 30µl of Injection Solution was added to each samples well of the SEQ96 plate. 
9. The plate was then placed on an orbital shaker for 5min at 200rpm, to ensure that 
samples were sufficiently resuspended. 
10. Subsequently, samples were resuspended again by pipetting up and down 20 times, 
and transferred to a 96 well injection plate.   
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Appendix I 
Clone sequence data 
 
 
 
H19 61 (Sucrose) 
 
 
 
 
 
 
H19 62 (EtOH) 
 
 
 
 
 
 
 
 
 
 
- A p p e n d i c e s -  
 
 
 182
H19 63 (EtOH) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- A p p e n d i c e s -  
 
 
 183
H19 65 (EtOH) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- A p p e n d i c e s -  
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H19 66 (EtOH) 
 
 
 
 
 
 
 
 
 
H19 68 (EtOH) 
 
 
 
 
 
 
- A p p e n d i c e s -  
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H19 69 (Sucrose) 
 
 
 
 
 
 
 
H19 70 (Sucrose) 
 
 
 
 
H19 71 (Sucrose) 
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H19 72 (Sucrose) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- A p p e n d i c e s -  
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H19 73 (Sucrose) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- A p p e n d i c e s -  
 
 
 188
H19 74 (Sucrose) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- A p p e n d i c e s -  
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Rasgrf1 ICR 
Rasgrf1 60 (EtOH) 
 
 
 
 
 
 
 
Rasgrf1 61 (Sucrose) 
 
 
 
 
 
Rasgrf1 62 (EtOH) 
 
 
Rasgrf1 63 (EtOH) 
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Rasgrf1 65 (EtOH) 
 
 
 
 
 
 
 
Rasgrf1 66 (EtOH) 
 
Rasgrf1 68 (EtOH) 
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 191
 
Rasgrf1 69 (Sucrose) 
 
 
 
Rasgrf1 70 (Sucrose) 
 
Rasgrf1 71 (Sucrose) 
 
Rasgrf1 72 (Sucrose) 
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Rasgrf1 73 (Sucrose) 
 
 
 
 
 
 
Rasgrf1 74 (Sucrose) 
 
 
 
 
IG-DMR 
IG-DMR 62 (EtOH) 
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IG-DMR 63 (EtOH) 
 
 
 
 
 
 
IG-DMR 65 (EtOH) 
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IG-DMR 66 (EtOH) 
 
 
 
 
 
 
 
 
 
 
 
IG-DMR 68 (EtOH) 
 
 
 
 
 
 
 
 
 
 
 
- A p p e n d i c e s -  
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IG-DMR 71 (Sucrose) 
 
 
 
 
 
 
 
 
 
 
IG-DMR 72 (Sucrose) 
 
 
 
 
 
 
 
 
 
 
 
 
 
- A p p e n d i c e s -  
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IG-DMR 73 (Sucrose) 
 
 
 
 
 
 
 
 
 
 
Snrpn ICR 
 
Snrpn 60 (EtOH) 
 
Snrpn 61 (Sucrose) 
 
 
 
- A p p e n d i c e s -  
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Snrpn 62 (EtOH) 
 
Snrpn 63 (EtOH) 
 
Snrpn 65 (EtOH) 
 
Snrpn 66 (EtOH) 
 
 
 
 
 
 
- A p p e n d i c e s -  
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Snrpn 68 (EtOH) 
 
Snrpn 70 (Sucrose) 
 
Snrpn 71 (Sucrose) 
 
Snrpn 72 (Sucrose) 
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Snrpn 73 (Sucrose) 
 
Snrpn 74 (Sucrose) 
 
 
 
 
Open lollipops (o) = unmethylated CpG 
Filled lollipops (•) = methylated CpG 
Absent lollipops = data missing 
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Appendix J 
LTS robust regression macro script 
DATA changed;  
SET alldata.nosire; 
 
RUN; 
%MACRO ROBUSTMOUSE (DATA=,DV=,IV=,M=,CONTROLS=); 
TITLE 'ROBUST LTS Base'; 
PROC ROBUSTREG data=&DATA /*outest=mouse1*/ FWLS METHOD=LTS; 
Base: MODEL &DV=&CONTROLS/DIAGNOSTICS LEVERAGE; 
RUN; 
TITLE 'ROBUST LTS IV_DV'; 
PROC ROBUSTREG data=&DATA FWLS METHOD=LTS; 
IV_DV: MODEL &DV=&CONTROLS &IV/DIAGNOSTICS LEVERAGE; 
RUN; 
ODS LISTING CLOSE; 
ODS OUTPUT PARAMETERESTIMATESF=PATHA; 
TITLE 'ROBUST LTS IV_M'; 
PROC ROBUSTREG data=&DATA FWLS METHOD=LTS; 
IV_M: MODEL &M=&CONTROLS &IV/DIAGNOSTICS LEVERAGE;  
RUN; 
DATA PATHA; 
SET PATHA(WHERE=(PARAMETER='Treatment')); 
Keep ESTIMATE STDERR; 
LABEL ESTIMATE='PATHAEST'; 
RENAME ESTIMATE=PATHAEST; 
LABEL STDERR='STDERRA'; 
RENAME STDERR=STDERRA; 
 
ODS OUTPUT PARAMETERESTIMATESF=PATHB; 
TITLE 'ROBUST LTS IV_M_DV'; 
PROC ROBUSTREG data=&DATA FWLS METHOD=LTS; 
IV_M_DV: MODEL &DV=&CONTROLS &M &IV/DIAGNOSTICS LEVERAGE; 
RUN; 
DATA PATHB; 
SET PATHB(WHERE=(PARAMETER='/*Region/CpG of interest*/')); 
KEEP ESTIMATE STDERR; 
LABEL ESTIMATE='PATHBEST'; 
RENAME ESTIMATE=PATHBEST; 
LABEL STDERR='STDERRB'; 
RENAME STDERR=STDERRB; 
DATA PATHAB; 
 
MERGE PATHA PATHB; 
PATHAB=PATHAEST*PATHBEST; 
SEAB=SQRT(PATHAEST*PATHAEST*STDERRB*STDERRB+PATHBEST*PATHBEST*STDERRA*STD
ERRA); 
TSTAT=PATHAB/SEAB; 
RUN; 
PROC PRINT DATA=PATHAB; 
RUN; 
ODS OUTPUT CLOSE; 
ODS LISTING; 
%MEND ROBUSTMOUSE; 
%ROBUSTMOUSE (DATA=CHANGED,DV=DAY/*day of 
interest*/,IV=TREATMENT,M=/*region/CpG of interest*/,CONTROLS=SEX 
LITTER_SIZE) 
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97.9294.00100.0099.00100.0099.0095.50
93100991009995
95100991009996Sucrose74
96.1793.0094.0096.50100.0098.0095.50
9395971009896
9393961009895Sucrose73
96.8394.0099.0097.00100.0099.5091.50
9499971009991
94999710010092Sucrose72
97.5093.50100.0097.00100.0099.0095.50
93100971009995
94100971009996Sucrose71
97.6793.50100.0097.50100.0099.5095.50
941009810010096
93100971009995Sucrose70
97.7593.50100.0098.00100.0099.5095.50
93100981009995
941009810010096Sucrose69
97.8394.00100.0098.00100.0099.0096.00
94100981009996
94100981009996EtOH68
95.5891.0094.5094.00100.0099.0095.00
9195941009995
9194941009995EtOH66
95.5888.5091.5098.50100.0099.5095.50
899210010010096
8891971009995EtOH65
97.2593.00100.0096.50100.0099.0095.00
92100961009894
941009710010096EtOH63
94.0092.0082.0096.50100.0098.0095.50
9482981009996
9082951009795EtOH62
97.8394.00100.0098.00100.0099.0096.00
94100981009996
94100981009996Sucrose61
97.4293.00100.0098.00100.0098.5095.00
93100981009896
93100981009994EtOH60
CpG7CpG6CpG5CpG4CpG3CpG2
Average 
methylation 
(%)
H19 CTCF 1 methylation (%)
TreatmentMale
Appendix K 
Pyrosequencing data 
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70.0666.3372.0069.0076.0070.0067.00
687169777169
667170757067
65746876696563 / EtOH3
59.4758.6759.3353.3365.0064.0056.50
607063816965
61464549??
55625265594863 / EtOH2
71.1167.0073.3369.3376.6772.0068.33
748172867773
697272747270
58676470676263 / EtOH183
76.0875.0076.5076.3380.0072.0076.67
757678817378
757775807276
75?7679717663 /  EtOH5
63.3962.3363.6760.0068.3364.3361.67
636460686463
626360696461
62646068656163 /  EtOH4
78.2875.3378.3376.0083.3379.0077.67
767877847979
747875837977
76797683797763 /  EtOH3
63.6732.0068.3367.3377.0070.0067.33
?6968787168
316767776967
33696776706763 /  EtOH2
68.2865.6767.0068.3372.0069.0067.67
666669726968
656868736968
66676871696763 /  EtOH182
CpG7CpG6CpG5CpG4CpG3CpG2
Average 
methylation 
(%)
H19 CTCF 1 methylation (%)
Sire / TreatmentPupDam
70.2867.6768.0070.3379.3370.0066.33
686871807167
676870796966
68687079706670 / Sucrose190
61.5059.0064.0060.0065.3361.3359.33
616662666262
586459666058
58625964625868 / EtOH6
63.6759.0059.6762.0070.0068.0063.33
606062716564
606162706463
57586269756368 / EtOH5
77.3372.6773.6771.6798.0075.0073.00
737372997773
737373987574
72757097737268 / EtOH4
66.1161.6765.6766.3373.0065.3364.67
636767736766
606766756264
62636671676468 / EtOH3
64.0060.0065.0062.0072.0064.3360.67
6165?726561
606563726360
59656172656168 / EtOH2
72.7870.6771.3372.0081.6771.6769.33
707272827270
717172837169
71717280726968 / EtOH189
80.0674.3380.0078.0095.0077.0076.00
748277957677
757979947775
7479789678?66 / EtOH187
64.3962.3363.6763.3368.6764.6763.67
646364716565
596363666463
64656369656363 / EtOH5
66.2463.1470.5764.7171.1463.5764.29
616564686363
606862696564
606764726564
627367745966
668566716465
666865716564
67686573646463 / EtOH4
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88.0084.0086.0086.3399.3386.6785.67
8587871008786
8486861008685
83858698878672 / Sucrose2
68.1764.6769.3365.6775.0066.0068.33
737268827073
627469756967
59626068596572 / Sucrose1100
79.8380.3379.6781.6791.0076.3370.00
818082927671
817982907670
79808191776974 / Sucrose6
75.1171.6774.0075.0081.0074.3374.67
737576827477
717475807474
71737481757374 / Sucrose5
72.8969.6772.6771.0079.0073.6771.33
717271807472
697271787470
69747179737274 / Sucrose4
69.3963.6770.0070.6775.3369.0067.67
677173777069
617170746967
63686975686774 / Sucrose3
75.0073.0072.3375.6779.3375.6774.00
747276807675
747276807573
71737578767474 / Sucrose2
66.2864.0066.6766.3371.6765.3363.67
646866716563
636866736563
65646771666574 / Sucrose198
82.2876.6783.3382.3389.0082.0080.33
818484918383
738479868179
76828490827972 / Sucrose3
84.5080.3385.3384.3388.0085.3383.67
828585898684
798684888584
80858487858372 / Sucrose2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
77.8373.3379.3376.6782.3379.0076.33
757977837978
728076827976
73797782797572 / Sucrose195
79.3174.5081.0080.0085.3380.3374.67
758181868076
748179858074
?818085817471 / Sucrose5
80.5078.3373.6780.3387.3384.0079.33
797480898378
787381858481
78748088857971 / Sucrose4
75.2273.3377.6772.0081.0074.6772.67
747873827573
737772807472
73787181757371 / Sucrose3
63.6159.6767.6762.3366.3363.6762.00
626863656463
596863686362
58676166646171 / Sucrose2
71.5668.3370.0070.0080.3371.3369.33
697071807171
687072817169
68706780726871 / Sucrose191
76.1174.0078.3366.0081.6778.3378.33
747965837979
747966817878
74776781787870 / Sucrose6
64.5661.0065.0064.3367.0066.3363.67
626665696765
616465666663
60656366666370 / Sucrose5
76.0874.6776.5073.0086.0075.3371.00
767774877672
747673867470
74?7285767170 / Sucrose4
71.6768.0072.3371.3377.6771.3369.33
687372787171
677270787168
69727277726970 / Sucrose3
74.1766.6774.6768.3380.3377.0078.00
697565817674
657371767780
66766984788070 / Sucrose2
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79.0676.0081.3380.0081.3376.0079.67
788280827681
788180827679
72818080767972 / Sucrose9
93.3988.6795.3391.33100.0094.0091.00
9096931009492
8896931009391
889488100959072 / Sucrose8
88.9490.6793.3364.33100.0096.0089.33
9095641009690
9192651009689
919364100968972 / Sucrose7
79.7275.6777.6776.6786.3382.6779.33
767777888281
767777868379
75797685837872 / Sucrose6
68.8958.6769.0068.0074.6772.0071.00
586968757171
58?70757271
60696674737172 / Sucrose5
71.5668.0069.6771.0082.6770.3367.67
687071837168
696972847068
67707081706772 / Sucrose4
66.0064.0067.0064.0072.0066.0063.00
646264726664
647765736663
?626371666272 / Sucrose3
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 80.0780.6782.0076.6778.3382.67
8483778187
7881797980
80*10074758163 / EtOH4
62.20100.00100.0025.0044.3341.67
100100294356
100100*523240
10010021582963 / EtOH3
48.33100.00100.005.6720.0016.00
??623?
10010081714
1001003?1863 / EtOH2
64.07100.00100.0016.3364.0040.00
100100205330
100100156114
10010014787663 / EtOH183
84.1383.0085.0083.6783.3385.67
8488838387
8282858585
838583828563 /  EtOH5
72.9374.0073.0072.0072.0073.67
7373707272
7575757476
747171707363 /  EtOH4
89.3389.6794.6785.0085.0092.33
90100??96
9091868791
899384839063 /  EtOH3
83.6783.6792.3378.0080.3384.00
87100728383
8390828184
818780778563 /  EtOH2
79.2780.6780.6777.3378.0079.67
7981767879
8281807981
818076777963 /  EtOH182
CpG15CpG14CpG13CpG12CpG11
Average 
methylation (%)
H19 CTCF 2 methylation (%)
Sire / TreamnetPupDam
78.6080.0079.0077.0076.6780.33
7880747779
8081807880
827677758270 / Sucrose3
79.8082.3389.0070.6777.0080.00
8292697779
8388747882
828769767970 / Sucrose2
81.2781.0082.0080.3380.6782.33
8082808083
8284828284
818079808070 / Sucrose190
76.8779.3382.0075.0072.0076.00
8589746266
7780797982
767772758068 / EtOH6
70.0069.3357.3374.0072.6776.67
8077737376
7976767278
491973737668 / EtOH5
83.8783.6794.3380.6779.3381.33
7992788085
8691808078
8610084788168 / EtOH4
77.1377.0078.3376.3374.6779.33
7880767579
7980797581
747574747868 / EtOH3
74.1372.6783.6770.0070.3374.00
7073677075
7678737275
7210070697268 / EtOH2
79.2079.3378.6777.3378.0082.67
8078767882
8081807984
787776778268 / EtOH189
74.9081.0074.5072.3371.3375.33
7878757772
7071716867
95?71698766 / EtOH187
78.7379.6779.3378.0076.3380.33
7778767779
8183827677
817776768563 / EtOH5
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 88.5396.0098.6787.6791.0069.33
96100909271
9699879267
969786897072 / Sucrose2
86.7387.3386.6785.6785.0089.00
8991868689
8786868590
868385848872 / Sucrose195
87.6788.3387.6786.6786.0089.67
8889878689
8888878790
898686859071 / Sucrose5
91.6788.0095.0090.3390.6794.33
8994909093
8797919295
889490909571 / Sucrose4
83.6086.3386.6784.0076.6784.33
8689838186
8887858184
8584*61688371 / Sucrose3
78.8077.6777.6778.6777.3382.67
7878787880
8079817986
757677758271 / Sucrose2
80.2081.0083.6775.3378.6782.33
8085768084
8183757982
828375778171 / Sucrose191
83.4085.3379.0085.6784.3382.67
8480848583
8679888583
867885838270 / Sucrose6
75.0773.6773.0078.6773.6776.33
7373787476
7575817576
737177727770 / Sucrose5
87.2087.6792.3384.0084.0088.00
8693848486
9094858589
879083838970 / Sucrose4
75.3374.0080.6772.6773.3376.00
7482737677
7380747275
758071727672 / Sucrose3
90.2791.00100.0083.6787.3389.33
90100899094
92100798586
9110083878872 / Sucrose2
83.30100.00100.0072.0073.5071.00
100100776171
100100???
1001006786?72 / Sucrose1100
81.9378.0090.0079.6780.0082.00
7690808182
8092808082
788879798274 / Sucrose6
83.1389.6781.6780.3379.6784.33
9182768085
8982838083
898182798574 / Sucrose5
79.2784.6777.3377.6775.6781.00
7778777583
7778787680
1007678768074 / Sucrose4
79.8778.6788.3376.0074.0082.33
7983777483
7884767482
799875748274 / Sucrose3
85.2087.3390.0085.6778.6784.33
8691868186
8792857883
898786778474 / Sucrose2
77.7384.6776.3375.6773.6778.33
7879747477
7677787679
1007375717974 / Sucrose198
89.6089.3387.6789.6787.6793.67
9188888893
8987918893
888890879572 / Sucrose3
- A p p e n d i c e s -  
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87.4788.0094.0079.6788.6787.00
8797828989
8990818987
889576888572 / Sucrose9
94.4798.6788.6794.6793.0097.33
10087959497
9991949396
978895929972 / Sucrose8
95.20100.00100.0089.3393.0093.67
100100889295
100100869391
10010094949572 / Sucrose7
86.6088.0088.6787.0081.6787.67
8983888290
8783878287
8810086818672 / Sucrose6
78.0776.3377.3376.0076.0084.67
7677767785
7678777685
777775758472 / Sucrose5
82.2785.6783.0079.3379.6783.67
8386808184
8683798084
888079788372 / Sucrose4
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 88.07100.0075.50100.0079.0072.5089.50100.00
10075100787089100
10076100807590100Sucrose74
80.93100.0060.00100.0067.5070.0083.5085.50
1005410065718491
1006610070698380Sucrose73
92.00100.0072.00100.0072.00100.00100.00100.00
1007210072100100100Sucrose72
88.50100.0080.5099.0078.0077.0094.5090.50
100809880769890
1008110076789191Sucrose71
88.14100.0078.5098.5079.5079.5089.5091.50
100819983809092
100769876798991Sucrose70
74.50100.0075.00100.0065.0035.0052.0094.50
1007610064355389
10074100663551100Sucrose69
82.43100.0078.50100.0080.0076.5052.5089.50
1007810080755487
1007910080785192EtOH68
88.4399.5076.00100.0078.5079.0089.0097.00
997610078818594
10076100797793100EtOH66
85.43100.0062.00100.0078.0076.5091.5090.00
1006310080769180
10061100767792100EtOH65
92.4397.0089.5097.5090.0076.0097.00100.00
100100971007598100
947998807796100EtOH63
81.8698.0073.00100.00100.0034.0091.0077.00
9873100100349177EtOH62
88.07100.0077.50100.0078.5077.0091.5092.00
1007610080789393
1007910077769091Sucrose61
84.9397.0074.00100.0076.0072.0087.5088.00
947610074728992
1007210078728684EtOH60
CpG26CpG25CpG24CpG23CpG22CpG21CpG20
Average 
methylation (%)
Rasgrf1 CTCF methylation (%)
TreatmentMale
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75.0788.5064.5092.0060.0060.0080.5080.00
88629051548179
8967946966808168 / EtOH5
76.9391.5059.5089.5063.0060.5099.0075.50
87568260559874
96639766661007768 / EtOH4
69.8682.0059.0081.5053.0058.0081.0074.50
85578052577772
7961835459857768 / EtOH3
71.2992.5055.0084.5059.0054.0079.0075.00
90558856507776
9555816258817468 / EtOH2
58.7184.0025.0088.5054.0040.0043.0076.50
1001610060443381
6834774836537268 / EtOH189
60.3691.5023.5098.5050.0035.0046.0078.00
83339736266568
100141006444278866 / EtOH187
65.3682.0054.0085.5051.5053.0065.0066.50
78548848506663
8654835556647063 / EtOH5
40.1455.5010.0064.0032.5030.0046.0043.00
5596931274742
5611593433454463 / EtOH4
64.1477.0052.5074.0055.0051.0069.0070.50
76507251496967
7855765953697463 / EtOH3
73.0790.0059.0088.0063.0059.0077.5075.00
85558756557570
9563897063808063 / EtOH2
73.0088.0052.5092.0061.0053.5081.5082.50
86519559527882
9054896355858363 / EtOH183
73.9395.0061.0090.0054.5063.0081.0073.00
95608446588264
9562966368808263 /  EtOH5
69.1489.5050.0087.0054.0053.0072.0078.50
90488353527176
8952915554738163 /  EtOH4
*no data available*
63 /  EtOH3
80.1493.0063.5097.0066.5062.0092.5086.50
86639865609288
10064966864938563 /  EtOH2
65.36100.0035.5093.0043.5046.0055.0084.50
100339345445582
10038934248558763 /  EtOH182
CpG26CpG25CpG24CpG23CpG22CpG21CpG20
Average 
methylation (%)
Rasgrf1 CTCF methylation (%)
Sire / TreatmentPupDam
74.4394.5061.0082.5064.0060.5077.0081.50
93628563637581
9660806558798272 / Sucrose3
69.2998.0048.0086.5053.5056.0070.0073.00
96608460587777
10036894754636972 / Sucrose2
64.0797.5033.5088.5048.0040.5065.0075.50
100348853406573
9533894341657872 / Sucrose195
62.50100.0028.5094.0061.5050.0034.0069.50
100358856514063
100221006749287671 / Sucrose5
78.5098.0059.0096.0061.0058.0097.0080.50
??????84
9859966158977771 / Sucrose4
78.0097.5061.0095.5064.5064.0081.5082.00
100579559618082
9565967067838271 / Sucrose3
68.0793.0041.50100.0055.0040.5070.5076.00
974210054397073
89411005642717971 / Sucrose2
74.5097.5056.0088.0063.5058.0084.0074.50
100537961538167
9559976663878271 / Sucrose191
57.4387.5049.0060.0043.5035.5056.5070.00
82475140354974
9351694736646670 / Sucrose6
50.5087.5039.0044.0056.5023.5027.5075.50
84324458212675
9146445526297670 / Sucrose5
58.2176.0050.0069.0050.5047.5057.0057.50
74497147455758
7851675450575770 / Sucrose4
73.7190.0056.0091.0062.5059.0078.5079.00
85608862578582
9552946361727670 / Sucrose3
63.7196.5044.0085.5056.0045.0058.0061.00
94428954425663
9946825848605970 / Sucrose2
39.9348.0027.0058.5029.0025.5044.5047.00
47295728234446
4925603028454870 / Sucrose190
72.7193.0059.5084.5051.5060.0081.5079.00
87569034568377
9963796964808168 / EtOH6
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 33.7978.5025.5030.5023.0018.508.5052.00
81202716131756
763134302404872 / Sucrose9
72.2155.5060.0089.0070.5065.5084.5080.50
47659673718487
6455826860857472 / Sucrose8
71.9386.0055.5086.5062.5060.0083.0070.00
89638763668280
8348866254846072 / Sucrose7
60.9378.0046.5073.5043.0059.0064.5062.00
77456944586661
7948784260636372 / Sucrose6
73.2194.0048.0093.5061.5056.0076.5083.00
1004710065597888
8849875853757872 / Sucrose5
72.93100.0040.00100.0066.5055.0063.0086.00
1003910064546285
100411006956648772 / Sucrose4
68.7990.0052.0080.5056.5055.5071.5075.50
94528054547274
8652815957717772 / Sucrose3
43.57100.0011.0078.509.0012.5014.5079.50
10010779131579
1001280912148072 / Sucrose2
66.7186.5052.0085.0053.5048.0071.0071.00
84518453476871
8953865449747172 / Sucrose1100
64.0092.0051.0075.0051.0053.5059.0066.50
89517446515769
9551765656616474 / Sucrose6
73.2191.5057.0090.0057.0059.0080.0078.00
88579053558278
9557906163787874 / Sucrose5
64.9384.5049.5075.5048.5058.0064.0074.50
81517247576279
8848795059667074 / Sucrose4
68.3685.5046.5082.0058.5051.0077.5077.50
83447759498077
8849875853757874 / Sucrose3
75.7189.5056.5086.5064.0061.5096.5075.50
89549065619574
9059836362987774 / Sucrose2
72.2994.5057.0082.5057.0063.5079.5072.00
95648362657573
9450825262847174 / Sucrose198
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2.290.002.001.501.505.004.002.00
0400750
0033334
Sucrose74
6.076.5012.002.673.677.677.003.00
??54984
81305883
51132652
Sucrose73
4.934.009.005.502.504.506.502.50
?952572
4963463
Sucrose72
3.932.002.503.333.006.336.673.67
??5512149
0222220
4332542
Sucrose71
3.483.671.672.001.675.335.334.67
8560548
3000320
00058106
Sucrose70
21.3315.3383.671.338.6715.3312.6712.33
1386012171218
2085010221811
138044788
Sucrose69
1.791.005.500.001.002.502.500.00
2202220
0900330
EtOH68
4.313.507.671.332.336.006.672.67
?823794
4822552
3702662
EtOH66
3.572.002.331.331.336.679.671.67
0000653
?3227122
44227120
EtOH65
2.435.000.000.000.006.005.001.00
8000970
2000332
EtOH63
2.713.672.331.671.334.003.672.33
4504655
3220320
4030342
EtOH62
2.140.002.002.500.002.505.003.00
0450530
0000076
Sucrose61
2.930.004.500.001.504.505.005.00
?403455
0500555
EtOH60
CpG12CpG11CpG10CpG9CpG8CpG7CpG6
Average 
methylation (%)
Snrpn methylation (%)
TreatmentMale
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64.5065.0070.0060.5048.0084.0064.0060.00
66696150836459
68 / EtOH1
64716046856461
89
62.5752.0066.5064.5044.0082.0070.5058.50
50656945817058
66 / EtOH1
54686043837159
87
58.2156.5059.5055.5049.5071.0060.0055.50
55595651696056
63 / EtOH5
58605548736055
65.2960.5068.5066.5053.5082.0064.5061.50
58676753876460
63706654776563
63 / EtOH4
66.3665.0070.0063.5051.5082.0068.0064.50
66706553816864
64706250836865
63 / EtOH3
60.1458.5062.5059.5051.0070.5060.0059.00
57635753696159
60626249725959
63 / EtOH2
64.2961.0070.0062.0048.0081.5067.0060.50
60716350816761
62696146826760
63 / EtOH183
67.1466.5065.5067.5057.5078.5069.0065.50
67656759787065
66666856796866
63 /  EtOH5
63.0060.5069.0059.5047.0082.0063.5059.50
60696048816459
61695946836360
63 /  EtOH4
65.2161.5071.0062.5051.0082.0064.0064.50
62716252836465
61716350816464
63 /  EtOH3
67.0062.5072.0067.5051.0084.0071.0061.00
61726852837161
64726750857161
63 /  EtOH2
62.4362.5065.0061.5054.5071.5062.0060.00
62656055706259
63656354736261
63 /  EtOH182
CpG12CpG11CpG10CpG9CpG8CpG7CpG6
Average 
methylation (%)
Snrpn methylation (%)
Sire / TreatmentPupDam
45.5736.0039.5042.0030.5069.5055.5046.00
37424031625440
35374430775752
71 / Sucrose4
44.3634.5038.5035.0037.5067.0049.0049.00
38363533645249
31413542704649
71 / Sucrose3
44.0040.0035.0038.0032.5074.0048.5040.00
42353829734433
38353836755347
71 / Sucrose2
60.2960.0061.5060.5051.5071.0061.5056.00
59616053696155
61626150736257
71 / Sucrose191
56.3655.0058.0060.0050.5064.5054.5052.00
55586251645551
55585850655453
70 / Sucrose6
59.4361.5062.0055.5051.5068.0062.0055.50
61615653686255
62635550686256
70 / Sucrose5
57.1455.5055.0057.5052.5064.5058.0057.00
55535854645856
56575751655858
70 / Sucrose4
62.9362.0062.5063.0051.5079.5063.5058.50
61626254706358
63636449896459
70 / Sucrose3
62.5764.5064.5065.5058.0072.0057.5056.00
64646559725756
65656657725856
70 / Sucrose2
59.7158.5061.5059.5050.5067.5061.5059.00
58605851676157
59636150686261
70 / Sucrose190
63.5763.0061.5064.5052.0075.5062.5066.00
62606552756264
64636452766368
68 / EtOH6
54.7154.0056.0055.0047.5066.0053.0051.50
52565248645451
56565847685252
68 / EtOH5
68.0768.5068.5062.5064.0077.0071.0065.00
68676366767163
69706262787167
68 / EtOH4
56.4356.0057.0057.0045.0069.0056.0055.00
56575745695655
68 / EtOH3
69.2974.5078.5060.0035.00100.0072.5064.50
607356371007162
898464331007467
68 / EtOH2
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 71.8665.5072.5070.0070.5080.0074.0070.50
63726968797470
68737173817471
72 / Sucrose5
59.8656.0061.0058.5053.0071.0060.5059.00
55605852706058
57625954726160
72 / Sucrose4
55.9354.0057.5056.0051.5061.5058.0053.00
54585551625753
54575752615953
72 / Sucrose3
67.3666.5066.5070.0064.5076.0065.5062.50
65666866736661
68677263796564
72 / Sucrose2
56.1454.0056.5055.5050.5063.0057.5056.00
54565550635655
54575651635957
72 / Sucrose1100
74.7967.0072.5067.0064.00100.0076.5076.50
667065631007675
687569651007778
74 / Sucrose6
67.0762.5067.5063.0058.5083.5065.5069.00
62676358806469
63686359876769
74 / Sucrose5
61.9357.5062.5060.5055.0073.0065.0060.00
56605854736459
59656356736661
74 / Sucrose4
48.2140.0042.0046.0036.0076.5052.5044.50
39454434825141
41394838715448
74 / Sucrose3
55.0046.0045.5050.0053.0080.5056.5053.50
49444955816354
43475151805053
74 / Sucrose2
57.0056.0058.0056.0050.0066.5056.5056.00
56575749675657
98
56595551665755
74 / Sucrose1
61.3662.5061.0058.0054.0069.5063.5061.00
62615656686459
63616052716363
72 / Sucrose3
54.7950.0051.0049.0044.0073.0057.0059.50
51514946735957
49514942735562
72 / Sucrose2
59.5756.5063.0054.5048.0074.5062.5058.00
56645651716358
95
57625345786258
72 / Sucrose1
69.3670.0069.5068.0061.0078.5071.5067.00
70696964777266
70706758807168
71 / Sucrose5
83.7175.0081.5084.0077.0096.0087.0085.50
75828477978786
75818477958785
72 / Sucrose9
65.4367.0067.5062.5061.5067.5065.5066.50
67666261676566
67696362686667
72 / Sucrose8
69.4365.5067.0067.0066.0081.0070.5069.00
65666566816969
66686966817269
72 / Sucrose7
67.6461.5064.5071.0064.5078.0073.0061.00
61637165797261
62667164777461
72 / Sucrose6
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Appendix L 
Multilevel regression results 
 
Region specific analyses 
Period: day 30-39 
 
Mixed-effects REML regression                   Number of obs      =        69 
 
----------------------------------------------------------- 
                |   No. of       Observations per Group 
 Group Variable |   Groups    Minimum    Average    Maximum 
----------------+------------------------------------------ 
            mse |       35          1        2.0          2 
           sire |       35          1        2.0          2 
----------------------------------------------------------- 
 
                                                Wald chi2(8)       =     17.08 
Log restricted-likelihood = -162.09873          Prob > chi2        =    0.0293 
 
------------------------------------------------------------------------------ 
      weight |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
_Itreatmen~1 |  -1.209851   1.123593    -1.08   0.282    -3.412053    .9923515 
     _Isex_1 |  -2.426736   .7321241    -3.31   0.001    -3.861672   -.9917988 
       ctcf1 |  -.0189967   .0622948    -0.30   0.760    -.1410923    .1030988 
       ctcf2 |   .0207945   .0511226     0.41   0.684     -.079404     .120993 
     rasgrf1 |   .0173602   .0340929     0.51   0.611    -.0494605     .084181 
       snrpn |   .0318729   .0559211     0.57   0.569    -.0777305    .1414762 
       _cons |   14.58672   5.802733     2.51   0.012     3.213575    25.95987 
------------------------------------------------------------------------------ 
 
Period: day 40 - 63 
 
Mixed-effects REML regression                   Number of obs      =       136 
 
----------------------------------------------------------- 
                |   No. of       Observations per Group 
 Group Variable |   Groups    Minimum    Average    Maximum 
----------------+------------------------------------------ 
            mse |       34          4        4.0          4 
           sire |       34          4        4.0          4 
----------------------------------------------------------- 
 
                                                Wald chi2(8)       =    213.54 
Log restricted-likelihood = -265.52104          Prob > chi2        =    0.0000 
 
------------------------------------------------------------------------------ 
      weight |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
_Itreatmen~1 |   -1.00385   .5976475    -1.68   0.093    -2.175217     .167518 
     _Isex_1 |  -4.787918     .38949   -12.29   0.000    -5.551304   -4.024531 
       ctcf1 |  -.0344713   .0350531    -0.98   0.325     -.103174    .0342315 
       ctcf2 |   .0061444   .0273852     0.22   0.822    -.0475296    .0598184 
     rasgrf1 |   .0037344   .0181585     0.21   0.837    -.0318556    .0393244 
       snrpn |   .0239696   .0297308     0.81   0.420    -.0343017     .082241 
       _cons |   25.03098   3.115071     8.04   0.000     18.92555    31.13641 
------------------------------------------------------------------------------ 
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CpG site specific analyses 
Period: day 30-39 
 
 
 
Mixed-effects REML regression                   Number of obs      =        69 
 
----------------------------------------------------------- 
                |   No. of       Observations per Group 
 Group Variable |   Groups    Minimum    Average    Maximum 
----------------+------------------------------------------ 
            mse |       35          1        2.0          2 
           sire |       35          1        2.0          2 
----------------------------------------------------------- 
 
                                                Wald chi2(29)      =     10.49 
Log restricted-likelihood = -186.30781          Prob > chi2        =    0.9994 
 
------------------------------------------------------------------------------ 
      weight |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
_Itreatmen~1 |  -1.286406    4.31192    -0.30   0.765    -9.737613    7.164801 
     _Isex_1 |  -2.593695   2.057701    -1.26   0.207    -6.626715    1.439325 
     h19cpg1 |   .0715712   .7317518     0.10   0.922    -1.362636    1.505778 
     h19cpg2 |   .3732926    .526723     0.71   0.479    -.6590655    1.405651 
     h19cpg3 |   .1110855    .455746     0.24   0.807    -.7821603    1.004331 
     h19cpg4 |  -.1719754    .435407    -0.39   0.693    -1.025357    .6814066 
     h19cpg5 |  -.0279914   .5813911    -0.05   0.962    -1.167497    1.111514 
     h19cpg6 |  -.1930399   .2737113    -0.71   0.481    -.7295042    .3434245 
    h19cpg11 |  -.2568221   .5842693    -0.44   0.660    -1.401969    .8883248 
    h19cpg12 |   .0965403   .4095353     0.24   0.814     -.706134    .8992147 
    h19cpg13 |   .1056471   .2546755     0.41   0.678    -.3935077    .6048019 
    h19cpg14 |  -.0428082   .1928243    -0.22   0.824    -.4207368    .3351203 
    h19cpg15 |  -.0041308   .2520058    -0.02   0.987    -.4980531    .4897915 
rasgrf1cpg20 |  -.0198742   .2197475    -0.09   0.928    -.4505714    .4108229 
rasgrf1cpg21 |   .0746328   .1563451     0.48   0.633    -.2317979    .3810635 
rasgrf1cpg22 |    .212412   .4260954     0.50   0.618    -.6227198    1.047544 
rasgrf1cpg23 |  -.0276157   .1471397    -0.19   0.851    -.3160044    .2607729 
rasgrf1cpg24 |  -.1142225   .2148275    -0.53   0.595    -.5352766    .3068316 
rasgrf1cpg25 |  -.2323963   .2199385    -1.06   0.291    -.6634679    .1986753 
rasgrf1cpg26 |   .0155868   .1944886     0.08   0.936    -.3656039    .3967774 
   snrpncpg6 |   .2999133    .543293     0.55   0.581    -.7649214    1.364748 
   snrpncpg7 |  -.1634216    .581732    -0.28   0.779    -1.303595    .9767522 
   snrpncpg8 |   .0685574   .2668933     0.26   0.797    -.4545438    .5916586 
   snrpncpg9 |  -.2433805   .2883526    -0.84   0.399    -.8085413    .3217803 
  snrpncpg10 |  -.3055619   .4257494    -0.72   0.473    -1.140015    .5288915 
  snrpncpg11 |  -.4103058    .637474    -0.64   0.520    -1.659732    .8391202 
  snrpncpg12 |   .7258726   .7165462     1.01   0.311    -.6785323    2.130277 
       _cons |   23.07388   39.27387     0.59   0.557    -53.90149    100.0493 
------------------------------------------------------------------------------ 
 
 
 
Period: day 40-63 
 
 
 
Mixed-effects REML regression                   Number of obs      =       559 
 
----------------------------------------------------------- 
                |   No. of       Observations per Group 
 Group Variable |   Groups    Minimum    Average    Maximum 
----------------+------------------------------------------ 
            mse |       35         15       16.0         16 
           sire |       35         15       16.0         16 
----------------------------------------------------------- 
 
                                                Wald chi2(29)      =      2.24 
Log restricted-likelihood = -1668.4292          Prob > chi2        =    1.0000 
 
------------------------------------------------------------------------------ 
      weight |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
_Itreatmen~1 |  -.9821916   3.433995    -0.29   0.775    -7.712698    5.748315 
     _Isex_1 |  -.6568974   1.642706    -0.40   0.689    -3.876541    2.562746 
     h19cpg1 |    .122442   .5808451     0.21   0.833    -1.015993    1.260877 
     h19cpg2 |   .1463721   .4158907     0.35   0.725    -.6687587    .9615028 
     h19cpg3 |   .1110418   .3626125     0.31   0.759    -.5996655    .8217492 
     h19cpg4 |   -.189572   .3457058    -0.55   0.583     -.867143     .487999 
     h19cpg5 |  -.1106162   .4635065    -0.24   0.811    -1.019072    .7978398 
     h19cpg6 |  -.0951105   .2185617    -0.44   0.663    -.5234836    .3332625 
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    h19cpg11 |  -.1368006   .4663982    -0.29   0.769    -1.050924     .777323 
    h19cpg12 |   .1089556   .3270006     0.33   0.739    -.5319538    .7498649 
    h19cpg13 |   .0325164   .2026719     0.16   0.873    -.3647132    .4297459 
    h19cpg14 |    .013797   .1538475     0.09   0.929    -.2877386    .3153325 
    h19cpg15 |  -.0304492   .2010716    -0.15   0.880    -.4245423     .363644 
rasgrf1cpg20 |    .030434   .1751112     0.17   0.862    -.3127777    .3736456 
rasgrf1cpg21 |   .0128896   .1236685     0.10   0.917    -.2294962    .2552754 
rasgrf1cpg22 |   .1854026   .3389164     0.55   0.584    -.4788614    .8496666 
rasgrf1cpg23 |  -.0443129   .1165129    -0.38   0.704    -.2726739    .1840481 
rasgrf1cpg24 |  -.0783701   .1715434    -0.46   0.648    -.4145889    .2578487 
rasgrf1cpg25 |  -.1310222   .1755458    -0.75   0.455    -.4750856    .2130413 
rasgrf1cpg26 |  -.0139374   .1553025    -0.09   0.928    -.3183248      .29045 
   snrpncpg6 |   .1915629   .4336135     0.44   0.659    -.6583039     1.04143 
   snrpncpg7 |  -.1143765   .4602383    -0.25   0.804    -1.016427     .787674 
   snrpncpg8 |   .0780861   .2130066     0.37   0.714    -.3393991    .4955713 
   snrpncpg9 |  -.1254523    .230242    -0.54   0.586    -.5767183    .3258138 
  snrpncpg10 |  -.1968681   .3399688    -0.58   0.563    -.8631947    .4694585 
  snrpncpg11 |  -.2664288   .5089723    -0.52   0.601    -1.263996    .7311385 
  snrpncpg12 |   .4346117   .5714447     0.76   0.447    -.6853992    1.554623 
       _cons |   13.83798    31.3347     0.44   0.659    -47.57691    75.25287 
------------------------------------------------------------------------------
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100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100.00%1074
100%100%100%100%100%100%100%90%100%100%100%100%100%100%100%90%98.76%1073
100%100%100%90%90%100%100%90%100%100%90%90%100%100%100%100%96.79%1072
100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100.00%371
100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100.00%270
100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100.00%569
100%100%100%100%100%100%100%100%100%100%80%100%100%80%83%100%96.27%661
Sucrose
100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100.00%568
92%100%100%100%100%100%100%92%100%100%64%100%100%100%100%100%96.90%1266
100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100.00%1065
100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100.00%1363
100%83%100%100%100%67%100%100%100%100%67%100%100%100%100%100%94.82%662
* unable to 
obtain data *60
EtOH
16151413121110987654321
CTCF binding site # 2CTCF binding site # 1
Avg. methylation per site
Avg. 
methylation of 
sample
No. clones 
analysed
MaleTreatment
Appendix M 
Clone data of sperm samples 
 
H19 ICR 
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* unable to obtain data *74
100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100.00%773
100%63%100%100%100%88%100%100%100%100%100%100%100%100%100%100%100%100%100%100%88%100%100%75%100%100%100%88%100%100%100%96.74%872
100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%50%63%100%100%100%100%100%63%100%100%100%100%100%95.96%871
* unable to obtain data *70
* unable to obtain data *69
* unable to obtain data *61
Sucrose
100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%60%80%100%100%100%100%100%80%100%100%100%100%100%97.36%568
100%89%100%100%100%100%100%100%89%100%100%89%67%100%78%100%100%100%100%100%100%100%100%100%89%100%100%100%100%100%100%96.78%966
100%100%100%100%100%100%100%100%100%100%100%100%100%0%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%96.78%465
100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%50%100%100%100%98.30%463
100%100%100%100%100%100%100%100%100%100%100%100%100%100%83%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%99.45%662
* unable to obtain data *60
EtOH
31302928272625242322212019181716151413121110987654321
Avg. methylation per site
Avg. 
methylation 
of sample
No. 
clones 
analysed
MaleTreatment
IG-DMR 
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100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%474
100.00%87.50%100.00%100.00%87.50%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%87.50%100.00%100.00%100.00%87.50%100.00%100.00%87.50%100.00%100.00%100.00%87.50%100.00%87.50%96.98%873
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%60.00%100.00%100.00%98.60%572
83.30%83.30%83.30%83.30%100.00%100.00%83.30%100.00%100.00%100.00%100.00%100.00%100.00%83.30%100.00%100.00%100.00%83.30%83.30%83.30%100.00%100.00%80.00%100.00%100.00%100.00%100.00%100.00%100.00%88.72%671
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%80.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%99.32%570
100.00%50.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%98.27%669
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%83.30%50.00%100.00%100.00%100.00%100.00%100.00%100.00%97.72%661
Sucrose
100.00%87.50%87.50%100.00%100.00%100.00%100.00%87.50%87.50%100.00%75.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%87.50%100.00%100.00%97.00%868
100.00%90.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%90.00%70.00%100.00%100.00%100.00%90.00%80.00%90.00%100.00%100.00%100.00%100.00%90.00%100.00%100.00%100.00%100.00%100.00%96.56%1066
100.00%100.00%81.80%100.00%81.80%100.00%100.00%100.00%100.00%100.00%100.00%100.00%81.80%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%98.13%1165
100.00%100.00%100.00%100.00%100.00%75.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%0.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%95.53%463
100.00%100.00%100.00%100.00%100.00%100.00%100.00%0.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%96.50%262
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%1060
EtOH
2928272625242322212019181716151413121110987654321
CTCF binding site
Avg. methylation per site
Avg. 
methylation of 
sample
No. 
clones
MaleTreatment
Rasgrf1 ICR 
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0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%25.00%0.00%0.00%0.00%0.01925474
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%273
0.00%0.00%0.00%0.00%0.00%0.00%9.10%9.10%0.00%9.10%0.00%0.00%90.90%0.00%0.00%0.00%9.10%1172
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%25.00%0.00%0.00%1.55%471
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%370
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%669
??0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%361
Sucrose
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%33.30%2.23%368
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%20.00%0.00%0.00%0.00%1.24%566
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%265
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%263
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%362
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%50.00%0.00%0.00%0.00%3.10%260
EtOH
16151413121110987654321
Avg. methylation per siteAvg. 
methylation 
of sample
No. 
clones
MaleTreatment
 
Snrpn ICR 
 
 
 
Regions in grey blocks show CTCF binding regions 
? = no data 
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Appendix N 
Correlation Table 
 
 
Spearman Correlation Coefficients    Key: a p<0.1             
Prob > |r| under H0: Rho=0      ** p<0.05            
Number of Observations      *** p<0.001            
                      
                      
Offspring Weight (g) 
Genetic region 
Growth 
Rate Day2 Day4 Day6 Day8 Day10 Day12 Day14 Day16 Day18 Day20 Day22 Day24 Day26 Day28 Day30 Day35 Day42 Day49 Day56 Day63 
CTCF1 0.0836 0.0085 0.0647 0.0939 -0.0348 0.1138 0.0456 0.1192 0.0756 0.1395 0.1021 0.1159 0.1021 0.0787 0.1631 0.1779 0.3579 0.2853 0.1694 0.2208 0.0810 
CTCF1 0.6329 0.9608 0.7075 0.5859 0.8405 0.5088 0.7919 0.4887 0.6614 0.4171 0.5536 0.5007 0.5536 0.6484 0.3419 0.2993 0.0348 0.0966 0.3306 0.2025 0.6438 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
H19CpG2 0.2708 -0.0883 -0.0160 0.0353 -0.0307 0.0880 0.0703 0.1490 0.1693 0.2099 0.1910 0.2443 0.2222 0.1953 0.3033 0.3765 0.5181 0.4458 0.3152 0.4220 0.2689 
H19CpG2 0.1156 0.6088 0.9263 0.8381 0.8591 0.6099 0.6838 0.3857 0.3237 0.2191 0.2644 0.1511 0.1928 0.2537 0.0721 0.0236 0.0014 0.0073 0.0651 0.0116 0.1183 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
H19CpG3 0.2339 -0.0275 0.0622 0.0976 0.0372 0.1443 0.1124 0.1719 0.1709 0.1914 0.1988 0.2497 0.2292 0.2049 0.3200 0.3716 0.5026 0.4276 0.2932 0.3866 0.2372 
H19CpG3 0.1762 0.8735 0.7185 0.5711 0.8294 0.4013 0.5138 0.3160 0.3190 0.2636 0.2451 0.1420 0.1787 0.2306 0.0571 0.0257 0.0021 0.0104 0.0874 0.0218 0.1701 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
H19CpG4 0.2568 0.0481 0.1474 0.1669 0.1417 0.2302 0.2050 0.2867 0.2907 0.2963 0.3053 0.3333 0.2674 0.2241 0.3560 0.3952 0.5214 0.4563 0.3269 0.4052 0.2693 
H19CpG4 0.1364 0.7806 0.3910 0.3308 0.4096 0.1768 0.2305 0.0900 0.0855 0.0793 0.0702 0.0470 0.1149 0.1889 0.0331 0.0170 0.0013 0.0059 0.0552 0.0158 0.1178 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
H19CpG5 0.1677 0.1068 0.2289 0.2194 0.1138 0.2702 0.1670 0.2729 0.2533 0.2625 0.2866 0.3208 0.2860 0.2491 0.3309 0.3580 0.4748 0.3692 0.2910 0.2756 0.1920 
H19CpG5 0.3357 0.5353 0.1794 0.1986 0.5087 0.1110 0.3304 0.1073 0.1360 0.1220 0.0902 0.0564 0.0908 0.1429 0.0487 0.0320 0.0040 0.0290 0.0899 0.1091 0.2691 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
H19CpG6 0.1684 -0.0813 0.0003 0.0390 -0.0319 0.1217 0.0724 0.1603 0.1662 0.1684 0.1973 0.2587 0.2506 0.2287 0.3047 0.3577 0.4929 0.3519 0.2398 0.3127 0.1712 
H19CpG6 0.3334 0.6375 0.9988 0.8215 0.8533 0.4796 0.6746 0.3503 0.3326 0.3262 0.2488 0.1276 0.1405 0.1797 0.0708 0.0322 0.0026 0.0382 0.1652 0.0674 0.3253 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
H19CpG7 0.1027 0.0567 0.1779 0.1544 0.0885 0.2263 0.1859 0.2838 0.3118 0.3000 0.2757 0.2647 0.2364 0.1881 0.2699 0.2563 0.3862 0.3255 0.1818 0.2312 0.1164 
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H19CpG7 0.5572 0.7425 0.2992 0.3687 0.6080 0.1844 0.2776 0.0935 0.0641 0.0754 0.1037 0.1187 0.1651 0.2719 0.1114 0.1313 0.0219 0.0564 0.2960 0.1815 0.5054 
  35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
CTCF2 0.2723 0.0215 0.1572 0.2003 0.1481 0.2413 0.2814 0.3336 0.3757 0.3583 0.3110 0.3485 0.2744 0.2585 0.3359 0.3828 0.5012 0.3913 0.3351 0.3549 0.2866 
CTCF2 0.1136 0.9010 0.3600 0.2415 0.3885 0.1562 0.0964 0.0468 0.0239 0.0319 0.0649 0.0373 0.1053 0.1280 0.0452 0.0212 0.0022 0.0201 0.0491 0.0364 0.0951 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
H19CpG11 0.2533 0.0327 0.1648 0.1744 0.0551 0.1426 0.1393 0.1642 0.1649 0.1623 0.1523 0.2089 0.1487 0.1708 0.2770 0.3441 0.4699 0.3977 0.3509 0.3540 0.2648 
H19CpG11 0.1420 0.8500 0.3369 0.3089 0.7494 0.4067 0.4179 0.3385 0.3366 0.3444 0.3753 0.2215 0.3868 0.3192 0.1020 0.0399 0.0044 0.0180 0.0388 0.0369 0.1242 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
H19CpG12 0.2840 -0.0684 0.0843 0.1085 0.0528 0.1614 0.1957 0.2133 0.2392 0.2343 0.1957 0.2157 0.1611 0.1784 0.2882 0.3281 0.4506 0.4353 0.3333 0.3743 0.2858 
H19CpG12 0.0983 0.6919 0.6249 0.5286 0.7598 0.3469 0.2527 0.2116 0.1600 0.1690 0.2527 0.2065 0.3478 0.2979 0.0882 0.0507 0.0066 0.0090 0.0504 0.0268 0.0960 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
H19CpG13 0.2129 0.1225 0.2212 0.2453 0.1317 0.2502 0.2607 0.2675 0.3047 0.3286 0.2564 0.2387 0.2078 0.2001 0.2643 0.2897 0.4015 0.3896 0.2740 0.2809 0.2200 
H19CpG13 0.2196 0.4767 0.1948 0.1494 0.4438 0.1411 0.1246 0.1148 0.0708 0.0504 0.1312 0.1610 0.2240 0.2419 0.1193 0.0866 0.0168 0.0207 0.1112 0.1021 0.2041 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
H19CpG14 0.2271 -0.1173 -0.0411 -0.0592 -0.0172 0.0112 -0.0368 0.0823 0.1296 0.0471 0.1703 0.2783 0.2424 0.2924 0.3529 0.4053 0.4005 0.1860 0.2395 0.2326 0.2429 
H19CpG14 0.1896 0.4957 0.8117 0.7317 0.9209 0.9482 0.8312 0.6334 0.4513 0.7848 0.3207 0.1003 0.1543 0.0835 0.0348 0.0142 0.0171 0.2848 0.1659 0.1788 0.1597 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
H19CpG15 0.1373 -0.1169 0.0004 -0.0654 -0.0728 -0.0539 -0.1357 0.0018 0.1129 0.0691 0.1314 0.2104 0.2160 0.2633 0.3198 0.3620 0.3645 0.1807 0.0937 0.1772 0.1376 
H19CpG15 0.4317 0.4972 0.9982 0.7048 0.6731 0.7551 0.4299 0.9917 0.5122 0.6887 0.4448 0.2180 0.2059 0.1208 0.0573 0.0300 0.0313 0.2988 0.5924 0.3086 0.4307 
  35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
Rasgrf1 -0.1867 0.2929 0.3173 0.3936 0.2755 0.2681 0.1880 0.2066 0.1436 0.1674 0.0793 0.1540 0.1730 0.1226 -0.0822 -0.0067 -0.0605 -0.1432 -0.1839 -0.1592 -0.1643 
Rasgrf1 0.2903 0.0877 0.0633 0.0193 0.1091 0.1194 0.2795 0.2337 0.4106 0.3364 0.6507 0.3772 0.3205 0.4830 0.6389 0.9694 0.7338 0.4192 0.2979 0.3684 0.3532 
 34.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 34.0000 34.0000 34.0000 34.0000 34.0000 
Rasgrf1CpG20 -0.0861 0.1143 0.2232 0.1646 0.0941 0.1392 0.0485 0.0791 0.0508 0.1681 0.1248 0.1588 0.1339 0.0894 -0.0494 0.0465 -0.1326 -0.1067 -0.0993 -0.1000 -0.0843 
Rasgrf1CpG20 0.6283 0.5131 0.1975 0.3448 0.5909 0.4252 0.7820 0.6517 0.7722 0.3346 0.4751 0.3622 0.4432 0.6097 0.7780 0.7906 0.4547 0.5479 0.5764 0.5736 0.6356 
 34.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 34.0000 34.0000 34.0000 34.0000 34.0000 
Rasgrf1CpG21 -0.2753 0.3020 0.2591 0.3714 0.2804 0.2998 0.1938 0.2090 0.1753 0.1512 0.0701 0.1511 0.1958 0.1523 -0.0810 -0.0752 -0.1067 -0.2169 -0.2517 -0.2339 -0.2459 
Rasgrf1CpG21 0.1151 0.0779 0.1329 0.0280 0.1028 0.0801 0.2647 0.2282 0.3139 0.3859 0.6889 0.3864 0.2596 0.3824 0.6437 0.6675 0.5481 0.2179 0.1511 0.1831 0.1609 
 34.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 34.0000 34.0000 34.0000 34.0000 34.0000 
Rasgrf1CpG22 -0.1904 0.3417 0.3244 0.4484 0.3223 0.3328 0.2336 0.2566 0.1959 0.1794 0.1200 0.1820 0.2344 0.2013 -0.0325 -0.0269 -0.0314 -0.0698 -0.1888 -0.1699 -0.1669 
Rasgrf1CpG22 0.2807 0.0445 0.0573 0.0069 0.0590 0.0508 0.1769 0.1367 0.2594 0.3025 0.4924 0.2954 0.1754 0.2463 0.8528 0.8780 0.8599 0.6951 0.2849 0.3368 0.3455 
 34.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 34.0000 34.0000 34.0000 34.0000 34.0000 
Rasgrf1CpG23 -0.0399 0.2380 0.2900 0.3301 0.2216 0.1515 0.1127 0.1095 0.0136 0.0781 0.0397 0.1356 0.1423 0.1031 0.0782 0.1579 0.1267 -0.0289 -0.0292 0.0010 -0.0278 
- A p p e n d i c e s -  
 
 
 223
Rasgrf1CpG23 0.8227 0.1687 0.0911 0.0528 0.2008 0.3850 0.5193 0.5314 0.9382 0.6557 0.8207 0.4373 0.4149 0.5557 0.6552 0.3648 0.4752 0.8711 0.8697 0.9955 0.8759 
 34.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 34.0000 34.0000 34.0000 34.0000 34.0000 
Rasgrf1CpG24 -0.0150 0.2894 0.3989 0.4274 0.3088 0.3242 0.2760 0.3284 0.2459 0.3019 0.2494 0.2882 0.2835 0.2372 0.0493 0.1774 0.0424 -0.0844 -0.0677 -0.0766 -0.0026 
Rasgrf1CpG24 0.9330 0.0918 0.0176 0.0104 0.0711 0.0574 0.1086 0.0541 0.1545 0.0779 0.1485 0.0932 0.0989 0.1700 0.7784 0.3080 0.8120 0.6352 0.7035 0.6668 0.9884 
 34.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 34.0000 34.0000 34.0000 34.0000 34.0000 
Rasgrf1CpG25 -0.2584 0.1180 0.1127 0.2313 0.1536 0.1385 0.0832 0.0852 0.0477 0.0093 -0.0700 -0.0095 0.0549 0.0416 -0.1743 -0.1557 -0.1495 -0.1983 -0.2978 -0.2522 -0.2382 
Rasgrf1CpG25 0.1401 0.4995 0.5193 0.1813 0.3783 0.4276 0.6347 0.6265 0.7858 0.9579 0.6894 0.9567 0.7539 0.8123 0.3166 0.3718 0.3988 0.2609 0.0872 0.1501 0.1749 
 34.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 34.0000 34.0000 34.0000 34.0000 34.0000 
Rasgrf1CpG26 0.0729 0.1202 0.3827 0.3560 0.2250 0.3229 0.3391 0.4128 0.3625 0.4265 0.3945 0.3842 0.3476 0.2949 0.2092 0.2599 0.2032 0.1241 0.0308 0.0648 0.0753 
Rasgrf1CpG26 0.6822 0.4914 0.0233 0.0358 0.1938 0.0585 0.0463 0.0137 0.0324 0.0106 0.0190 0.0227 0.0408 0.0854 0.2278 0.1316 0.2491 0.4843 0.8628 0.7157 0.6721 
  34.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 35.0000 34.0000 34.0000 34.0000 34.0000 34.0000 
Snrpn 0.2950 -0.1330 -0.1452 -0.0454 -0.0471 0.0587 -0.0539 0.0075 0.0263 -0.0109 0.1016 0.1639 0.1801 0.2529 0.2241 0.2739 0.3370 0.2762 0.2511 0.3521 0.2815 
Snrpn 0.0854 0.4394 0.3982 0.7925 0.7850 0.7339 0.7548 0.9655 0.8792 0.9495 0.5556 0.3396 0.2933 0.1367 0.1889 0.1060 0.0477 0.1083 0.1457 0.0380 0.1014 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
SnrpnCpG6 0.1711 -0.1395 -0.1165 -0.0508 -0.0441 0.0633 -0.0643 0.0032 0.0446 -0.0081 0.0923 0.1465 0.1437 0.2254 0.1660 0.1794 0.2315 0.1454 0.1262 0.2045 0.1634 
SnrpnCpG6 0.3258 0.4171 0.4987 0.7684 0.7986 0.7139 0.7095 0.9851 0.7963 0.9628 0.5925 0.3940 0.4031 0.1862 0.3331 0.2952 0.1809 0.4046 0.4699 0.2386 0.3484 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
SnrpnCpG7 0.3136 -0.0951 -0.1284 -0.0446 -0.0556 0.0626 -0.0491 0.0043 0.0430 -0.0072 0.0967 0.1675 0.1665 0.2304 0.1779 0.2478 0.3198 0.2689 0.2706 0.3544 0.3050 
SnrpnCpG7 0.0665 0.5811 0.4555 0.7964 0.7473 0.7169 0.7763 0.9804 0.8033 0.9667 0.5747 0.3288 0.3319 0.1764 0.2994 0.1450 0.0611 0.1182 0.1160 0.0367 0.0749 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
SnrpnCpG8 0.0292 0.0703 0.0653 0.1582 0.0345 0.2023 -0.0323 0.0205 -0.0251 -0.0476 0.0461 0.1268 0.2310 0.3008 0.1419 0.1714 0.1004 0.0533 0.0943 0.0782 0.0339 
SnrpnCpG8 0.8679 0.6837 0.7051 0.3567 0.8415 0.2368 0.8518 0.9056 0.8844 0.7827 0.7897 0.4612 0.1752 0.0746 0.4092 0.3175 0.5660 0.7611 0.5902 0.6553 0.8466 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
SnrpnCpG9 0.4005 -0.1136 -0.1144 -0.0619 -0.0722 -0.0066 -0.0223 0.0560 0.0730 0.0761 0.1924 0.2077 0.1581 0.1666 0.3060 0.3153 0.4551 0.4093 0.3827 0.4604 0.3809 
SnrpnCpG9 0.0171 0.5096 0.5065 0.7199 0.6755 0.9696 0.8972 0.7458 0.6723 0.6591 0.2609 0.2243 0.3570 0.3314 0.0695 0.0610 0.0060 0.0146 0.0233 0.0054 0.0240 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
SnrpnCpG10 0.3404 -0.2388 -0.2481 -0.1361 -0.0924 -0.0085 -0.0743 -0.0229 -0.0012 -0.0322 0.0888 0.1853 0.1944 0.2686 0.2583 0.3022 0.3859 0.3303 0.3044 0.4134 0.3234 
SnrpnCpG10 0.0454 0.1607 0.1446 0.4287 0.5921 0.9608 0.6666 0.8944 0.9946 0.8524 0.6067 0.2793 0.2559 0.1132 0.1283 0.0733 0.0220 0.0527 0.0754 0.0136 0.0581 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
SnrpnCpG11 0.2039 -0.2311 -0.2292 -0.1476 -0.1517 -0.0508 -0.1632 -0.1434 -0.1289 -0.1730 -0.0695 0.0113 0.0649 0.1807 0.0924 0.1811 0.1638 0.1759 0.1434 0.2490 0.1853 
SnrpnCpG11 0.2400 0.1751 0.1788 0.3904 0.3770 0.7688 0.3416 0.4042 0.4536 0.3131 0.6871 0.9480 0.7070 0.2915 0.5921 0.2905 0.3471 0.3122 0.4111 0.1492 0.2866 
 35.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 36.0000 35.0000 35.0000 35.0000 35.0000 35.0000 
SnrpnCpG12 0.3316 -0.2072 -0.1935 -0.0748 -0.0427 0.0611 -0.0026 0.0296 0.0255 0.0153 0.1042 0.1584 0.1937 0.2659 0.2584 0.2831 0.3385 0.2932 0.2738 0.3486 0.3185 
- A p p e n d i c e s -  
 
 
 224
SnrpnCpG12 0.0516 0.2254 0.2581 0.6646 0.8049 0.7235 0.9881 0.8638 0.8826 0.9293 0.5454 0.3560 0.2576 0.1170 0.1282 0.0943 0.0467 0.0874 0.1115 0.0402 0.0623 
                                            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- A p p e n d i c e s -  
 
 
 225
Appendix O 
Mediation analyses 
 
Region Day 
Direct 
effect of 
EtOH (g) 
PATHAEST STDERRA PATHBEST STDERRB PATHAB SEAB TSTAT Total 
effect (g) 
           
CTCF1 35 -1.5416 -6.5797 2.1734 -0.0553 0.0224 0.36369 0.19013 1.91289
a -1.90529
H19CpG12 35 -1.75 -4.881 1.9467 -0.0262 0.0102 0.12781 0.07133 1.79178
a -1.87781
H19CpG11 35 -1.3766 -5.6523 1.7507 -0.0179 0.0109 0.1011 0.069288 1.4591 -1.4777
CTCF1 49 -1.0772 -6.5797 2.1734 -0.0472 0.0248 0.31065 0.19297 1.60983 -1.38785
H19CpG13 35 -1.3207 -5.3146 1.8412 -0.0117 0.009 0.062102 0.052256 1.18842 -1.3828
CTCF2 35 -1.2484 -5.4252 2.1327 -0.0151 0.0206 0.081724 0.11651 0.70146 -1.33012
CTCF1 42 -1.1171 -6.5797 2.1734 -0.0273 0.022 0.17957 0.15652 1.1473 -1.29667
CTCF1 30 -0.9527 -6.5797 2.1734 -0.0452 0.0242 0.29742 0.18692 1.59112 -1.25012
H19CpG4 49 -0.9767 -7.9719 2.5353 -0.0169 0.024 0.1345 0.19587 0.68666 -1.1112
H19CpG15 35 -1.2026 -2.2159 2.9757 0.0516 0.0172 -0.11443 0.1583 -0.72286 -1.08817
H19CpG12 49 -0.9185 -4.881 1.9467 -0.0193 0.0158 0.094186 0.085693 1.0991 -1.01269
H19CpG2 49 -0.8526 -5.735 2.3385 -0.0258 0.0312 0.14778 0.18883 0.78264 -1.00038
H19CpG5 49 -0.8524 -6.9471 2.5031 -0.0196 0.027 0.13636 0.19374 0.7038 -0.98876
CTCF2 49 -0.8686 -5.4252 2.1327 -0.0195 0.025 0.10559 0.142 0.74357 -0.97419
H19CpG11 49 -0.8993 -5.6523 1.7507 -0.0129 0.0132 0.072962 0.077993 0.9355 -0.97226
SnrpnCpG9 35 -0.9947 1.6162 2.9376 -0.0192 0.0221 -0.03098 0.066645 -0.4648 -0.96372
H19CpG6 49 -0.8286 -5.8555 2.2447 -0.0212 0.0324 0.12406 0.19553 0.63449 -0.95266
H19CpG14 35 -0.9167 0.3017 3.9271 0.04 0.0163 0.012077 0.15727 0.07679 -0.90462
- A p p e n d i c e s -  
 
 
 226
H19CpG5 35 -0.8845 -6.9471 2.5031 -0.0025 0.0293 0.017534 0.20372 0.086071 -0.90203
H19CpG13 49 -0.8472 -5.3146 1.8412 -0.0081 0.0106 0.043203 0.058421 0.73951 -0.8904
H19CpG7 49 -0.815 -5.6764 2.4144 -0.013 0.019 0.073957 0.11258 0.65692 -0.88896
Rasgrf1CpG24 35 -0.8848 0.1385 3.4798 0.0096 0.0135 0.001328 0.033417 0.039753 -0.88347
SnrpnCpG12 35 -0.8893 0.3908 2.2802 -0.021 0.0209 -0.00819 0.048482 -0.16896 -0.88111
H19CpG11 42 -0.8249 -5.6523 1.7507 -0.0081 0.0109 0.04559 0.063011 0.72352 -0.87049
CTCF1 56 -0.7104 -6.5797 2.1734 -0.0216 0.0295 0.14231 0.19988 0.712 -0.85271
Rasgrf1CpG22 35 -0.8823 3.1981 3.0615 0.0106 0.0137 0.033926 0.054499 0.62251 -0.84837
H19CpG12 42 -0.8004 -4.881 1.9467 -0.0089 0.0131 0.043419 0.066294 0.65494 -0.84382
Rasgrf1 35 -0.8625 2.3071 2.6578 0.0115 0.0164 0.026616 0.048697 0.54657 -0.83588
SnrpnCpG12 42 -0.8333 0.3908 2.2802 0.0176 0.0182 0.006876 0.040739 0.16878 -0.82642
Rasgrf1CpG23 35 -0.8272 -1.4357 2.8161 0.0019 0.0146 -0.00272 0.021659 -0.12572 -0.82448
Rasgrf1CpG26 35 -0.8271 -2.5837 2.1284 0.0024 0.0151 -0.00615 0.039439 -0.15597 -0.82095
H19CpG3 49 -0.7608 -6.0626 2.1291 -0.0094 0.0328 0.056824 0.20009 0.284 -0.81762
H19CpG11 56 -0.7418 -5.6523 1.7507 -0.0125 0.0136 0.070439 0.079651 0.88435 -0.81224
H19CpG13 42 -0.783 -5.3146 1.8412 -0.0046 0.0087 0.024316 0.04719 0.51528 -0.80732
H19CpG4 30 -0.6986 -7.9719 2.5353 -0.0134 0.0273 0.1066 0.21989 0.48481 -0.8052
SnrpnCpG7 35 -0.9554 6.834 2.0319 -0.0227 0.0268 -0.15536 0.18893 -0.8223 -0.80004
Rasgrf1CpG21 35 -0.8985 8.1327 7.9456 0.0124 0.0094 0.10123 0.12515 0.8089 -0.79727
H19CpG7 30 -0.7793 -5.6764 2.4144 -0.0023 0.0207 0.013187 0.11745 0.11228 -0.79249
Rasgrf1CpG25 35 -0.8504 5.9818 2.6455 0.0116 0.0136 0.069473 0.08677 0.80066 -0.78093
SnrpnCpG11 42 -0.8161 3.174 2.6795 0.012 0.0184 0.038097 0.06672 0.571 -0.778
H19CpG2 35 -0.8237 -5.735 2.3385 0.0094 0.0306 -0.05366 0.17672 -0.30364 -0.77004
Rasgrf1CpG20 35 -0.7983 4.6627 2.9813 -0.0074 0.0173 -0.03458 0.083654 -0.41334 -0.76372
H19CpG12 56 -0.6988 -4.881 1.9467 -0.0133 0.0164 0.06492 0.084057 0.77233 -0.76372
SnrpnCpG12 56 -0.7671 0.3908 2.2802 0.0288 0.0225 0.011252 0.066235 0.16988 -0.75585
- A p p e n d i c e s -  
 
 
 227
SnrpnCpG10 42 -0.7675 1.636 2.4809 0.0097 0.0198 0.0159 0.040446 0.39311 -0.7516
Rasgrf1 30 -0.7596 2.3071 2.6578 0.008 0.0172 0.018348 0.045036 0.4074 -0.74125
H19CpG13 56 -0.6969 -5.3146 1.8412 -0.0081 0.0109 0.043257 0.059784 0.72356 -0.74016
SnrpnCpG9 42 -0.7688 1.6162 2.9376 0.0178 0.0195 0.028786 0.061093 0.47119 -0.74001
Rasgrf1CpG23 30 -0.7388 -1.4357 2.8161 0.0013 0.0153 -0.00182 0.022302 -0.08174 -0.73698
H19CpG6 35 -0.8095 -5.8555 2.2447 0.0129 0.0333 -0.07555 0.19709 -0.38331 -0.73395
CTCF2 42 -0.7191 -5.4252 2.1327 -0.0024 0.0207 0.013018 0.11237 0.11585 -0.73212
SnrpnCpG8 35 -0.8042 3.7843 2.5247 -0.0203 0.0218 -0.07673 0.097088 -0.7903 -0.72747
Rasgrf1CpG22 30 -0.734 3.1981 3.0615 -0.002 0.0147 -0.00653 0.047583 -0.13728 -0.72747
Rasgrf1CpG21 30 -0.7352 8.1327 7.9456 -0.0014 0.0098 -0.01113 0.080221 -0.1387 -0.72407
H19CpG5 56 -0.6324 -6.9471 2.5031 -0.0125 0.0309 0.087079 0.21671 0.40183 -0.71948
SnrpnCpG12 49 -0.7063 0.3908 2.2802 0.0014 0.0226 0.000534 0.009354 0.05705 -0.70577
SnrpnCpG11 56 -0.7715 3.174 2.6795 0.0213 0.0212 0.067551 0.088151 0.7663 -0.70395
H19CpG14 42 -0.7043 0.3017 3.9271 0.0222 0.0152 0.006698 0.087307 0.076722 -0.6976
H19CpG14 49 -0.7007 0.3017 3.9271 0.0162 0.019 0.004878 0.063758 0.076516 -0.69582
H19CpG7 56 -0.6309 -5.6764 2.4144 -0.0113 0.0217 0.064006 0.12612 0.50751 -0.69491
SnrpnCpG7 49 -0.6945 6.834 2.0319 -0.0003 0.0288 -0.00199 0.19661 -0.01014 -0.69251
SnrpnCpG8 42 -0.694 3.7843 2.5247 -0.0016 0.0195 -0.00599 0.073802 -0.08113 -0.68801
CTCF2 56 -0.6329 -5.4252 2.1327 -0.0099 0.0258 0.053494 0.14174 0.37742 -0.68639
SnrpnCpG10 56 -0.7264 1.636 2.4809 0.0251 0.0243 0.041103 0.073942 0.55589 -0.6853
H19CpG15 49 -0.7094 -2.2159 2.9757 0.0109 0.0231 -0.02424 0.060693 -0.39942 -0.68516
Snrpn 42 -0.785 6.9352 2.5099 0.0146 0.022 0.10117 0.15713 0.64385 -0.68383
SnrpnCpG9 30 -0.6982 1.6162 2.9376 -0.0105 0.0257 -0.01705 0.051864 -0.32864 -0.68116
SnrpnCpG6 30 -0.7091 7.5643 2.3092 -0.0043 0.0271 -0.0326 0.20513 -0.15894 -0.6765
H19CpG15 42 -0.7242 -2.2159 2.9757 0.0217 0.0186 -0.04798 0.076495 -0.62728 -0.67622
SnrpnCpG10 49 -0.6795 1.636 2.4809 -0.0023 0.0241 -0.0037 0.039906 -0.09277 -0.6758
- A p p e n d i c e s -  
 
 
 228
SnrpnCpG6 42 -0.7652 7.5643 2.3092 0.012 0.021 0.090765 0.16113 0.56331 -0.67444
Rasgrf1CpG24 42 -0.671 0.1385 3.4798 0.0015 0.0129 0.000213 0.005647 0.037753 -0.67079
Rasgrf1CpG23 42 -0.6668 -1.4357 2.8161 -0.0018 0.0141 0.002615 0.020837 0.1255 -0.66941
SnrpnCpG7 42 -0.7521 6.834 2.0319 0.0122 0.024 0.083694 0.16564 0.50527 -0.66841
SnrpnCpG8 49 -0.6853 3.7843 2.5247 -0.0045 0.0236 -0.01694 0.089968 -0.1883 -0.66836
Rasgrf1 42 -0.6707 2.3071 2.6578 0.0023 0.0159 0.005263 0.037143 0.1417 -0.66544
Rasgrf1CpG21 42 -0.6769 8.1327 7.9456 0.0016 0.0087 0.013351 0.072244 0.1848 -0.66355
H19CpG3 35 -0.7767 -6.0626 2.1291 0.019 0.0321 -0.11497 0.19867 -0.57868 -0.66173
Rasgrf1CpG20 42 -0.662 4.6627 2.9813 -0.0004 0.0166 -0.00183 0.077558 -0.0236 -0.66017
Rasgrf1CpG22 42 -0.6654 3.1981 3.0615 -0.0018 0.0126 -0.00568 0.04074 -0.13933 -0.65972
H19CpG7 35 -0.7525 -5.6764 2.4144 0.0166 0.0194 -0.09426 0.11698 -0.80574 -0.65824
SnrpnCpG9 49 -0.6671 1.6162 2.9376 -0.0072 0.0241 -0.01159 0.044284 -0.26176 -0.65551
H19CpG5 42 -0.6729 -6.9471 2.5031 0.0036 0.0248 -0.02476 0.17279 -0.14328 -0.64814
Rasgrf1CpG24 30 -0.6485 0.1385 3.4798 0.0259 0.0112 0.003594 0.090288 0.039809 -0.64491
H19CpG2 30 -0.6999 -5.735 2.3385 0.0097 0.0313 -0.05536 0.18064 -0.30649 -0.64454
Rasgrf1CpG24 49 -0.6398 0.1385 3.4798 0.0021 0.0144 0.000287 0.007488 0.038369 -0.63951
Rasgrf1CpG26 49 -0.6329 -2.5837 2.1284 -0.0015 0.016 0.003806 0.041558 0.091584 -0.63671
Rasgrf1CpG25 42 -0.6496 5.9818 2.6455 -0.0035 0.0126 -0.02103 0.075829 -0.27727 -0.62858
Rasgrf1CpG23 49 -0.6268 -1.4357 2.8161 0.0016 0.0157 -0.00226 0.02295 -0.09847 -0.62454
SnrpnCpG9 56 -0.6527 1.6162 2.9376 0.0268 0.0242 0.043299 0.087909 0.49255 -0.6094
SnrpnCpG6 35 -0.7419 7.5643 2.3092 -0.018 0.0253 -0.13612 0.19559 -0.69596 -0.60578
H19CpG11 30 -0.5546 -5.6523 1.7507 -0.009 0.0161 0.050768 0.092583 0.54834 -0.60537
Snrpn 49 -0.6535 6.9352 2.5099 -0.0071 0.027 -0.04897 0.18837 -0.25998 -0.60453
Rasgrf1CpG26 42 -0.6419 -2.5837 2.1284 0.0153 0.0133 -0.03944 0.047243 -0.83492 -0.60246
H19CpG7 42 -0.6403 -5.6764 2.4144 0.0075 0.0175 -0.04278 0.1009 -0.42401 -0.59752
H19CpG12 30 -0.5425 -4.881 1.9467 -0.0112 0.0194 0.054745 0.097401 0.56206 -0.59725
- A p p e n d i c e s -  
 
 
 229
SnrpnCpG11 49 -0.6198 3.174 2.6795 -0.0072 0.021 -0.0227 0.069288 -0.32755 -0.59711
H19CpG5 30 -0.674 -6.9471 2.5031 0.0117 0.0288 -0.08097 0.20192 -0.40098 -0.59303
Rasgrf1 49 -0.602 2.3071 2.6578 -0.0088 0.0176 -0.02029 0.04693 -0.43235 -0.58171
H19CpG14 30 -0.5908 0.3017 3.9271 0.0327 0.0151 0.009869 0.12853 0.07678 -0.58093
SnrpnCpG6 56 -0.8432 7.5643 2.3092 0.0348 0.0305 0.26316 0.24417 1.07777 -0.58004
SnrpnCpG10 35 -0.6201 1.636 2.4809 -0.0275 0.024 -0.04504 0.078795 -0.57164 -0.57506
H19CpG15 30 -0.6526 -2.2159 2.9757 0.0404 0.0179 -0.08953 0.12663 -0.70701 -0.56307
SnrpnCpG8 30 -0.555 3.7843 2.5247 0.0011 0.0229 0.004109 0.08665 0.047425 -0.55089
H19CpG6 30 -0.5649 -5.8555 2.2447 0.0029 0.0293 -0.01725 0.17163 -0.10053 -0.54765
H19CpG14 56 -0.5529 0.3017 3.9271 0.0252 0.0192 0.007595 0.099021 0.076697 -0.54531
H19CpG13 30 -0.5127 -5.3146 1.8412 -0.0053 0.0129 0.028423 0.069468 0.40916 -0.54112
Rasgrf1CpG20 30 -0.6012 4.6627 2.9813 0.0148 0.0159 0.068836 0.086351 0.79717 -0.53236
H19CpG4 35 -0.7457 -7.9719 2.5353 0.0268 0.0224 -0.21388 0.19079 -1.121 -0.53182
Snrpn 56 -0.6903 6.9352 2.5099 0.0242 0.0274 0.16756 0.19933 0.84063 -0.52274
Rasgrf1CpG21 49 -0.5805 8.1327 7.9456 -0.0073 0.0093 -0.05916 0.094934 -0.62312 -0.52135
H19CpG15 56 -0.5759 -2.2159 2.9757 0.0247 0.0233 -0.05467 0.089805 -0.6088 -0.52123
SnrpnCpG8 56 -0.5307 3.7843 2.5247 -0.0062 0.0241 -0.02353 0.092726 -0.25373 -0.50717
Rasgrf1CpG22 49 -0.5566 3.1981 3.0615 -0.0195 0.0133 -0.06233 0.073237 -0.85103 -0.49427
Rasgrf1CpG26 30 -0.5716 -2.5837 2.1284 0.0366 0.0212 -0.09467 0.095341 -0.99301 -0.47693
Rasgrf1CpG24 56 -0.4757 0.1385 3.4798 0.0018 0.0147 0.000253 0.006667 0.037917 -0.47545
Snrpn 35 -0.6629 6.9352 2.5099 -0.0272 0.0269 -0.18864 0.19854 -0.95016 -0.47426
SnrpnCpG7 56 -0.6803 6.834 2.0319 0.0302 0.029 0.20612 0.20713 0.9951 -0.47418
Rasgrf1CpG20 56 -0.4717 4.6627 2.9813 0.0012 0.0189 0.005675 0.088014 0.064476 -0.46603
Rasgrf1 56 -0.4565 2.3071 2.6578 -0.0033 0.018 -0.00755 0.042449 -0.17786 -0.44895
Rasgrf1CpG25 30 -0.5097 5.9818 2.6455 -0.0106 0.0119 -0.06347 0.076351 -0.83134 -0.44623
Rasgrf1CpG23 56 -0.4546 -1.4357 2.8161 0.0067 0.0159 -0.00964 0.029653 -0.32514 -0.44496
- A p p e n d i c e s -  
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Rasgrf1CpG25 49 -0.5615 5.9818 2.6455 -0.0198 0.013 -0.11856 0.093649 -1.26597 -0.44294
SnrpnCpG6 49 -0.5858 7.5643 2.3092 -0.0196 0.0256 -0.14804 0.19862 -0.74536 -0.43776
H19CpG6 42 -0.5664 -5.8555 2.2447 0.0224 0.0275 -0.13095 0.16848 -0.77723 -0.43545
SnrpnCpG12 30 -0.4321 0.3908 2.2802 -0.0155 0.0216 -0.00604 0.036232 -0.16667 -0.42606
Rasgrf1CpG20 49 -0.4687 4.6627 2.9813 -0.0099 0.0179 -0.046 0.088547 -0.51952 -0.4227
Rasgrf1CpG22 56 -0.4393 3.1981 3.0615 -0.0054 0.0151 -0.01726 0.051065 -0.33793 -0.42204
Rasgrf1CpG26 56 -0.446 -2.5837 2.1284 0.0095 0.0162 -0.0246 0.046554 -0.52851 -0.4214
SnrpnCpG7 30 -0.5168 6.834 2.0319 -0.0148 0.0249 -0.10119 0.17274 -0.5858 -0.41561
Rasgrf1CpG21 56 -0.4186 8.1327 7.9456 -0.0059 0.0099 -0.04829 0.092989 -0.51931 -0.37031
H19CpG2 42 -0.5275 -5.735 2.3385 0.0281 0.0281 -0.16104 0.17387 -0.92622 -0.36646
SnrpnCpG10 30 -0.4017 1.636 2.4809 -0.0224 0.0203 -0.03664 0.064758 -0.56583 -0.36506
Snrpn 30 -0.4626 6.9352 2.5099 -0.0142 0.0261 -0.09873 0.18448 -0.53519 -0.36387
SnrpnCpG11 35 -0.4602 3.174 2.6795 -0.0327 0.02 -0.10371 0.10811 -0.95935 -0.35649
H19CpG2 56 -0.4453 -5.735 2.3385 0.0175 0.033 -0.10008 0.19347 -0.51732 -0.34522
Rasgrf1CpG25 56 -0.4178 5.9818 2.6455 -0.0124 0.0141 -0.07403 0.090478 -0.81816 -0.34377
H19CpG6 56 -0.4376 -5.8555 2.2447 0.0184 0.0343 -0.1077 0.20533 -0.52454 -0.3299
SnrpnCpG11 30 -0.346 3.174 2.6795 -0.0183 0.02 -0.05797 0.080249 -0.72234 -0.28803
CTCF2 30 -0.3194 -5.4252 2.1327 0.0105 0.0305 -0.05723 0.16708 -0.34251 -0.26217
H19CpG4 56 -0.4202 -7.9719 2.5353 0.0213 0.0242 -0.16981 0.2004 -0.84735 -0.25039
H19CpG4 42 -0.4981 -7.9719 2.5353 0.0339 0.0186 -0.27034 0.17111 -1.57994 -0.22776
H19CpG3 56 -0.3657 -6.0626 2.1291 0.0299 0.0334 -0.18129 0.2124 -0.85353 -0.18441
H19CpG3 42 -0.4173 -6.0626 2.1291 0.0452 0.028 -0.27375 0.195 -1.40386 -0.14355
H19CpG3 30 -0.0164 -6.0626 2.1291 0.066 0.0381 -0.40033 0.27053 -1.47978 0.38393
 
ap<0.1 
